{
    "testId": 374827449,
    "parentTestId": null,
    "userId": 4331736,
    "sequenceId": 18,
    "qbankId": 2,
    "isSim": 0,
    "testModeId": 0,
    "testModeName": "Timed",
    "questionModeId": 0,
    "questionModeName": "ALL",
    "testName": "",
    "totalQuestionCorrect": 28,
    "correctToIncorrect": 2,
    "incorrectToCorrect": 4,
    "incorrectToIncorrect": 2,
    "timeInSeconds": 2276,
    "averageTimeSpentInSeconds": 122,
    "otherAverageTimeSpentInSeconds": 62,
    "isStarted": true,
    "isEnded": true,
    "formId": 0,
    "bLockId": 0,
    "subscriptionId": 13863865,
    "lastQuestionVisited": 39,
    "containsMediaQuestion": false,
    "sectionId": 1010,
    "sectionName": "Step 2 Review",
    "difficultyLevelId": null,
    "difficultyLevelName": null,
    "testTypeId": null,
    "testTypeName": null,
    "allottedTime": null,
    "allottedTimeTypeId": null,
    "canResume": null,
    "assignmentId": null,
    "canViewAssignmentResult": null,
    "questionModeIds": "1",
    "testSource": 1,
    "testTypes": "",
    "questionList": [
        {
            "exhibits": null,
            "sequenceId": 1,
            "questionId": 5698,
            "questionIndex": 10754,
            "questionText": "<p>A 17-year-old boy presents to the emergency department for evaluation.&nbsp; The patient shares that he has not been well since his girlfriend ended their relationship last month.&nbsp; He has been unable to complete his schoolwork and is uninterested in playing the sports he previously enjoyed.&nbsp; The patient spends most of his time in his room and has not been eating as much.&nbsp; He says, &#x22;It&#39;s too much effort to even get out of bed.&nbsp; I thought everything was going well, and suddenly she just ended it.&nbsp; I don&#39;t want to see her ever again.&#x22;&nbsp; On further questioning, the patient reports that he has trouble falling asleep and keeps checking his ex-girlfriend&#39;s social media posts to see what she is doing in the evenings.&nbsp; He has thought about hanging himself with a rope his father keeps in the garage and states that he is scared he would act on these thoughts.&nbsp; The patient then says, &#x22;Please don&#39;t tell my parents anything.&nbsp; They don&#39;t believe in getting help for things like this, but I know I need a place that will help me stay safe.&#x22;&nbsp; Which of the following is the most appropriate next step in management?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s anhedonia, amotivation, appetite loss, sleep disturbance, limited energy, and suicidal ideation are consistent with a major depressive disorder causing significant social and academic impairment.&nbsp; In addition, he endorses a <strong>suicide plan with uncertain intent</strong> (&#x22;scared he would act&#x22;), which justifies the need for <strong>inpatient psychiatric hospitalization</strong> for stabilization.</p><p>In general, parental consent is required for the assessment and treatment of minors.&nbsp; However, in most jurisdictions, there is an <strong>exception</strong> that allows <strong>minors age &#8805;17</strong> (age &#8805;16 in some states) to <strong>consent</strong> for themselves to <strong>inpatient psychiatric hospitalization</strong>&nbsp;<strong>(Choices A and D)</strong>.&nbsp; Because this patient has had a significant decline, active suicidal ideation, and is open to inpatient care (&#x22;place that will help me stay safe&#x22;), moving forward with hospitalization is the appropriate next step in management.</p><p>Furthermore, depending on the state, if a minor consents to inpatient psychiatric hospitalization, then confidentiality must be maintained, and <strong>protected health information cannot be released without the minor&#39;s consent (Choice B)</strong>.&nbsp; However, although his request (&#x22;please don&#39;t tell my parents anything&#x22;) should be respected, he should also be encouraged to discuss his condition with them (eg, sharing safety concerns) given the necessary future reliance on the parents for support (eg, post-hospitalization treatment plans, home safeguarding [eg, removing the rope, securing firearms]).</p><p><strong>Educational objective:</strong><br>Minors age &#8805;17 with impairing depressive symptoms and active suicidal ideation should be hospitalized for stabilization.&nbsp; Parental consent is ideal but not required for hospitalization because teenagers can legally consent for themselves.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 4449,
            "topic": "Suicide",
            "titleId": 4449,
            "title": "Suicide",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "3",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Discuss the need for breaking confidentiality because parental consent must be obtained for the patient to be hospitalized",
                    "choiceNumber": 1,
                    "correctTaken": 1271,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discuss the need for breaking confidentiality because the parents must be informed of the patient&#39;s diagnosis and treatment recommendations",
                    "choiceNumber": 2,
                    "correctTaken": 3119,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Encourage the patient to share safety concerns with his parents, but explain that parental consent is not required for hospitalization",
                    "choiceNumber": 3,
                    "correctTaken": 11424,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inform the parents about the patient&#39;s suicidal thoughts and hospitalize the patient only if the parents provide consent",
                    "choiceNumber": 4,
                    "correctTaken": 530,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1154,1509,true,-1,1*501,675,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": null,
            "questionMedia": null,
            "timeSpent": 91,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 16344,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 70,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 538,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 2,
            "questionId": 4816,
            "questionIndex": 4816,
            "questionText": "<p>A 24-year-old woman comes to the office for a preemployment health evaluation before starting a job at a day care.&nbsp; When asked how she is doing, the patient says, &#x22;I was dating a guy, but he stopped returning my phone calls last week, so I&#39;m feeling pretty low.&nbsp; My mom says that he wasn&#39;t the right match for me and that I can&#39;t rely on men to feel good about myself.&nbsp; I&#39;ve had low self-esteem for as long as I can remember, and my mood has always been down, probably since high school.&#x22;&nbsp; She has had no appetite changes or sleep disturbances.&nbsp; Although the patient dates, she has never had a serious relationship because she believes she is unattractive and does not have much to contribute.&nbsp; The patient describes having a close relationship with her mother, with whom she has been living since graduating from college, and likes watching movies and cooking with her.&nbsp; In review of systems, she indicates intermittent headaches, occasional abdominal bloating and constipation, and fatigue.&nbsp; Vital signs are normal.&nbsp; Physical examination and routine laboratory evaluation show no abnormalities.&nbsp; She has no thoughts of suicide.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T38313\" style=\"overflow-x:auto;\" tid=\"4645\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Persistent depressive disorder (dysthymia)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Chronic depressed mood &#8805;<strong>2 years</strong> (1 year in children/adolescents)</li><li>No symptom-free period for &gt;2 months</li><li>Presence of &#8805;<strong>2</strong> of the following:<ul style=\"list-style-type:circle;\"><li>Poor appetite or overeating</li><li>Insomnia or hypersomnia</li><li>Low energy or fatigue</li><li>Low self-esteem</li><li>Poor concentration or difficulty making decisions</li><li>Feelings of hopelessness</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Specifiers</strong></p></td><td><ul><li>With <strong>pure dysthymic syndrome</strong>: criteria for major depressive episode never met</li><li>With intermittent major depressive episodes</li><li>With persistent major depressive episodes: criteria for major depressive episode met throughout previous 2 years</li></ul></td></tr></tbody></table></div><p>Persistent depressive disorder (PDD) <strong>(dysthymia)</strong> is a chronic, low-grade depression that lasts for years.&nbsp; Diagnosis requires <strong>depressed mood</strong> more days than not for <strong>&#8805;2 years</strong> (1 year in children) and <strong>&#8805;2 additional depressive symptoms</strong>.</p><p>This patient reports chronically low mood since high school (ie, at least 6 years), low self-esteem (eg, believes she is unattractive, does not have much to contribute), and fatigue, thus meeting the criteria for PDD.&nbsp; In addition, PDD can include superimposed major depressive episodes that may be either intermittent or persistent (ie, full major depressive criteria met for last 2 years).&nbsp; If major depressive episodes have not also occurred, PDD is a pure dysthymic syndrome subtype.</p><p>Treatment of PDD with or without a history of a major depressive episode includes antidepressants, psychotherapy, or a combination thereof.</p><p><strong>(Choice A)</strong>&nbsp; Although this patient initially relates feeling low to her recent romantic rejection, her chronic depressive symptoms since high school are more consistent with PDD.&nbsp; Adjustment disorder is not diagnosed if the criteria for another disorder are met.</p><p><strong>(Choice B)</strong>&nbsp; Avoidant personality disorder includes feelings of inadequacy; however, people with avoidant personality disorder avoid social interactions in which rejection or embarrassment may occur.&nbsp; In contrast, this patient demonstrates a willingness to pursue romantic relationships despite the possibility of rejection.</p><p><strong>(Choice C)</strong>&nbsp; Dependent personality disorder involves limited confidence in one&#39;s abilities.&nbsp; However, this leads to a constant and excessive need to be taken care of that is demonstrated by submissive, clinging behaviors to avoid separation, findings not seen in this patient.</p><p><strong>(Choice D)</strong>&nbsp; Significant overlap exists between PDD and a major depressive episode, and they can occur simultaneously.&nbsp; However, this patient does not demonstrate enough symptoms (eg, appetite or sleep issues, anhedonia, suicidal ideation) to fully meet the criteria for a <a href=\"17482\">major depressive episode</a>.</p><p><strong>(Choice F)</strong>&nbsp; Somatic symptoms (eg, fatigue, headache, abdominal concerns) are common in depression.&nbsp; This patient has clear depressive symptoms and is not excessively preoccupied with or seeking treatment for her physical symptoms, making somatic symptom disorder less likely.</p><p><strong>Educational objective:</strong><br>Persistent depressive disorder is characterized by chronic depressed mood and &#8805;2 other depressive symptoms lasting &#8805;2 years.&nbsp; Treatment with antidepressants and/or psychotherapy can improve symptoms and quality of life.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 13780,
            "topic": "Dysthymia",
            "titleId": 13780,
            "title": "Dysthymia",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder with depressed mood",
                    "choiceNumber": 1,
                    "correctTaken": 113,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Avoidant personality disorder",
                    "choiceNumber": 2,
                    "correctTaken": 877,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dependent personality disorder",
                    "choiceNumber": 3,
                    "correctTaken": 1519,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 4,
                    "correctTaken": 25,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Persistent depressive disorder (dysthymia)",
                    "choiceNumber": 5,
                    "correctTaken": 2511,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Somatic symptom disorder",
                    "choiceNumber": 6,
                    "correctTaken": 86,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "156,192,true,-1,1*524,636,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26845258",
                    "mediaDataId": 0,
                    "title": "Course of depression in a 10-year prospective study: evidence for qualitatively distinct subgroups.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26845258",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 123,
            "othersAvgTimeSpent": 89,
            "notes": null,
            "peopleTaken": 5131,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 49,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 2253,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 3,
            "questionId": 14401,
            "questionIndex": 15810,
            "questionText": "<p>A 52-year-old man comes to the office because of increasing fatigue and poor concentration at work over the past month.&nbsp; The patient is a biology professor at a local university. &nbsp;He&nbsp;reports that he has been through a &#x22;tough year&#x22; because his 19-year-old son died of a heroin overdose 6 months ago and his book was recently rejected for publication.&nbsp; He sleeps 12-14 hours a day but does not feel well rested. &nbsp;He&nbsp;is frequently late for his morning office hours because it is difficult for him to get out of bed.&nbsp; He says, &#x22;I&#39;m so distracted at work I forget what I&#39;ve already lectured on and end up repeating myself.&#x22;&nbsp; The patient has stopped exercising and socializing with friends, saying, &#x22;After work, all I want to do is go straight home and get back into bed.&#x22;&nbsp; Physical examination shows no abnormalities.&nbsp; Mental status examination shows a tired, strained appearance and sad mood.&nbsp; He has no suicidal ideation.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t42287\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\" style=\"width:75.0%;\"><p align=\"center\"><strong>Major depressive disorder</strong></p></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>Diagnosis</strong></p></td><td style=\"width:75.0%;\"><ul><li>&ge;5 of the following symptoms lasting &ge;2 weeks (at least 1 symptom must be either depressed mood or loss of interest/pleasure):<ul style=\"list-style-type:circle;\"><li>Depressed mood</li><li>Loss of interest or pleasure</li><li>Change in appetite or weight</li><li>Insomnia or hypersomnia</li><li>Psychomotor retardation or agitation</li><li>Low energy</li><li>Poor concentration or indecisiveness</li><li>Thoughts of worthlessness or inappropriate guilt</li><li>Recurrent thoughts of death or suicide</li></ul></li><li>No history of mania or hypomania</li><li>Not due to substances or another medical condition</li></ul></td></tr></tbody></table></div><p>This patient&#39;s history of <strong>sad mood</strong>, <strong>loss of interest</strong>, <strong>fatigue</strong>, <strong>hypersomnia</strong>, and <strong>impaired concentration</strong> lasting &#8805;2 weeks is consistent with <strong>major depressive disorder (MDD)</strong>.&nbsp; Although his depressive symptoms were likely triggered and/or exacerbated by bereavement and professional setbacks, they are persistent, severe, and functionally impairing.&nbsp; MDD is the appropriate diagnosis when symptoms are sufficient in number, duration, and severity to meet diagnostic criteria.&nbsp; This patient should be offered treatment for MDD consisting of psychotherapy and/or antidepressant medications.</p><p><strong>(Choice A)</strong>&nbsp; Adjustment disorder with depressed mood is characterized by depressive symptoms that develop in response to a stressor but is not diagnosed when criteria are met for another disorder, such as MDD.</p><p><strong>(Choice C)</strong>&nbsp; Although depressive symptoms are common in a normal grief reaction, sadness is typically focused on the deceased and decreases in intensity over time.&nbsp; Although his son died 6 months ago, this patient has depression that has worsened over the past month and involves more persistent sadness and pervasive anhedonia.&nbsp; Excessive guilt, self-critical ruminations, and suicidality related to feelings of worthlessness and hopelessness can also help distinguish MDD from normal grief.</p><p><strong>(Choice D)</strong>&nbsp; Persistent complex bereavement disorder (also referred to as complicated grief) is characterized by persistent yearning for the deceased and prolonged emotional pain related to the loss, accompanied by maladaptive, ruminative thoughts and dysfunctional behaviors.</p><p><strong>(Choice E)</strong>&nbsp; Persistent depressive disorder is characterized by depressive symptoms lasting &#8805;2 years.</p><p><strong>(Choice F)</strong>&nbsp; Post-traumatic stress disorder is characterized by intrusive re-experiencing of a traumatic event (eg, flashbacks, intense memories), negative mood and cognitions, avoidance, and hyperarousal lasting &#8805;1 month.</p><p><strong>Educational objective:</strong><br>Major depressive disorder can be differentiated from adjustment disorders and normal grief reactions by the persistence and severity of symptoms.&nbsp; Pervasive sadness and anhedonia that do not decrease in severity over time should raise suspicion for major depression.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder with depressed mood",
                    "choiceNumber": 1,
                    "correctTaken": 1049,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 2,
                    "correctTaken": 13956,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal grief reaction",
                    "choiceNumber": 3,
                    "correctTaken": 883,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Persistent complex bereavement disorder",
                    "choiceNumber": 4,
                    "correctTaken": 969,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Persistent depressive disorder (dysthymia)",
                    "choiceNumber": 5,
                    "correctTaken": 102,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Post-traumatic stress disorder",
                    "choiceNumber": 6,
                    "correctTaken": 28,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24042244",
                    "mediaDataId": 0,
                    "title": "Grief, depression, and the DSM-5.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24042244",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27629598",
                    "mediaDataId": 0,
                    "title": "Major depressive disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27629598",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 150,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 16987,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 82,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 480,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 4,
            "questionId": 11317,
            "questionIndex": 12469,
            "questionText": "<p>A 24-year-old man is brought to the emergency department by his wife due to bizarre behavior.&nbsp; She noticed a change in his behavior shortly after he started a fasting diet 4-5 days ago.&nbsp; He has become irritable and moody and has been snapping at his wife and children.&nbsp; The patient says that he is being haunted by large, shadowy figures that &#x22;come from another world and are trying to take me with them.&#x22;&nbsp; He has anxiety, is sleeping less than usual, and has stopped going to work.&nbsp; The patient also has abdominal pain, constipation, and a tingling sensation in his fingertips.&nbsp; Medical history includes major depression and gastroesophageal reflux disease.&nbsp; His father also suffered from unexplained psychiatric episodes.&nbsp; The patient does not use tobacco, alcohol, or illicit drugs.&nbsp; His medications include omeprazole and acetaminophen.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 140/80 mm Hg, pulse is 110/min, and respirations are 16/min.&nbsp; The abdomen is soft, bowel sounds are decreased, and there is no rebound tenderness or rigidity.&nbsp; Neurologic examination is within normal limits except for decreased sensation in the fingertips and mild weakness in the right arm.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Acute intermittent porphyria (AIP)</strong>, an <strong>autosomal dominant</strong> disorder involving alterations in enzymes involved in heme biosynthesis, is characterized by <strong>acute, intermittent neurovisceral attacks</strong>.&nbsp; New onset of psychiatric and neurologic abnormalities following a period of fasting, accompanied by unexplained, acute <strong>abdominal pain</strong> and a family history of similar episodic symptoms, is strongly suggestive of AIP.&nbsp; Elevated urinary <strong>porphobilinogen</strong> levels during an attack are diagnostic.&nbsp;&nbsp;The mechanism by which AIP affects the nervous system is not fully understood but is likely related to differences in expression of the altered&nbsp;enzymes; common precipitants of attacks include <strong>fasting</strong> (carbohydrate restriction induces enzyme synthesis), certain medications (eg, carbamazepine, phenytoin, rifampin), tobacco, and alcohol.</p><p>Abdominal pain, the most common symptom in AIP, is <strong>neuropathic</strong>; therefore, abdominal tenderness in response to direct palpation is frequently absent on physical examination.&nbsp; Other clinical manifestations include vomiting, constipation, sensory and motor neuropathies (eg, decreased sensation in fingertips), and tachycardia.&nbsp; <strong>Psychiatric symptoms</strong> may be nonspecific and include anxiety, insomnia, restlessness, mood fluctuations, and psychotic symptoms (eg, hallucinations, delusions).&nbsp; Acute symptoms may last for days to weeks and usually resolve between attacks.&nbsp; The age of onset is typically in the 20s or 30s.</p><p><strong>(Choice B)</strong>&nbsp; Early findings in Lyme disease include erythema migrans, nonspecific systemic symptoms, and carditis, with arthritic symptoms occurring later.&nbsp; Common neurologic manifestations of Lyme disease include radiculopathies, meningitis, and cranial neuropathies (eg, facial palsy).&nbsp; Abdominal pain and psychosis are rare.</p><p><strong>(Choice C)</strong>&nbsp; Although this patient has a history of major depressive disorder, diagnosis of a recurrent major depressive episode requires a 2-week duration and cannot be made when a patient&#39;s presentation is better explained by a medical illness (as in this patient with classic symptoms of AIP).</p><p><strong>(Choice D)</strong>&nbsp; Schizophrenia is characterized by psychotic symptoms that have persisted for at least 6 months and are not better explained by a medical condition.</p><p><strong>(Choice E)</strong>&nbsp; Wilson disease leads to copper accumulation in tissues, causing insidious onset of hepatic, psychiatric, and neurologic dysfunction.&nbsp; Abdominal pain in Wilson disease is generally due to acute hepatitis or liver failure (eg, jaundice, right upper quadrant pain).&nbsp; Neurologic findings typically affect movement (eg, dysarthria, dystonia, tremor, parkinsonism) and are almost always accompanied by corneal copper deposits (Kayser-Fleischer rings).&nbsp; None of these findings are seen in this patient, in whom acute symptom onset&nbsp;following a period of fasting suggests AIP.</p><p><strong>Educational objective:</strong><br>Acute intermittent porphyria should be suspected in patients with sudden-onset abdominal pain, neuropsychiatric symptoms (eg, neuropathies, anxiety, mood changes, psychosis), and a family history of similar episodes.&nbsp; Elevated urine porphobilinogen during an attack is diagnostic.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 21828,
            "topic": "Acute intermittent porphyria",
            "titleId": 21828,
            "title": "Acute intermittent porphyria",
            "topicAttributeId": 330661,
            "topicAttribute": "Psychotic disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute intermittent porphyria",
                    "choiceNumber": 1,
                    "correctTaken": 13076,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lyme disease",
                    "choiceNumber": 2,
                    "correctTaken": 171,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive episode with psychotic features",
                    "choiceNumber": 3,
                    "correctTaken": 1536,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Schizophrenia",
                    "choiceNumber": 4,
                    "correctTaken": 971,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Wilson disease",
                    "choiceNumber": 5,
                    "correctTaken": 5481,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "225,440,true,-1,1*667,852,true,-1,1*2579,2622,true,-1,1*853,1026,true,-1,1*1065,1074,true,-1,1*1165,1178,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19268005",
                    "mediaDataId": 0,
                    "title": "Neurological manifestations of acute intermittent porphyria.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19268005",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25016127",
                    "mediaDataId": 0,
                    "title": "Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25016127",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 80,
            "othersAvgTimeSpent": 70,
            "notes": null,
            "peopleTaken": 21235,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1884,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 5,
            "questionId": 13584,
            "questionIndex": 14968,
            "questionText": "<p>A 24-year-old man is brought to the emergency department by his wife after he attempted to barricade himself in the garage.&nbsp; Three weeks ago, while working at a construction site, the patient was almost hit by a falling metal beam.&nbsp; Since the incident, he has become increasingly distressed and believes his supervisor arranged for the beam to deliberately hit him.&nbsp; Earlier today, the patient received a routine work email and is now convinced it contains a hidden message warning that his life is still in danger.&nbsp; He used cannabis and cocaine intermittently in college but has not used either drug for the past year.&nbsp; The patient has no prior medical or psychiatric conditions.&nbsp; Vital signs are within normal limits, physical examination is unremarkable, and urine drug screen is negative.&nbsp; The patient appears hypervigilant and becomes agitated when hospital admission is discussed but calms down after having a conversation with his wife.&nbsp; The patient agrees to hospitalization; however, once admitted, he refuses to take any medications.&nbsp; His condition improves over the course of several days without any pharmacotherapy.&nbsp; The patient is discharged and returns to work without issue.&nbsp; Which of the following is the most likely diagnosis for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t38889\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Differential diagnosis of DSM-5 psychotic disorders</strong></p></td></tr><tr><td><p align=\"center\"><strong>Brief psychotic disorder</strong></p></td><td><p>&ge;1 days &amp; &lt;1 month, sudden onset, full return to function</p></td></tr><tr><td><p align=\"center\"><strong>Schizophreniform disorder</strong></p></td><td><p>&ge;1 months &amp; &lt;6 months, same symptoms as schizophrenia, functional decline not required</p></td></tr><tr><td><p align=\"center\"><strong>Schizophrenia</strong></p></td><td><p>&ge;6 months (includes &ge;1 months of active symptoms, can include prodromal &amp; residual periods), requires functional decline</p></td></tr><tr><td><p align=\"center\"><strong>Schizoaffective disorder</strong></p></td><td><p>Mood episode with concurrent active-phase symptoms of schizophrenia + &ge;2 weeks of delusions or hallucinations in the absence of prominent mood symptoms</p></td></tr><tr><td><p align=\"center\"><strong>Delusional disorder</strong></p></td><td><p>&ge;1 delusions &amp; &ge;1 months, no other psychotic symptoms, normal functioning apart from direct impact of delusions</p></td></tr></tbody></table></div><p>The presence of <strong>&#8805;1 psychotic symptoms</strong> (eg, delusions, hallucinations, disorganized speech, grossly disorganized or catatonic behavior) lasting &#8805;1 days and <strong>&lt;1 month</strong>, with <strong>full return to functioning</strong>, is consistent with <strong>brief psychotic disorder</strong>.&nbsp; As in this case, in which the patient acutely developed paranoid delusions and bizarre behavior following a life-threatening incident, symptoms of brief psychotic disorder often develop in reaction to a marked <strong>stressor</strong>.&nbsp; Diagnosis requires ruling out psychotic disorders due to substances or medical conditions and longitudinal assessment to confirm remission within a month.</p><p>Brief psychotic disorder can be differentiated from other psychotic disorders by duration.&nbsp; In delusional disorder, &#8805;1 delusion must be present for &#8805;1 months <strong>(Choice E)</strong>.&nbsp; In schizophreniform disorder, psychotic symptoms last &#8805;1 months and &lt;6 months <strong>(Choice G)</strong>.&nbsp; This patient&#39;s symptoms resolved within a month.</p><p><strong>(Choices A and F)</strong>&nbsp; Acute stress disorder (ASD) and posttraumatic stress disorder (PTSD) are other possible consequences of traumatic exposure.&nbsp; They are characterized by symptoms of intrusion (eg, flashbacks, nightmares), negative mood, dissociation, avoidance, and arousal.&nbsp; In ASD, symptoms last from &#8805;3 days to &#8804;1 month, and in PTSD, symptoms last for &gt;1 month.&nbsp; Bizarre psychotic symptoms and disorganized behavior are not typical.</p><p><strong>(Choice B)</strong>&nbsp; Adjustment disorder is not characterized by psychotic symptoms and is not diagnosed when criteria are met for a more specific disorder.</p><p><strong>(Choice C)</strong>&nbsp; Although psychotic symptoms can be seen in a manic episode of bipolar disorder, this patient lacks other characteristic manic symptoms (eg, elated mood, increased energy, pressured speech, decreased need for sleep).</p><p><strong>(Choice H)</strong>&nbsp; Substance-induced psychotic disorder should always be considered in the differential diagnosis of an acute psychotic episode.&nbsp; Even though some substances are not identified by urine drug screening (eg, synthetic cannabinoids), this patient reports abstaining from drug use for the past year and has no signs of drug use on physical examination (eg, injected or dilated pupils, abnormal vital signs, altered reflexes, tremors), making substance-induced psychotic disorder unlikely.</p><p><strong>Educational objective:</strong><br>Brief psychotic disorder involves the presence of &#8805;1 psychotic symptoms lasting &#8805;1 days and &lt;1 month, with full return to the previous level of functioning.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17738,
            "topic": "Brief psychotic disorder",
            "titleId": 17738,
            "title": "Brief psychotic disorder",
            "topicAttributeId": 330661,
            "topicAttribute": "Psychotic disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute stress disorder",
                    "choiceNumber": 1,
                    "correctTaken": 4640,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder",
                    "choiceNumber": 2,
                    "correctTaken": 131,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bipolar disorder with psychotic features",
                    "choiceNumber": 3,
                    "correctTaken": 59,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Brief psychotic disorder",
                    "choiceNumber": 4,
                    "correctTaken": 9599,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Delusional disorder",
                    "choiceNumber": 5,
                    "correctTaken": 1369,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Posttraumatic stress disorder",
                    "choiceNumber": 6,
                    "correctTaken": 288,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Schizophreniform disorder",
                    "choiceNumber": 7,
                    "correctTaken": 207,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Substance-induced psychotic disorder",
                    "choiceNumber": 8,
                    "correctTaken": 678,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26764163",
                    "mediaDataId": 0,
                    "title": "Prognosis of brief psychotic episodes: a meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26764163",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26087685",
                    "mediaDataId": 0,
                    "title": "Short-term course and outcome of acute and transient psychotic disorders: differences from other types of psychosis with acute onset.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26087685",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23707641",
                    "mediaDataId": 0,
                    "title": "Structure of the psychotic disorders classification in DSM-5.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23707641",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 259,
            "othersAvgTimeSpent": 67,
            "notes": null,
            "peopleTaken": 16971,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 57,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 17,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 6,
            "questionId": 14440,
            "questionIndex": 15849,
            "questionText": "<p>A 22-year-old man comes to the emergency department with his roommate due to depression and thoughts of killing himself.&nbsp; The patient says, &#x22;I&#39;ve been struggling for weeks, but my roommate convinced me to finally get help.&#x22;&nbsp; The patient has not attended classes the past 2 weeks because he feels exhausted and has been sleeping throughout the day.&nbsp; He has no appetite and must force himself to eat at least 1 meal a day.&nbsp; The roommate says, &#x22;The whole week before he got depressed, he was doing great.&nbsp; He was reading ahead for class and working in the lab with almost no sleep.&nbsp; He was so excited about his research and would talk about it nonstop to anyone who would listen.&#x22;&nbsp; The patient takes no medication.&nbsp; Physical examination and laboratory studies are unremarkable; urine drug screen is negative.&nbsp; He appears tearful and has suicidal ideation.&nbsp; The patient is admitted for inpatient psychiatric treatment.&nbsp; Which of the following is the most appropriate pharmacotherapy at present?</p>",
            "questionHeader": "",
            "explanationText": "<p>Patients with depressive symptoms should be carefully assessed for a history of manic or hypomanic episodes to differentiate unipolar (depressive episodes only) from bipolar disorders (hypomanic/manic and depressive episodes).&nbsp; This patient&#39;s course of illness is consistent with <strong>bipolar disorder</strong> as he experienced a one-week episode of hypomanic symptoms (eg, decreased need for sleep, hyperactivity, pressured speech with increased productivity) followed by a &#8805;2-week period of depressive symptoms (eg, depressed mood, suicidal ideation, low energy, hypersomnia, decreased appetite).</p><p>Treatment of bipolar depression differs from treatment of unipolar depression.&nbsp; <strong>Antidepressant monotherapy</strong> should generally be <strong>avoided</strong> with bipolar disorder due to the <strong>risk of inducing mania</strong>; it would be particularly risky in this patient who was recently in a hypomanic episode.&nbsp; First-line medications for treatment of acute bipolar depression include the second-generation antipsychotics <strong>quetiapine</strong> and <strong>lurasidone</strong>.&nbsp; Lamotrigine, lithium, valproate, and the combination of olanzapine and fluoxetine have also demonstrated efficacy.</p><p><strong>(Choices A, B, and E)</strong>&nbsp; Bupropion, fluoxetine, and mirtazapine are first-line antidepressants that would be appropriate in unipolar major depressive disorder.&nbsp; They should be avoided in this patient with bipolar disorder due to the risk of inducing hypomania or mania.&nbsp; In general, antidepressant use in bipolar disorder should be limited to use as an adjunct in combination with an antimanic drug.</p><p><strong>(Choice C)</strong>&nbsp; Gabapentin is an anticonvulsant with no evidence to support its use in treating acute bipolar depression.</p><p><strong>(Choice D)</strong>&nbsp; The first-generation antipsychotic haloperidol has not shown efficacy in the treatment of bipolar depression.&nbsp; It has a high risk of extrapyramidal side effects due to its potent D2 antagonism.</p><p><strong>Educational objective:</strong><br>The second-generation antipsychotics quetiapine and lurasidone are first-line medications for the treatment of acute bipolar depression.&nbsp; Antidepressant monotherapy should be avoided due to the risk of inducing mania.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17629,
            "topic": "Bipolar disorder",
            "titleId": 17629,
            "title": "Bipolar disorder",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bupropion",
                    "choiceNumber": 1,
                    "correctTaken": 620,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Fluoxetine",
                    "choiceNumber": 2,
                    "correctTaken": 2113,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Gabapentin",
                    "choiceNumber": 3,
                    "correctTaken": 277,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Haloperidol",
                    "choiceNumber": 4,
                    "correctTaken": 1056,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mirtazapine",
                    "choiceNumber": 5,
                    "correctTaken": 1246,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Quetiapine",
                    "choiceNumber": 6,
                    "correctTaken": 11907,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30069121",
                    "mediaDataId": 0,
                    "title": "Treatment of acute bipolar depression.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30069121",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26876316",
                    "mediaDataId": 0,
                    "title": "Treatment of bipolar depression: evolving recommendations.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26876316",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25028535",
                    "mediaDataId": 0,
                    "title": "Quetiapine for acute bipolar depression: a systematic review and meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25028535",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 184,
            "othersAvgTimeSpent": 52,
            "notes": null,
            "peopleTaken": 17219,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 69,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 641,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 7,
            "questionId": 13692,
            "questionIndex": 15082,
            "questionText": "<p>A 27-year-old man comes to the office to follow up on bipolar disorder.&nbsp; The patient was hospitalized 6 months ago after disrobing on the subway, shouting at passengers, and attacking the security guards who tried to subdue him.&nbsp; He was diagnosed with bipolar disorder and started on a psychiatric medication regimen that proved effective.&nbsp; He has been stable from a psychiatric perspective since discharge, but today he has fatigue, constipation, and myalgias that have steadily worsened over the last month.&nbsp; His other medical problems include hypertension and hyperlipidemia for which he takes an antihypertensive and a statin.&nbsp; Temperature is 36.7 C (98 F), blood pressure is 129/72 mm Hg, pulse is 52/min, and respirations are 12/min.&nbsp; Examination is within normal limits.&nbsp; Which of the following is the most likely cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s fatigue, constipation, myalgias, and bradycardia are most consistent with lithium-induced hypothyroidism.&nbsp; <strong>Lithium</strong> is considered a <strong>first-line</strong> treatment for <strong>bipolar disorder</strong>; however, its use is associated with a number of side effects, including thyroid abnormalities and renal dysfunction.</p><p>Approximately 25% of patients treated with lithium will develop <strong>hypothyroidism</strong>.&nbsp; A much smaller percentage will experience hyperthyroidism.&nbsp; Because of the drug&#39;s propensity to interfere with thyroid function, patients prescribed lithium should have baseline TSH levels drawn prior to starting therapy and <strong>TSH</strong> testing repeated <strong>every 6-12 months</strong> for the duration of treatment.&nbsp; Patients who develop hypothyroidism are generally managed symptomatically with addition of T4 (eg, levothyroxine) rather than discontinuation of lithium.</p><p><strong>(Choices A and H)</strong>&nbsp; Amitriptyline (a tricyclic antidepressant) is associated with constipation, drowsiness, and other anticholinergic side effects; vortioxetine (a serotonin reuptake inhibitor and 5-HT3 receptor antagonist) can cause nausea.&nbsp; Neither is associated with abnormal thyroid function.</p><p><strong>(Choices B and D)</strong>&nbsp; The calcium channel blocker amlodipine is associated with lower extremity edema and the ACE inhibitor lisinopril is associated with increased creatinine, hyperkalemia, cough, and angioedema.</p><p><strong>(Choices C and F)</strong>&nbsp; Aripiprazole and lurasidone are second-generation antipsychotics.&nbsp; Compared to olanzapine and clozapine (also second-generation antipsychotics), these agents have a lower risk of metabolic side effects (eg, weight gain, hyperglycemia).&nbsp; They are not associated with abnormal thyroid function.</p><p><strong>(Choice G)</strong>&nbsp; The HMG-CoA reductase inhibitor simvastatin can cause myalgias, but is not typically associated with constipation, fatigue, or bradycardia.&nbsp; Other side effects of statins include liver function test abnormalities and rhabdomyolysis.</p><p><strong>Educational objective:</strong><br>Approximately 25% of patients treated with lithium will develop hypothyroidism, requiring that all patients have regular TSH monitoring every 6-12 months.&nbsp; Lithium-induced hypothyroidism is generally treated with T4 supplementation rather than discontinuation of lithium.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 14210,
            "topic": "Lithium",
            "titleId": 14210,
            "title": "Lithium",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "5",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Amitriptyline",
                    "choiceNumber": 1,
                    "correctTaken": 987,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Amlodipine",
                    "choiceNumber": 2,
                    "correctTaken": 514,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Aripiprazole",
                    "choiceNumber": 3,
                    "correctTaken": 917,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lisinopril",
                    "choiceNumber": 4,
                    "correctTaken": 142,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lithium",
                    "choiceNumber": 5,
                    "correctTaken": 8124,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lurasidone",
                    "choiceNumber": 6,
                    "correctTaken": 532,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Simvastatin",
                    "choiceNumber": 7,
                    "correctTaken": 4599,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Vortioxetine",
                    "choiceNumber": 8,
                    "correctTaken": 172,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1014,1108,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26003379",
                    "mediaDataId": 0,
                    "title": "Long-term effects of lithium on renal, thyroid, and parathyroid function:  a retrospective analysis of laboratory data.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26003379",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22265699",
                    "mediaDataId": 0,
                    "title": "Lithium toxicity profile:  a systematic review and meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22265699",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 134,
            "othersAvgTimeSpent": 67,
            "notes": null,
            "peopleTaken": 15987,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 51,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 479,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 8,
            "questionId": 13693,
            "questionIndex": 15083,
            "questionText": "<p>A 38-year-old man is evaluated for a 2-month history of depressed mood.&nbsp; He explains, &#x22;I&#39;m just exhausted all the time.&nbsp; I can&#39;t sleep.&nbsp; I can&#39;t think.&nbsp; I just feel worn out.&#x22;&nbsp; During further discussion, the patient tearfully admits to thoughts of suicide but has no plan or intent to act on these thoughts.&nbsp; He has no medical conditions.&nbsp; Family history is significant for type 2 diabetes mellitus and hypertension in his father and hyperthyroidism in his mother.&nbsp; After physical examination and laboratory workup, major depressive disorder is diagnosed and antidepressant therapy is initiated.&nbsp; The patient&#39;s symptoms do not respond to monotherapy, so an antipsychotic medication is added.&nbsp; Over the course of several months, the patient&#39;s antidepressant dose is increased to the maximal therapeutic dose.&nbsp; At his 6-month follow-up, the patient&#39;s mood is improved and his depression is in remission.&nbsp; Temperature is 36.7 C (98.1 F), blood pressure is 148/91 mm Hg, pulse is 72/min, and respirations are 14/min.&nbsp; Compared to his most recent visit, he has lost 0.5 kg (1.1 lb); he has also new-onset hypertension.&nbsp; Which of the following medications is the most likely cause of this adverse effect?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Venlafaxine</strong>, an antidepressant in the serotonin-norepinephrine reuptake inhibitor class, has been associated with <strong>dose-dependent hypertension</strong>.&nbsp; At lower doses, venlafaxine primarily inhibits the reuptake of serotonin.&nbsp; As the dose increases, however, the drug also inhibits norepinephrine reuptake, potentially causing increased systolic and diastolic blood pressure.&nbsp; The hypertensive effect is especially significant at doses &gt;300 mg daily, in which the incidence may be &gt;10%.</p><p>Although the blood pressure increase is generally modest for most patients taking venlafaxine, <strong>blood pressure</strong> should be <strong>monitored regularly</strong>.&nbsp; If sustained increases are noted, dose reduction or discontinuation should be considered.&nbsp; In patients with preexisting hypertension, blood pressure should be well controlled prior to starting venlafaxine, or an alternative antidepressant with a more favorable side effect profile should be considered.</p><p><strong>(Choices A and G)</strong>&nbsp; Although second-generation antipsychotics (SGAs) are associated with weight gain, which can subsequently contribute to hypertension, they do not cause hypertension directly.&nbsp; Aripiprazole and ziprasidone are the least likely SGAs to cause weight gain, and this patient has actually lost weight since the initiation of therapy.</p><p><strong>(Choices B, C, and E)</strong>&nbsp; The selective serotonin reuptake inhibitors paroxetine and sertraline do not inhibit norepinephrine reuptake and are not associated with hypertension.&nbsp; Mirtazapine antagonizes presynaptic alpha-2 adrenergic receptors and is associated with increased appetite and sedation but not hypertension.</p><p><strong>(Choice D)</strong>&nbsp; Phenelzine is a monoamine oxidase inhibitor (MAOI) that is not used as a first-line antidepressant due to its unfavorable side effect profile and dietary restrictions.&nbsp; At therapeutic doses, MAOIs commonly cause hypotension, not hypertension.&nbsp; MAOI hypertensive crisis refers to severe hypertension that can occur after patients on MAOIs ingest foods containing tyramine, a sympathomimetic.</p><p><strong>Educational objective:</strong><br>Venlafaxine is a serotonin-norepinephrine reuptake inhibitor that can cause dose-dependent hypertension.&nbsp; Blood pressure should be monitored regularly, especially at higher doses.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 15808,
            "topic": "Antidepressants",
            "titleId": 15808,
            "title": "Antidepressants",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Aripiprazole",
                    "choiceNumber": 1,
                    "correctTaken": 1998,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mirtazapine",
                    "choiceNumber": 2,
                    "correctTaken": 1761,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Paroxetine",
                    "choiceNumber": 3,
                    "correctTaken": 841,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Phenelzine",
                    "choiceNumber": 4,
                    "correctTaken": 3424,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sertraline",
                    "choiceNumber": 5,
                    "correctTaken": 941,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Venlafaxine",
                    "choiceNumber": 6,
                    "correctTaken": 9956,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Ziprasidone",
                    "choiceNumber": 7,
                    "correctTaken": 1413,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "399,508,true,-1,1*742,953,true,-1,1*1323,1616,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25328745",
                    "mediaDataId": 0,
                    "title": "Accelerated hypertension after venlafaxine usage.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25328745",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "22195528",
                    "mediaDataId": 0,
                    "title": "Drug-induced hypertension: an unappreciated cause of secondary hypertension.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/22195528",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 163,
            "othersAvgTimeSpent": 68,
            "notes": null,
            "peopleTaken": 20334,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 49,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 458,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 9,
            "questionId": 4848,
            "questionIndex": 4848,
            "questionText": "<p>A 32-year-old woman with bipolar disorder comes to the office for evaluation of infertility.&nbsp; She says, &#x22;I was hospitalized 2 years ago for a manic episode.&nbsp; We found a good combination of medications, and my condition has been stable.&nbsp; Now, I feel ready to start a family, and my husband and I have been trying to get pregnant for the past year.&nbsp; I was hopeful when my period was late but disappointed when the pregnancy test was negative.&#x22;&nbsp; The patient&#39;s last menstrual period was 4 months ago; before that, menses were erratic, occurring every 30-60 days and lasting 4-8 days.&nbsp; Medications include lithium and aripiprazole.&nbsp; Vital signs and physical examination are normal, as are serum TSH, creatinine, and hemoglobin A1c levels.&nbsp; Serum prolactin is markedly elevated at 400 ng/mL (normal: &lt;20).&nbsp; In office urine pregnancy test is negative.&nbsp; Which of the following is the best next step in management of this patient&#39;s hyperprolactinemia?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T84054\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Hyperprolactinemia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical manifestations</strong></p></td><td><ul><li>Premenopausal women: oligomenorrhea/amenorrhea, infertility, galactorrhea</li><li>Postmenopausal women: mass effect symptoms (eg, headache, visual field defects) if due to large adenoma</li><li>Men: hypogonadism (decreased libido, erectile dysfunction), mass effect symptoms</li></ul></td></tr><tr><td><p align=\"center\"><strong>Causes</strong></p></td><td><ul><li>Physiologic (eg, pregnancy, breastfeeding)</li><li>Chest wall injury (eg, burns, herpes zoster)</li><li>Prolactinoma</li><li>Infiltrative pituitary/hypothalamic disorders (eg, malignancy, sarcoidosis)</li><li>Medications (eg, antipsychotics, metoclopramide)</li><li>Hypothyroidism</li><li>Chronic kidney disease</li></ul></td></tr><tr><td><p align=\"center\"><strong>Evaluation</strong></p></td><td><ul><li>Serum prolactin</li><li>MRI of pituitary (if cause not known)</li></ul></td></tr></tbody></table></div><p>This patient has <strong>hyperprolactinemia</strong> with <a href=\"54364\">oligomenorrhea/amenorrhea</a> and a markedly elevated serum prolactin level.&nbsp; Prolactin is primarily under inhibitory regulation by <a href=\"3419\">dopaminergic neurons from the hypothalamus</a>; therefore, in patients taking antidopaminergic medications (eg, antipsychotics, metoclopramide), medication-induced hyperprolactinemia should be considered.</p><p>Hyperprolactinemia is a common adverse effect of antipsychotic medications, primarily the first-generation (conventional) drugs (eg, haloperidol).&nbsp; It is also common with risperidone, for which prolactin levels up to 300 ng/mL have been reported.&nbsp; However, aside from risperidone (which the patient is not taking), medication-induced hyperprolactinemia usually causes only a moderate elevation (&lt;100 ng/mL) of serum prolactin.&nbsp; Elevations with <strong>second-generation (atypical) antipsychotics</strong>, including aripiprazole (which the patient is taking), are <strong>generally minimal</strong> because these agents have lower affinity for the dopamine D<font size=\"2\"><sub>2</sub></font> receptor<strong>&nbsp;(Choice D)</strong>.</p><p>Therefore, <strong>higher prolactin levels</strong> (&#8805;100 ng/mL), as seen in this patient, are unlikely to be due to medication effect, and a prolactin-secreting pituitary adenoma <strong>(prolactinoma)</strong> should be ruled out.&nbsp; Therefore, <strong>MRI of the brain</strong> (ie, pituitary) is indicated.&nbsp; Imaging is also needed for patients with hyperprolactinemia associated with mass-effect symptoms (eg, headache, visual field defects).</p><p><strong>(Choices A and E)</strong>&nbsp; Lithium is a mood stabilizer used to treat bipolar disorder.&nbsp; Its main adverse effects include weight gain, nausea, tremor, and polyuria.&nbsp; It also can cause hypothyroidism, which may affect fertility but is usually associated with other symptoms (eg, weight gain, lethargy, dry skin, cold intolerance).&nbsp; The effect of lithium on prolactin is generally light and variable and is unlikely to be the cause of this patient&#39;s condition.</p><p><strong>(Choice C)</strong>&nbsp; This patient with oligomenorrhea/amenorrhea and a negative urine pregnancy test is very unlikely to be pregnant due to the high levels of prolactin and its inhibitory effect on the pulsatile release of GnRH.&nbsp; Without pulsatile GnRH, ovulation does not occur; therefore, a quantitative &#946;-hCG is unlikely to aid in the diagnosis.</p><p><strong>Educational objective:</strong><br>Hyperprolactinemia is a common adverse effect of antipsychotic medications, primarily the first-generation (conventional) drugs and risperidone; elevations with other second-generation (atypical) antipsychotics are generally minimal.&nbsp; Patients with markedly elevated prolactin levels that cannot be attributed to medication effect warrant MRI of the brain (pituitary) to rule out a prolactin-secreting adenoma (prolactinoma).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 15858,
            "topic": "Antipsychotics",
            "titleId": 15858,
            "title": "Antipsychotics",
            "topicAttributeId": 330661,
            "topicAttribute": "Psychotic disorders",
            "correctAnswer": "2",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Discontinue lithium",
                    "choiceNumber": 1,
                    "correctTaken": 192,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain MRI of the brain",
                    "choiceNumber": 2,
                    "correctTaken": 1945,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain quantitative &#946;-hCG level",
                    "choiceNumber": 3,
                    "correctTaken": 169,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain serum aripiprazole level",
                    "choiceNumber": 4,
                    "correctTaken": 2483,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain serum lithium level",
                    "choiceNumber": 5,
                    "correctTaken": 292,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1294,1942,true,-1,1*2193,2235,true,-1,1*961,975,true,-1,1*490,514,true,-1,1*440,485,true,-1,1*548,563,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "610",
                    "mediaDataId": 0,
                    "title": "Antipsychotics",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30889571",
                    "mediaDataId": 0,
                    "title": "Pitfalls in the diagnostic evaluation of hyperprolactinemia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30889571",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24140188",
                    "mediaDataId": 0,
                    "title": "Psychotropic-induced hyperprolactinemia: a clinical review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24140188",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 96,
            "othersAvgTimeSpent": 66,
            "notes": null,
            "peopleTaken": 5081,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 38,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 910,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 10,
            "questionId": 13664,
            "questionIndex": 15054,
            "questionText": "<p>A 26-year-old woman comes to the office for follow-up of depression.&nbsp; She was prescribed fluoxetine 2 weeks ago due to symptoms of depressed mood, lack of motivation, poor sleep, fatigue, and concentration difficulties at work.&nbsp; The patient reports that she is tolerating the medication without difficulty and that her depression began improving 2 days after starting it.&nbsp; She says, &#x22;I&#39;ve never felt better.&nbsp; I&#39;m so glad I started taking medication.&nbsp; Work has been going well, and I&#39;m even working extra shifts now.&#x22;&nbsp; The patient is sleeping 4 hours a night but reports that her energy is &#x22;excellent.&#x22;&nbsp; She says that she is figuring out how to invest her savings in the stock market and offers to share her tips.&nbsp; The patient does not use alcohol or recreational substances.&nbsp; Physical examination is normal.&nbsp; Mental status examination is remarkable for rapid speech.&nbsp; The patient has no suicidal ideation, delusions, or hallucinations.&nbsp; Which of the following is the most appropriate initial step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s elevated mood, decreased need for sleep, pressured speech, and increased activity and energy following exposure to the selective serotonin reuptake inhibitor fluoxetine are consistent with <strong>antidepressant-induced hypomania</strong>.</p><p>All antidepressants carry the risk for <a href=\"14074\">hypomania/mania</a>, and a medication-induced switch to hypomania may suggest an underlying bipolar disorder.&nbsp; In addition, atypically rapid improvement of depression after antidepressant initiation (as is this patient&#39;s improvement after 2 days compared to the typical 2 weeks) is an additional sign that she may have an underlying bipolar spectrum disorder.</p><p>The causative agent must be stopped in antidepressant-induced hypomania.&nbsp; Antidepressants are usually tapered slowly to prevent antidepressant discontinuation syndrome (fluoxetine&#39;s long half-life makes this less of a concern).&nbsp; However, patients with precipitated hypomania/mania require <strong>immediate discontinuation of the antidepressant</strong> to avoid further worsening of the condition and life-altering harm (eg, financial ruin, sexual indiscretion, hospitalization).&nbsp; After stopping fluoxetine, this patient should be followed closely to ensure resolution of symptoms.&nbsp; If hypomanic symptoms persist despite discontinuing the antidepressant, treatment with a mood stabilizer (eg, lithium, valproate) or an antipsychotic (eg, quetiapine) should be considered <strong>(Choices A and B)</strong>.</p><p><strong>(Choice C)</strong>&nbsp; An antidepressant serum level test may be helpful if there are concerns of toxicity; however, this patient&#39;s symptoms are consistent with a switch to hypomania, a known risk of antidepressants.&nbsp; A serum level would not assist in the management of this patient; the emergence of clinically significant hypomania is a reason to discontinue the medication regardless of its serum level.</p><p><strong>(Choice E)</strong>&nbsp; Fluoxetine may be more activating among antidepressants, and paroxetine can cause sedation to help with sleep; however, switching from fluoxetine to paroxetine is not appropriate because all antidepressants carry the risk for hypomania or mania.</p><p><strong>Educational objective:</strong><br>All antidepressants are associated with a risk for hypomania/mania in susceptible patients.&nbsp; The first step in management is discontinuation of the causative medication.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17629,
            "topic": "Bipolar disorder",
            "titleId": 17629,
            "title": "Bipolar disorder",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Add lithium",
                    "choiceNumber": 1,
                    "correctTaken": 771,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Add quetiapine",
                    "choiceNumber": 2,
                    "correctTaken": 210,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Check serum antidepressant level",
                    "choiceNumber": 3,
                    "correctTaken": 125,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinue fluoxetine",
                    "choiceNumber": 4,
                    "correctTaken": 3910,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Switch fluoxetine to paroxetine",
                    "choiceNumber": 5,
                    "correctTaken": 27,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "427,661,true,-1,1*735,1417,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26667012",
                    "mediaDataId": 0,
                    "title": "Do antidepressants increase the risk of mania and bipolar disorder in people with depression?  A retrospective electronic case register cohort study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26667012",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28558366",
                    "mediaDataId": 0,
                    "title": "Antidepressant-induced hypomania/mania in patients with major depression: evidence from the BRIDGE-II-MIX study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28558366",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 95,
            "othersAvgTimeSpent": 54,
            "notes": null,
            "peopleTaken": 5043,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 78,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 539,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 11,
            "questionId": 14513,
            "questionIndex": 15923,
            "questionText": "<p>A 74-year-old man comes to the office for a scheduled follow-up after hospitalization for a myocardial infarction 4 weeks ago.&nbsp; The patient has had no new cardiac symptoms and has adhered to his outpatient medication regimen.&nbsp; When asked how he has been, he says, &#x22;I just don&#39;t feel like my old self.&#x22;&nbsp; The patient&#39;s usual routine has been &#x22;disrupted&#x22; since he was discharged; he is not meeting with friends and has not been able to read the newspaper all the way through.&nbsp; He naps on his couch during the day and wakes up earlier than he wants to in the morning.&nbsp; The patient&#39;s medical history includes diet-controlled diabetes mellitus, hypertension, and obesity.&nbsp; Medications include aspirin, metoprolol, atorvastatin, lisinopril, and sublingual nitroglycerin as needed.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination is unremarkable except for moderate obesity.&nbsp; He reports low mood and appears slowed and subdued.&nbsp; The patient declines psychotherapy.&nbsp; Which of the following is the most appropriate pharmacotherapy?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t42287\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\" style=\"width:75.0%;\"><p align=\"center\"><strong>Major depressive disorder</strong></p></td></tr><tr><td style=\"width:25.0%;\"><p align=\"center\"><strong>Diagnosis</strong></p></td><td style=\"width:75.0%;\"><ul><li>&ge;5 of the following symptoms lasting &ge;2 weeks (at least 1 symptom must be either depressed mood or loss of interest/pleasure):<ul style=\"list-style-type:circle;\"><li>Depressed mood</li><li>Loss of interest or pleasure</li><li>Change in appetite or weight</li><li>Insomnia or hypersomnia</li><li>Psychomotor retardation or agitation</li><li>Low energy</li><li>Poor concentration or indecisiveness</li><li>Thoughts of worthlessness or inappropriate guilt</li><li>Recurrent thoughts of death or suicide</li></ul></li><li>No history of mania or hypomania</li><li>Not due to substances or another medical condition</li></ul></td></tr></tbody></table></div><p>The patient exhibits symptoms of <strong>major depressive disorder</strong> (MDD), which include low mood, anhedonia, impaired concentration, sleep disturbance, and psychomotor retardation.&nbsp; MDD may occur in up to one-fifth of patients who have had a recent myocardial infarction (MI).&nbsp; It may affect adherence to <strong>post-MI</strong> medical treatments and can increase the risk of cardiac mortality.&nbsp; Treatment options include psychotherapy and antidepressant medication.&nbsp; Combination therapy is likely to be more effective and is therefore recommended.</p><p><strong>Selective serotonin reuptake inhibitors</strong> (SSRIs) are used as first-line treatments after an acute MI because they are generally well tolerated and, compared with other classes of antidepressants, less likely to cause adverse cardiac effects.&nbsp; Among SSRIs, <strong>sertraline</strong> is preferred because it carries a very low risk of adverse drug interactions, especially with cardiac medications.&nbsp; The SSRI citalopram is generally avoided in patients with a recent MI due to its potential for dose-dependent QT prolongation <strong>(Choice A)</strong>.</p><p><strong>(Choice B)</strong>&nbsp; Tricyclic antidepressants such as desipramine can slow cardiac conduction by inhibition of fast sodium channels and therefore are not indicated in patients with severe cardiovascular disease.</p><p><strong>(Choice C)</strong>&nbsp; Although mirtazapine, an atypical antidepressant with noradrenergic and serotonergic effects, is not contraindicated in patients with cardiovascular disease, its propensity to cause sedation and weight gain make it a poor choice for this patient.</p><p><strong>(Choice D)</strong>&nbsp; Monoamine oxidase inhibitors such as phenelzine are not considered first-line treatment for MDD due to their side effect burden (eg, sedation, weight gain) and potential for drug and food interactions (eg, serotonin syndrome, tyramine hypertensive crisis).</p><p><strong>(Choice F)</strong>&nbsp; Trazodone, a serotonin-modulating antidepressant, is extremely sedating.&nbsp; It is used at a low dose primarily for sleep induction rather than for its antidepressant effects.&nbsp; Its orthostatic effects are problematic in the elderly.</p><p><strong>(Choice G)</strong>&nbsp; Venlafaxine, a serotonin-norepinephrine reuptake inhibitor, is associated with tachycardia and increased blood pressure; therefore, it is not recommended in a patient with a recent MI.</p><p><strong>Educational objective:</strong><br>Depression after myocardial infarction can increase the overall risk of cardiac mortality.&nbsp; Psychotherapy and antidepressant treatment (especially in combination) are likely to be effective.&nbsp; The selective serotonin reuptake inhibitor sertraline is considered a first-line treatment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 15808,
            "topic": "Antidepressants",
            "titleId": 15808,
            "title": "Antidepressants",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Citalopram",
                    "choiceNumber": 1,
                    "correctTaken": 3150,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Desipramine",
                    "choiceNumber": 2,
                    "correctTaken": 113,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mirtazapine",
                    "choiceNumber": 3,
                    "correctTaken": 1251,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Phenelzine",
                    "choiceNumber": 4,
                    "correctTaken": 181,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sertraline",
                    "choiceNumber": 5,
                    "correctTaken": 11309,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Trazodone",
                    "choiceNumber": 6,
                    "correctTaken": 1238,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Venlafaxine",
                    "choiceNumber": 7,
                    "correctTaken": 1586,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2389,2411,true,-1,1*2511,2566,true,-1,1*1073,1172,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26246788",
                    "mediaDataId": 0,
                    "title": "Treatment of affective disorders in cardiac disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26246788",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23293051",
                    "mediaDataId": 0,
                    "title": "Treatment of depression in cardiovascular disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23293051",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29275963",
                    "mediaDataId": 0,
                    "title": "QT prolongation, torsades de pointes, and psychotropic medications: a 5-year update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29275963",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 137,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 18828,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 445,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 12,
            "questionId": 14400,
            "questionIndex": 15809,
            "questionText": "<p>A 49-year-old woman comes to the office due to low mood.&nbsp; The patient has a 3-month history of worsening sadness, increased appetite with weight gain, and difficulty falling and staying asleep.&nbsp; She was dismissed from her part-time sales job 2 months ago due to poor performance and has been &#x22;too tired&#x22; to look for a new job.&nbsp; The patient&#39;s husband is threatening to leave her, and she has little contact with family or friends.&nbsp; She says, &#x22;My life is a mess, and I&#39;m not sure that my marriage can be saved.&nbsp; I&#39;ve had thoughts of taking all of my medications at once.&#x22;&nbsp; The patient admits to drinking increased amounts of alcohol &#x22;to cope.&#x22;&nbsp; She has hypothyroidism treated with levothyroxine; last year she had an episode of major depression for which she is currently on a maintenance dose of sertraline.&nbsp; Physical examination, including neurologic examination, shows no abnormalities.&nbsp; The patient is anxious, sad, and physically restless.&nbsp; She weeps softly throughout the interview, especially when discussing her marriage.&nbsp; Which of the following is the most appropriate next step in management?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient is at high risk for suicide.&nbsp; She has <strong>suicidal ideation</strong> with a <strong>specific plan</strong> in mind and <strong>access to means</strong>&nbsp;(eg, taking all her medications).&nbsp; She is under severe stress (eg, job loss, husband) and has little social support.&nbsp; In addition, she is drinking increasing amounts of alcohol, whose disinhibiting effects put her at risk of impulsively acting on her suicidal thoughts.&nbsp; Due to safety concerns, the most appropriate intervention is to <strong>hospitalize</strong> the patient to provide close monitoring and support while appropriate treatment is initiated.</p><p>Performing a <strong>suicide risk assessment</strong> is critical in determining the appropriate level of care (ie, outpatient vs. inpatient).&nbsp; Patients with active suicidal ideation (eg, thoughts of taking action to harm oneself) are at greater risk than patients with passive suicidal ideation (eg, wish to be dead or go to sleep and not wake up).&nbsp; Patients should be asked if they have thought of a specific method and the lethality of the method, whether any preparations (eg, hoarding pills) have been made, and if they have access to the means to commit suicide.&nbsp; Recent stressors and the adequacy of social supports should also be considered.</p><p><strong>(Choices A and C)</strong>&nbsp; Cognitive-behavioral therapy and couples therapy are appropriate treatment considerations but would not be the next step in management given the need for hospitalization.</p><p><strong>(Choice B)</strong>&nbsp; The efficacy of a &#x22;contract for safety,&#x22; in which the patient agrees not to act on suicidal thoughts and seek help instead, has not been demonstrated.&nbsp; It may provide a false sense of security to the clinician and place the patient at risk in an unsupervised setting.</p><p><strong>(Choice E)</strong>&nbsp; Inadequately treated hypothyroidism may be contributing to the patient&#39;s depression.&nbsp; However, thyroid function tests should be obtained prior to adjusting the levothyroxine dose, and hospitalizing the patient takes precedence.</p><p><strong>(Choices F and G)</strong>&nbsp; Increasing the dose of sertraline or changing the patient&#39;s antidepressant are treatment options but would not precede choosing inpatient level of care.</p><p><strong>Educational objective:</strong><br>Patients with depression should be carefully assessed for suicidal thoughts and behavior to determine the appropriate treatment setting.&nbsp; Patients with active suicidal ideation and both a plan and access to means are at increased risk and should be hospitalized.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Cognitive-behavioral therapy",
                    "choiceNumber": 1,
                    "correctTaken": 1089,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Contract for safety",
                    "choiceNumber": 2,
                    "correctTaken": 2021,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Couples therapy",
                    "choiceNumber": 3,
                    "correctTaken": 206,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hospital admission",
                    "choiceNumber": 4,
                    "correctTaken": 11546,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased levothyroxine dosing",
                    "choiceNumber": 5,
                    "correctTaken": 185,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased sertraline dosing",
                    "choiceNumber": 6,
                    "correctTaken": 1316,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Trial of different selective serotonin reuptake inhibitor",
                    "choiceNumber": 7,
                    "correctTaken": 735,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27262012",
                    "mediaDataId": 0,
                    "title": "Psychiatric emergencies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27262012",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23269211",
                    "mediaDataId": 0,
                    "title": "The role of general practitioners in prevention of depression-related suicides.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23269211",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26772209",
                    "mediaDataId": 0,
                    "title": "Suicide, suicide attempts, and suicidal ideation.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26772209",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 99,
            "othersAvgTimeSpent": 62,
            "notes": null,
            "peopleTaken": 17098,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 252,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 13,
            "questionId": 14572,
            "questionIndex": 15985,
            "questionText": "<p>A 40-year-old man comes to the office due to hand tremors for the past 2 months.&nbsp; The patient is an art teacher and has had difficulty demonstrating techniques in front of the class due to shaky hands.&nbsp; When noticing others looking at his hands, he becomes increasingly anxious and self-conscious, which tends to worsen the tremor.&nbsp; The patient has a history of bipolar disorder with a manic episode 6 months ago.&nbsp; He currently reports stable mood on the prescribed medication.&nbsp; The patient drinks alcohol occasionally and has not noticed any tremor changes with alcohol use.&nbsp; There is no family history of neurologic disorders.&nbsp; Vital signs are within normal limits.&nbsp; Physical examination shows fine, bilateral hand tremors that worsen with posture held against gravity.&nbsp; Muscle tone, strength, and deep tendon reflexes are normal throughout.&nbsp; Gait is normal.&nbsp; On mental status examination, he is cooperative and appears mildly anxious.&nbsp; The remainder of the physical examination shows no abnormalities.&nbsp; Which of the following is the most likely cause of this patient&#39;s current symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t61519\"><table class=\"table-default-style\"><tbody><tr><td><p align=\"center\"><strong>Tremor</strong></p></td><td><p align=\"center\"><strong>Clinical features</strong></p></td></tr><tr><td><p align=\"center\"><strong>Essential</strong></p></td><td><ul><li>Action tremor</li><li>Bilateral hands &amp;/or head</li><li>Improves with alcohol</li></ul></td></tr><tr><td><p align=\"center\"><strong>Parkinson disease</strong></p></td><td><ul><li>Resting tremor (decreases with movement)</li><li>Hands &amp; legs</li><li>&quot;Pill-rolling&quot;</li><li>Associated parkinsonian features (eg, rigidity, masked faces, short-stepped gait)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Cerebellar</strong></p></td><td><ul><li>Action tremor (increases as hand reaches target)</li><li>Associated ataxia, dysmetria, or gait disorder</li></ul></td></tr><tr><td><p align=\"center\"><strong>Physiologic</strong></p></td><td><ul><li>Action &amp; rest tremor</li><li>Low amplitude, high frequency (ie, &quot;fine&quot; tremor)</li><li>Not visible under normal circumstances</li><li>Enhanced with sympathetic activation (eg, anxiety, caffeine, hyperthyroidism)</li></ul></td></tr></tbody></table></div><p>This patient&#39;s <strong>fine action tremor</strong> of the hands that <strong>worsens with stress</strong> is consistent with <strong>physiologic tremor</strong>.&nbsp; Most individuals have a fine (ie, low-amplitude, high-frequency) tremor of the hands that usually goes unnoticed.&nbsp; However, the tremor may become visible when <strong>enhanced</strong> by increased sympathetic activity or <strong>certain medications</strong>.&nbsp; This patient&#39;s history of bipolar disorder suggests that his tremor is being enhanced by lithium.</p><p>Tremor is a common adverse effect of <strong>lithium</strong>, possibly due to increased iron accumulation in the substantia nigra.&nbsp; Lithium-induced enhanced physiologic tremor is typically <strong>symmetric</strong>, limited to the <strong>hands</strong> and upper limbs, and occurs when the medication is started or the dose is increased (eg, after a manic episode).&nbsp; It is <strong>nonprogressive</strong> and often decreases over time, even with no dosage reduction.</p><p>Lithium-enhanced physiologic tremor must be distinguished from tremor due to <a href=\"2530\">lithium toxicity</a>, which typically causes an irregular, coarse tremor involving multiple parts of the body (not just the hands) accompanied by gastrointestinal or additional neurologic symptoms.&nbsp; Lithium toxicity requires treatment (eg, hydration, hemodialysis); in contrast, lithium-enhanced physiologic tremor is often managed with watchful waiting and modification of aggravating factors.</p><p><strong>(Choice A)</strong>&nbsp; Lithium and other neuropsychiatric medications can cause dystonia.&nbsp; Dystonic tremors may present as irregular tremors exacerbated by stress.&nbsp; However, they occur with sustained muscle contractions (eg, wrist spasms, torticollis), typically in the same area as the tremor.</p><p><strong>(Choice B)</strong>&nbsp; Essential tremor (ET) is also usually seen most prominently in the hands and can be worsened by anxiety or outstretched arms.&nbsp; However, it is predominantly an action tremor, so it becomes more pronounced at the end of goal-directed movements and improves with rest.&nbsp; Unlike this patient&#39;s tremor, ET classically improves with alcohol.&nbsp; In addition, patients are typically older or have a family history (ET is often autosomal dominant). Further, this patient&#39;s likely medication history makes a medication-enhanced physiologic tremor more likely.</p><p><strong>(Choice C)</strong>&nbsp; Hyperthyroidism can cause an enhanced physiologic tremor indistinguishable from this patients&#39; based on tremor characteristics.&nbsp; However, additional symptoms (eg, weight loss, heat intolerance) and findings of hyperthyroidism (eg, tachycardia, hypertension, hyperreflexia) are typically present.</p><p><strong>(Choice D)</strong>&nbsp; In contrast to this patient, patients with Parkinson disease classically have a resting tremor that improves with intentional movement.&nbsp; In addition, tremor is accompanied by rigidity, bradykinesia, and gait disturbances.</p><p><strong>Educational objective:</strong><br>Certain medications (eg, lithium) can enhance a physiologic tremor, which is typically a fine, symmetric action tremor of the hands that increases with sympathetic activity.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 14210,
            "topic": "Lithium",
            "titleId": 14210,
            "title": "Lithium",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Dystonic tremor",
                    "choiceNumber": 1,
                    "correctTaken": 1357,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Essential tremor",
                    "choiceNumber": 2,
                    "correctTaken": 4654,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hyperthyroidism",
                    "choiceNumber": 3,
                    "correctTaken": 399,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Idiopathic Parkinson disease",
                    "choiceNumber": 4,
                    "correctTaken": 152,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Medication adverse effect",
                    "choiceNumber": 5,
                    "correctTaken": 12090,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "79,126,true,-1,1*1040,1441,true,-1,1*1442,1909,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27900734",
                    "mediaDataId": 0,
                    "title": "Lithium side effects and toxicity: prevalence and management strategies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27900734",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23834617",
                    "mediaDataId": 0,
                    "title": "Lithium tremor revisited: pathophysiology and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23834617",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 58,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 18664,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 903,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 14,
            "questionId": 10055,
            "questionIndex": 10780,
            "questionText": "<p>A 68-year-old man comes to the office due to balance problems over the last 2 weeks.&nbsp; He has had muscle stiffness and 3 near-falls recently.&nbsp; The patient has no musculoskeletal pain or visual problems.&nbsp; He has a history of bipolar disorder and anxiety and was started on valproate and risperidone for a manic episode 5 months ago.&nbsp; Other medical issues include hypertension that is controlled with hydrochlorothiazide.&nbsp; Temperature is 37.2 C (99 F) and blood pressure is 122/78 mm Hg supine and 130/80 mm Hg standing.&nbsp; The patient appears slightly anxious but no longer manic.&nbsp; There is an asymmetric resting tremor in both hands.&nbsp; Finger tapping is slow and irregular bilaterally.&nbsp; Which of the following is the most likely cause of this patient&#39;s current condition?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t39773\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\" style=\"width: 60%;\"><p align=\"center\"><strong>Antipsychotic extrapyramidal effects</strong></p></td><td style=\"width: 40%;\"><p align=\"center\"><strong>Pharmacotherapy<sup>*</sup></strong></p></td></tr><tr><td style=\"width: 20%;\"><p align=\"center\"><strong>Acute<br />dystonia</strong></p></td><td style=\"width: 40%;\"><ul><li>Sudden, sustained contraction of the neck, mouth, tongue &amp; eye muscles</li></ul></td><td style=\"width: 40%;\"><ul><li>Benztropine</li><li>Diphenhydramine</li></ul></td></tr><tr><td><p align=\"center\"><strong>Akathisia</strong></p></td><td style=\"width: 40%;\"><ul><li>Subjective restlessness, inability to sit still</li></ul></td><td style=\"width: 40%;\"><ul><li>Beta blocker (propranolol)</li><li>Benzodiazepine (lorazepam)</li><li>Benztropine</li></ul></td></tr><tr><td><p align=\"center\"><strong>Parkinsonism</strong></p></td><td><ul><li>Gradual-onset tremor, rigidity &amp; bradykinesia</li></ul></td><td><ul><li>Benztropine</li><li>Amantadine</li></ul></td></tr><tr><td><p align=\"center\"><strong>Tardive<br />dyskinesia</strong></p></td><td><ul><li>Gradual onset after prolonged therapy (&gt;6 months): dyskinesia of the mouth, face, trunk &amp; extremities</li></ul></td><td><ul><li>Valbenazine</li><li>Deutetrabenazine</li></ul></td></tr><tr><td colspan=\"3\"><p><sup>*</sup>Management may include reducing the dose or switching to another antipsychotic, depending on the clinical scenario.</p></td></tr></tbody></table></div><p>Medications that block the dopamine (D2) receptor may cause <strong>extrapyramidal symptoms (EPS)</strong>.&nbsp; The most common offending agents include first-generation <strong>antipsychotics</strong> (eg, haloperidol), second-generation antipsychotics (eg, risperidone) to varying degrees, and antiemetics (eg, <strong>metoclopramide</strong>).&nbsp; This patient likely has <strong>drug-induced parkinsonism</strong> as he developed bradykinesia (eg, slow finger tapping), rigidity, and resting tremor (may be asymmetric or symmetric) after starting risperidone.</p><p>EPS also include acute dystonia, which is characterized by the sudden onset of sustained muscle contractions resulting in twisting and abnormal postures (eg, torticollis) rather than the classic parkinsonian resting tremor found in this patient <strong>(Choice A)</strong>.&nbsp; Akathisia, another type of EPS, presents with subjective restlessness and an inability to stay still, as opposed to rigidity and bradykinesia <strong>(Choice B)</strong>.&nbsp; Tardive dyskinesia is also less likely as it typically occurs after prolonged (&gt;6 months) antipsychotic exposure and is characterized by dyskinetic movements that typically involve the mouth/face/trunk (eg, lip smacking, grimacing, choreoathetoid movements) <strong>(Choice H)</strong>.</p><p><strong>(Choice C)</strong>&nbsp; Cerebellar stroke is less likely as this patient&#39;s blood pressure is well controlled and he lacks other atherosclerotic risk factors (eg, diabetes, hyperlipidemia, smoking).&nbsp; The onset of symptoms following treatment with risperidone makes drug-induced parkinsonism more likely.</p><p><strong>(Choice D)</strong>&nbsp; Charcot-Marie-Tooth disease is a hereditary peripheral neuropathy that most commonly presents with lower extremity weakness, foot drop, and, in some cases at a later stage, tremor.</p><p><strong>(Choice F)</strong>&nbsp; Essential tremor typically presents with an action (as opposed to resting) tremor that worsens with fine motor activity.&nbsp; Tremor is typically the only abnormal neurologic finding.</p><p><strong>(Choice G)</strong>&nbsp; Neuroleptic malignant syndrome is characterized by lead-pipe rigidity; this patient&#39;s lack of mental status changes, high fever, and autonomic instability makes it unlikely.</p><p><strong>Educational objective:</strong><br>Medications that block the dopamine (D2) receptor (eg, antipsychotics, metoclopramide) may cause extrapyramidal symptoms, including acute dystonia, parkinsonism, akathisia, and tardive dyskinesia.&nbsp; Drug-induced parkinsonism typically presents with bradykinesia, rigidity, and tremor.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 15858,
            "topic": "Antipsychotics",
            "titleId": 15858,
            "title": "Antipsychotics",
            "topicAttributeId": 330661,
            "topicAttribute": "Psychotic disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute dystonia",
                    "choiceNumber": 1,
                    "correctTaken": 672,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Akathisia",
                    "choiceNumber": 2,
                    "correctTaken": 1052,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cerebellar stroke",
                    "choiceNumber": 3,
                    "correctTaken": 196,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Charcot-Marie-Tooth disease",
                    "choiceNumber": 4,
                    "correctTaken": 21,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Drug-induced parkinsonism",
                    "choiceNumber": 5,
                    "correctTaken": 14972,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Essential tremor",
                    "choiceNumber": 6,
                    "correctTaken": 306,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Neuroleptic malignant syndrome",
                    "choiceNumber": 7,
                    "correctTaken": 216,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Tardive dyskinesia",
                    "choiceNumber": 8,
                    "correctTaken": 1058,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "461,473,true,-1,1*688,719,true,-1,1*837,965,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "610",
                    "mediaDataId": 0,
                    "title": "Antipsychotics",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27779780",
                    "mediaDataId": 0,
                    "title": "Incidence and time trends of drug-induced parkinsonism:  a 30-year population-based study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27779780",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23540800",
                    "mediaDataId": 0,
                    "title": "Drug-induced parkinsonism.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23540800",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 98,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 18493,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 81,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 659,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 15,
            "questionId": 2356,
            "questionIndex": 2356,
            "questionText": "<p>A 23-year-old woman comes to the office for follow-up after a recent hospitalization.&nbsp; The patient had no known psychiatric history prior to being arrested by police 2 months ago after breaking into city hall to &#x22;find evidence of a secret organization plotting to take over the world.&#x22;&nbsp; When police officers took her into custody, she was speaking so rapidly that they had difficulty understanding her.&nbsp; She was subsequently hospitalized and prescribed appropriate treatment; symptoms improved, and she was discharged 2 weeks later.&nbsp; Since then, the patient has been taking medications as prescribed.&nbsp; She is &#x22;doing much better&#x22; and has no symptoms.&nbsp; Vital signs are within normal limits and physical examination is unremarkable.&nbsp; The patient&#39;s speech is regular in rhythm and rate and she appears calm.&nbsp; She is fully oriented and does not appear distracted.&nbsp; Laboratory studies are unremarkable except for serum calcium of 13.4 mg/dL.&nbsp; This patient is most likely taking which of the following medications?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s acute onset of rapid speech and symptoms of psychosis (ie, delusions about a secret organization), followed by a return to normal functioning with treatment, is consistent with a bipolar manic episode.&nbsp; Pharmacotherapy for an acute manic episode includes a mood stabilizer and/or an antipsychotic medication.&nbsp; This patient&#39;s serum calcium level suggests that she was prescribed <strong>lithium</strong>, which can cause <strong>hyperparathyroidism</strong> and associated <strong>hypercalcemia</strong>.</p><p>Lithium is indicated for acute mania and maintenance treatment of bipolar disorder.&nbsp; In addition to hyperparathyroidism, potential long-term side effects include <strong>nephrogenic diabetes insipidus</strong>, <strong>chronic kidney disease</strong>, and <strong>thyroid dysfunction</strong> (most often hypothyroidism).&nbsp; Furthermore, first-trimester lithium exposure is associated with <strong>teratogenic</strong> effects (eg, Ebstein anomaly).&nbsp; <a href=\"6988\">Current guidelines</a> recommend a baseline basic metabolic panel (including blood urea nitrogen and creatinine), calcium, urinalysis, pregnancy test in women of childbearing age, and <strong>thyroid function tests</strong> before lithium is prescribed.&nbsp; An ECG is also recommended in patients with risk factors for coronary artery disease because lithium may cause dysrhythmias in these patients.</p><p><strong>(Choices A and E)</strong>&nbsp; The second-generation antipsychotics aripiprazole and quetiapine may be used in the treatment of bipolar disorder but are not associated with hypercalcemia.&nbsp; The most significant potential side effects of second-generation antipsychotics are weight gain, hyperlipidemia, and diabetes mellitus.</p><p><strong>(Choices B, C, and F)</strong>&nbsp; The anticonvulsant mood stabilizers carbamazepine, lamotrigine, and valproate are not known to cause clinically significant hypercalcemia.&nbsp; Carbamazepine and lamotrigine are noted for their risk of producing the mucocutaneous rash known as Stevens-Johnson syndrome.&nbsp; Valproate is known for its risk of inducing fetal neural tube defects and should be used with caution in women of childbearing age.</p><p><strong>Educational objective:</strong><br>Lithium is indicated both for the treatment of acute mania and for maintenance therapy in bipolar disorder.&nbsp; Long-term side effects include hyperparathyroidism with hypercalcemia, nephrogenic diabetes insipidus, chronic kidney disease, and thyroid dysfunction, as well as teratogenic effects.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 2698,
            "topic": "Hypercalcemia",
            "titleId": 2698,
            "title": "Hypercalcemia",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Aripiprazole",
                    "choiceNumber": 1,
                    "correctTaken": 935,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Carbamazepine",
                    "choiceNumber": 2,
                    "correctTaken": 1085,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lamotrigine",
                    "choiceNumber": 3,
                    "correctTaken": 715,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lithium",
                    "choiceNumber": 4,
                    "correctTaken": 11591,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Quetiapine",
                    "choiceNumber": 5,
                    "correctTaken": 1342,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Valproate",
                    "choiceNumber": 6,
                    "correctTaken": 1303,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "741,766,true,-1,1*897,1254,true,-1,1*1432,1568,true,-1,1*1732,1928,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27900734",
                    "mediaDataId": 0,
                    "title": "Lithium side effects and toxicity: prevalence and management strategies.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27900734",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29260296",
                    "mediaDataId": 0,
                    "title": "Lithium-associated hypercalcemia: pathophysiology, prevalence, management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29260296",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 125,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 16971,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 922,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 16,
            "questionId": 4051,
            "questionIndex": 4051,
            "questionText": "<p>A 30-year-old man comes to the office due to chronic fatigue.&nbsp; When he is not working, the patient is often at home sleeping; he estimates that he sleeps approximately 12 hours a day.&nbsp; He has felt down since being passed over for a promotion last month and copes by overeating.&nbsp; The patient says he has never had a lot of energy and can remember only a few times since high school when he felt happy&mdash;a month he spent with his grandparents in Florida and a brief period when he felt really good after starting his first job.&nbsp; He has worked as a computer programmer since graduating from college.&nbsp; The patient socializes with friends but avoids dating due to his weight, saying, &#x22;I just know I will be rejected because I&#39;m fat.&#x22;&nbsp; Apart from obesity, the patient has no other medical conditions.&nbsp; He smokes marijuana 3 times a week, which he began doing in his mid-20s, to &#x22;help me relax and feel better about myself.&#x22;&nbsp; He also drinks 4 cups of coffee before going to work on weekdays, which he says helps with his energy level.&nbsp; There is a family history of bipolar disorder in a maternal uncle.&nbsp; Vital signs and physical examination are unremarkable.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t38313\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Persistent depressive disorder (dysthymia)</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Chronic depressed mood &#8805;<strong>2 years</strong> (1 year in children/adolescents)</li><li>No symptom-free period for &gt;2 months</li><li>Presence of &#8805;<strong>2</strong> of the following:<ul style=\"list-style-type:circle;\"><li>Poor appetite or overeating</li><li>Insomnia or hypersomnia</li><li>Low energy or fatigue</li><li>Low self-esteem</li><li>Poor concentration or difficulty making decisions</li><li>Feelings of hopelessness</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Specifiers</strong></p></td><td><ul><li>With <strong>pure dysthymic syndrome</strong>: criteria for major depressive episode never met</li><li>With intermittent major depressive episodes</li><li>With persistent major depressive episodes: criteria for major depressive episode met throughout previous 2 years</li></ul></td></tr></tbody></table></div><p>This patient&#39;s <strong>chronic depression</strong> since adolescence, accompanied by overeating, hypersomnia, and low self-esteem, is consistent with <strong>persistent depressive disorder</strong> (dysthymia).&nbsp; Diagnosis requires that the patient has had persistent depressive symptoms for <strong>&#8805;2 years</strong> and has never been without depressive symptoms for &gt;2 months at a time.&nbsp; In DSM-5, persistent depressive disorder also encompasses patients who have met the full criteria for major depressive disorder at some point during the illness.</p><p><strong>(Choice A)</strong>&nbsp; Although this patient came to the office after being passed over for a promotion, his depressive symptoms have been present since adolescence and meet the criteria for persistent depressive disorder.&nbsp; Adjustment disorders are not diagnosed if the patient meets the criteria for another disorder.</p><p><strong>(Choices B and D)</strong>&nbsp; This patient&#39;s brief periods of feeling better likely represent normal (not elevated) mood, and he lacks other symptoms of hypomania (eg, inflated self-esteem, increased energy, decreased need for sleep, pressured speech) required for the diagnosis of bipolar II disorder.&nbsp; Cyclothymic disorder involves &#8805;2 years of numerous periods with hypomanic and depressive symptoms that do not meet the full criteria for hypomanic or major depressive episodes.</p><p><strong>(Choices C and E)</strong>&nbsp; Although medical conditions should always be considered before making a psychiatric diagnosis, this patient&#39;s long-standing history of chronic sadness, low energy, and low self-esteem are more likely due to dysthymia.&nbsp; Chronic fatigue syndrome (also referred to as systemic exertion intolerance disease) is characterized by relatively sudden onset of overwhelming fatigue, often associated with an infection such as mononucleosis.&nbsp; Hypothyroidism is less likely in this patient who does not report other typical symptoms (eg, cold intolerance, constipation, dry skin, recent weight gain) and has a normal physical examination.</p><p><strong>(Choice G)</strong>&nbsp; Although the use of substances such as marijuana and caffeine can affect mood, energy levels, and sleep patterns, this patient reports long-standing symptoms beginning in high school, prior to the use of substances, making dysthymia the more likely diagnosis.&nbsp; Patients with mood disorders often self-medicate to manage their symptoms.</p><p><strong>Educational objective:</strong><br>Persistent depressive disorder (dysthymia) refers to a depressed mood lasting most days for &#8805;2 years.&nbsp; It includes patients with pure dysthymia and those with intermittent or persistent major depressive episodes.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 13780,
            "topic": "Dysthymia",
            "titleId": 13780,
            "title": "Dysthymia",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "6",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder with depressed mood",
                    "choiceNumber": 1,
                    "correctTaken": 793,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Bipolar II disorder",
                    "choiceNumber": 2,
                    "correctTaken": 269,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Chronic fatigue syndrome",
                    "choiceNumber": 3,
                    "correctTaken": 732,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Cyclothymic disorder",
                    "choiceNumber": 4,
                    "correctTaken": 1179,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hypothyroidism",
                    "choiceNumber": 5,
                    "correctTaken": 540,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Persistent depressive disorder (dysthymia)",
                    "choiceNumber": 6,
                    "correctTaken": 14940,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Substance-induced depressive disorder",
                    "choiceNumber": 7,
                    "correctTaken": 548,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "814,975,true,-1,1*1464,1687,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20471093",
                    "mediaDataId": 0,
                    "title": "Impairment in psychosocial functioning associated with dysthymic disorder in the NESARC study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20471093",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24448972",
                    "mediaDataId": 0,
                    "title": "Efficacy and acceptability of acute treatments for persistent depressive disorder: a network meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24448972",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 283,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 19001,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 79,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 803,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 17,
            "questionId": 14489,
            "questionIndex": 15898,
            "questionText": "<p>A 33-year-old woman comes to the office due to low mood and anxiety for the past 5 weeks.&nbsp; The patient broke up with her boyfriend 6 weeks ago and was recently passed over for a promotion at work.&nbsp; She says, &#x22;Nothing ever works out for me.&nbsp; I&#39;m never going to find anyone at my age, and the people getting promotions are all younger than me.&#x22;&nbsp; The patient feels worse about herself after looking at her ex-boyfriend&#39;s social media accounts and has been &#x22;stress eating&#x22; on the weekends.&nbsp; She has had no weight changes and continues to work out regularly.&nbsp; The patient has difficulty falling asleep and often lies awake at night worrying about her future.&nbsp; She likes having dinner with her friends but says, &#x22;All of them are partnered up.&nbsp; I miss having a boyfriend to spend time with.&#x22;&nbsp; The patient has no psychiatric history.&nbsp; Vital signs and physical examination are normal.&nbsp; She appears tearful and tends to look at the floor while speaking; she has no suicidal ideation.&nbsp; Which of the following is the most appropriate management for this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T70868\" style=\"overflow-x:auto;\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Adjustment disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Mood and behavioral symptom onset within 3 months of identifiable stressor</li><li>Marked distress and/or functional impairment</li><li>Does not meet criteria for another DSM-5 disorder</li></ul></td></tr><tr><td><p align=\"center\"><strong>Differential diagnosis</strong></p></td><td><ul><li>Normal stress response (not excessive, no significant impairment)</li><li>Acute stress disorder (traumatic event, intrusive re-experiencing)</li><li>Major depressive disorder (&#8805;2 weeks, 5/9 symptoms, depressed mood, SIGECAPS)</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Psychotherapy is the treatment of choice</li><li>Adjunctive pharmacotherapy (short term, reserved for rapid relief of impairing symptoms [eg, sleep aid, anxiolytic])</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SIGECAPS</strong> = <strong>S</strong>leep disturbance, loss of <strong>I</strong>nterest, excessive <strong>G</strong>uilt, low <strong>E</strong>nergy, impaired <strong>C</strong>oncentration, <strong>A</strong>ppetite disturbance, <strong>P</strong>sychomotor agitation/retardation, and <strong>S</strong>uicidal ideation.</p></td></tr></tbody></table></div><p>This patient&#39;s 5-week history of distressing symptoms (eg, low mood, difficulty falling asleep, hopelessness, tearfulness) in <strong>response to psychosocial stress</strong> (eg, ended relationship, lost promotion) is most consistent with an <strong>adjustment disorder</strong>.&nbsp; Adjustment disorders are characterized by mood, anxiety, and/or behavioral changes in response to an identifiable stressor that results in functional impairment and/or <strong>marked distress</strong>, as in this patient who seeks medical care for her troubling symptoms.</p><p>A nonpharmacologic approach (ie, psychotherapy as opposed to pharmacotherapy) is the first-line intervention for adjustment disorders.&nbsp; <strong>Psychotherapy targets maladaptive responses</strong> to stress, including the dysfunctional thought patterns contributing to low mood and anxiety (eg, &#x22;nothing ever works out,&#x22; &#x22;never going to find anyone&#x22;) while avoiding unnecessary polypharmacy.&nbsp; Short-term pharmacotherapy alone or with psychotherapy is reserved for patients who have more severe, persistent, and impairing symptoms.</p><p><strong>(Choices A, B, and C)</strong>&nbsp; The antidepressants bupropion, escitalopram, and mirtazapine are long-term, first-line treatment options for patients with severely impairing symptoms characteristic of major depressive or generalized anxiety disorder.&nbsp; This patient&#39;s symptoms are insufficient in number and severity to meet diagnostic criteria for a major depressive episode, which would involve more persistent sadness and/or anhedonia with further depressive symptoms (eg, low energy, impaired concentration, excessive guilt, suicidal thoughts).&nbsp; The duration of her anxiety symptoms is not long enough to diagnose a generalized anxiety disorder, which requires that symptoms persist for at least 6 months.&nbsp; Therefore, antidepressants are not indicated in this patient.</p><p><strong>(Choice E)</strong>&nbsp; Reassurance is appropriate only for patients whose symptoms do not result in marked distress or functional impairment.&nbsp; This patient&#39;s dysfunctional behavior and thought patterns would be best addressed with psychotherapy to help resolve current distress and develop skills to respond to future psychosocial stressors.</p><p><strong>Educational objective:</strong><br>Psychotherapy is the first-line treatment approach for patients with adjustment disorders.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bupropion",
                    "choiceNumber": 1,
                    "correctTaken": 121,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Escitalopram",
                    "choiceNumber": 2,
                    "correctTaken": 987,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Mirtazapine",
                    "choiceNumber": 3,
                    "correctTaken": 127,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Psychotherapy",
                    "choiceNumber": 4,
                    "correctTaken": 2987,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassurance only",
                    "choiceNumber": 5,
                    "correctTaken": 779,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "130",
                    "mediaDataId": 0,
                    "title": "Adjustment disorder",
                    "referenceTypeId": 18,
                    "referenceLink": null,
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31315203",
                    "mediaDataId": 0,
                    "title": "Adjustment disorder: current developments and future directions.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31315203",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30204563",
                    "mediaDataId": 0,
                    "title": "Psychotherapy of adjustment disorders: current state and future directions.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30204563",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 115,
            "othersAvgTimeSpent": 78,
            "notes": null,
            "peopleTaken": 5001,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 60,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 835,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 18,
            "questionId": 2494,
            "questionIndex": 2494,
            "questionText": "<p>A 33-year-old man with an unremarkable medical history comes to the office due to fatigue and weight loss over the past 3 months.&nbsp; He awakens at 4:00 AM each day and is unable to fall back asleep.&nbsp; The patient also mentions that he had enjoyed golf and playing with his children but now has little interest in either activity.&nbsp; Although he used to excel at work, he now has no motivation and &#x22;spaces out&#x22; at times.&nbsp; Physical examination and laboratory studies, including TSH level, are normal.&nbsp; The patient is diagnosed with major depressive disorder and prescribed fluoxetine.&nbsp; Two weeks later, he calls to report that he is sleeping and eating better but is still depressed.&nbsp; The patient is discouraged about his lack of improvement and says, &#x22;I don&#39;t feel like the medication is doing very much.&#x22;&nbsp; Which of the following is the most appropriate next step in pharmacological management?</p>",
            "questionHeader": "",
            "explanationText": "<p>Antidepressants take time to work, and this patient&#39;s lack of global improvement at the 2-week mark is not uncommon.&nbsp; In addition, although he still feels depressed, he shows signs of improvement in some depressive symptoms (ie, sleep and appetite) at his current dosage.&nbsp; An <strong>adequate antidepressant trial</strong> is generally considered to be at least <strong>4-6 weeks</strong>.&nbsp; The patient should be educated that 2 weeks is considered an inadequate trial and be encouraged to continue the medication for at least 2-4 more weeks.&nbsp; Inadequate antidepressant dose or duration is a common reason for perceived lack of response, and physicians must ensure that patients receive an adequate trial before recommending next-step treatments.</p><p><strong>(Choices A and B)</strong>&nbsp; Augmentation strategies such as adding aripiprazole or bupropion are generally considered when a patient has experienced a partial response to an adequate trial of monotherapy.&nbsp; It would be premature to add these medications after only 2 weeks of fluoxetine therapy.</p><p><strong>(Choices D and E)</strong>&nbsp; Switching to a different antidepressant is a reasonable strategy if the patient shows little improvement after a 4- to 6-week trial.&nbsp; Discontinuing fluoxetine would risk losing his partial response.</p><p><strong>(Choice F)</strong>&nbsp; Increasing the dose of fluoxetine is not indicated in this patient who is already showing signs of responding (ie, improved sleep and appetite) and would unnecessarily increase his risk of adverse effects.</p><p><strong>Educational objective:</strong><br>Adequate duration of an antidepressant trial is generally considered to be 6 weeks.&nbsp; Physicians should continue antidepressants at therapeutic dosages for at least 4-6 weeks before considering the next step in treatment.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Add aripiprazole to augment antidepressant response",
                    "choiceNumber": 1,
                    "correctTaken": 67,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Add bupropion to augment antidepressant response",
                    "choiceNumber": 2,
                    "correctTaken": 296,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Continue fluoxetine at present dose",
                    "choiceNumber": 3,
                    "correctTaken": 14448,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinue fluoxetine and begin a different selective serotonin reuptake inhibitor (SSRI)",
                    "choiceNumber": 4,
                    "correctTaken": 258,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinue fluoxetine and begin a nonselective SRI",
                    "choiceNumber": 5,
                    "correctTaken": 56,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increase dose of fluoxetine",
                    "choiceNumber": 6,
                    "correctTaken": 1737,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23531115",
                    "mediaDataId": 0,
                    "title": "Serotonergic drugs for depression and beyond.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23531115",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "20977871",
                    "mediaDataId": 0,
                    "title": "When should you move beyond first-line therapy for depression?",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/20977871",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27554483",
                    "mediaDataId": 0,
                    "title": "Systematic review of clinical practice guidelines for failed antidepressant treatment response in major depressive disorder, dysthymia, and sub threshold depression in adults.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27554483",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 63,
            "othersAvgTimeSpent": 41,
            "notes": null,
            "peopleTaken": 16862,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 86,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 169,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 19,
            "questionId": 14403,
            "questionIndex": 15812,
            "questionText": "<p>A 62-year-old woman comes to the office due to insomnia and depressed mood.&nbsp; She describes feeling angry and sad since her husband of 35 years unexpectedly announced that he wanted a divorce 2 months ago.&nbsp; She says, &#x22;I was devastated because I thought we had a pretty good marriage, better than most.&nbsp; My whole life has been turned upside down.&nbsp; I can&#39;t even think about going on dates at my age.&#x22;&nbsp; The patient stays up well past her usual bedtime worrying about living alone and supporting herself financially.&nbsp; She recently started drinking wine before bedtime to help her fall asleep.&nbsp; Although she was regularly eating lunch with friends, she has canceled multiple times because she &#x22;can&#39;t bear to go through the whole story again and again.&#x22;&nbsp; She has no suicidal ideation.&nbsp; The patient is tearful when discussing the divorce but brightens when asked about her grandchildren.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33834\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Differential diagnosis of depressed mood </strong></p></td></tr><tr><td><p align=\"center\"><strong>Major depressive disorder </strong></p></td><td><ul><li>&ge;2 weeks</li><li><strong>&ge;5 of 9 </strong>symptoms: depressed mood &amp; SIGECAPS</li><li>Significant functional impairment</li><li>No lifetime history of mania</li></ul></td></tr><tr><td><p align=\"center\"><strong>Persistent depressive disorder (dysthymia) </strong></p></td><td><ul><li>Chronic depressed mood &ge;2 years</li><li>&ge;2 of the following: appetite disturbance, sleep disturbance, low energy, low self-esteem, poor concentration, hopelessness</li></ul></td></tr><tr><td><p align=\"center\"><strong>Adjustment disorder with depressed mood </strong></p></td><td><ul><li>Onset within 3 months of identifiable stressor</li><li>Marked distress &amp;/or functional impairment</li><li>Does not meet criteria for another DSM-5-TR&nbsp;disorder</li></ul></td></tr><tr><td><p align=\"center\"><strong>Normal stress response </strong></p></td><td><ul><li>Not excessive or out of proportion to severity of stressor</li><li>No significant functional impairment</li></ul></td></tr><tr><td colspan=\"2\"><p><strong>SIGECAPS</strong> = <strong>S</strong>leep disturbance, loss of <strong>I</strong>nterest, excessive <strong>G</strong>uilt, low <strong>E</strong>nergy, impaired <strong>C</strong>oncentration, <strong>A</strong>ppetite disturbance, <strong>P</strong>sychomotor agitation/retardation, and <strong>S</strong>uicidal ideation.&nbsp;</p></td></tr></tbody></table></div><p>This patient&#39;s onset of depressive symptoms following the major life stressor of divorce and the absence of symptoms severe enough to diagnose major depressive disorder make <strong>adjustment disorder</strong> with depressed mood the most likely diagnosis.&nbsp; Adjustment disorder involves emotional or behavioral symptoms (eg, depression, anxiety, disturbance of conduct) developing <strong>within 3 months</strong> of an <strong>identifiable stressor</strong> and lasting &#8804;6 months once the stressor or its consequences ceases.</p><p>Symptoms in an adjustment disorder must be <strong>distressing</strong> and/or <strong>impairing</strong> (eg, this patient is distressed and seeking treatment) but are insufficient to meet full criteria for another mental disorder such as major depressive disorder.&nbsp; This patient has sadness, anxiety, and sleep disturbance related to the divorce and living alone.&nbsp; However, she does not experience the pervasive sadness, anhedonia, guilt, impaired concentration, appetite disturbance, psychomotor changes, or suicidality that characterize major depressive disorder.</p><p><strong>(Choice A)</strong>&nbsp; Acute stress disorder is characterized by reexperiencing events (ie, intrusive memories, flashbacks), avoidance, negative mood, dissociation, and hyperarousal lasting from 3 days to 1 month following a life-threatening traumatic event.</p><p><strong>(Choice C)</strong>&nbsp; Generalized anxiety disorder is characterized by excessive worry over multiple issues lasting &#8805;6 months.</p><p><strong>(Choice D)</strong>&nbsp; This patient&#39;s insomnia developed in response to a stressor.&nbsp; It is better explained as part of an adjustment disorder and would not be diagnosed separately.</p><p><strong>(Choice E)</strong>&nbsp; A diagnosis of major depressive disorder requires a 2-week period of &#8805;5 of 9 symptoms: depressed mood, decreased interest/pleasure, appetite disturbance, sleep disturbance, psychomotor agitation/retardation, loss of energy, excessive guilt, impaired concentration, and suicidal ideation.</p><p><strong>Educational objective:</strong><br>Adjustment disorder involves symptoms occurring within 3 months of an identifiable stressor that cause significant distress and/or impairment.&nbsp; It is not diagnosed if a patient meets diagnostic criteria for another mental disorder.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 396,
            "topic": "Adjustment disorders",
            "titleId": 396,
            "title": "Adjustment disorders",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute stress disorder",
                    "choiceNumber": 1,
                    "correctTaken": 1025,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder",
                    "choiceNumber": 2,
                    "correctTaken": 14072,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Generalized anxiety disorder",
                    "choiceNumber": 3,
                    "correctTaken": 165,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Insomnia disorder",
                    "choiceNumber": 4,
                    "correctTaken": 54,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 5,
                    "correctTaken": 1656,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28784404",
                    "mediaDataId": 0,
                    "title": "Adjustment disorder: prevalence, sociodemographic risk factors, and its subtypes in outpatient psychiatric clinic.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28784404",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25134873",
                    "mediaDataId": 0,
                    "title": "Seasonal affective disorder, grief reaction, and adjustment disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25134873",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "19558652",
                    "mediaDataId": 0,
                    "title": "Adjustment disorder: epidemiology, diagnosis and treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/19558652",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 75,
            "othersAvgTimeSpent": 51,
            "notes": null,
            "peopleTaken": 16972,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 83,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 317,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 20,
            "questionId": 16274,
            "questionIndex": 17716,
            "questionText": "<p>A 22-year-old man is brought to the emergency department by his roommate for evaluation of &#x22;weird behavior.&#x22;&nbsp; Eight days ago, the patient&#39;s father died in a car accident.&nbsp; Since then, the patient has been sleeping poorly and eating minimally.&nbsp; His roommate says, &#x22;He&#39;s been keeping all the lights off in the apartment.&nbsp; Yesterday when I walked in, he was sitting alone in the dark and whispering as if someone else was there.&nbsp; When I switched on the lights, he immediately closed his eyes and covered his ears.&#x22;&nbsp; The roommate reports that the patient is studying computer science and has been on the honor roll every semester, but for the past week, he has not gone to class or spent time with friends.&nbsp; As an adolescent, the patient was treated for a depressive episode shortly after his parents divorced.&nbsp; He has no significant medical history and does not take any medications.&nbsp; Vital signs are normal and physical examination is unremarkable.&nbsp; On mental status examination, he appears unkempt and hypervigilant.&nbsp; His responses are short and unrelated to the questions being asked.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p>This man&#39;s acute onset of <strong>disorganized, bizarre behavior</strong> (eg, keeping lights off, closing eyes, covering ears), <strong>disorganized speech</strong> (eg, nonsensical responses), and probable <strong>hallucinations</strong> (eg, whispering to himself in the dark) following the traumatic death of his father is consistent with <strong>brief psychotic disorder</strong> (BPD).&nbsp; BPD is characterized by psychotic symptoms lasting between 1 day and 1 month.&nbsp; As in this case, it is often <strong>triggered</strong> by a traumatic or <strong>stressful event</strong> and can be specified as &#x22;with marked stressor(s).&#x22;</p><p>When triggered by the loss of a loved one, BPD should be differentiated from a normal grief reaction.&nbsp; In a normal grief reaction, individuals may have hallucinatory experiences that are centered on maintaining a connection with the deceased (such as seeing, hearing, or being touched by the deceased) <strong>(Choice E)</strong>.&nbsp; Their behavior and speech, however, are not disorganized and they are still able to relate to others.&nbsp; In contrast, this man&#39;s behavior is bizarre and his responses on examination are nonsensical.</p><p><strong>(Choice A)</strong>&nbsp; Acute stress disorder is characterized by an intrusive re-experiencing of a traumatic event accompanied by symptoms of hyperarousal, dissociation, and avoidance lasting for &#8804;1 month.</p><p><strong>(Choice C)</strong>&nbsp; In delusional disorder, individuals have 1 or more delusions that have been present for at least 1 month.&nbsp; It is not accompanied by markedly bizarre behavior or impairment.</p><p><strong>(Choice D)</strong>&nbsp; Although psychotic symptoms and poor sleep can be seen in a manic episode of bipolar disorder, this patient does not display other key features of mania (eg, prominent mood symptoms, increased energy, grandiosity, talkativeness, excessive engagement in pleasurable activities).</p><p><strong>(Choice F)</strong>&nbsp; Persistent complex bereavement disorder is a prolonged and disabling grief reaction characterized by extreme and persistent yearning for the deceased that causes functional impairment and inability to resume normal life.</p><p><strong>(Choice G)</strong>&nbsp; In schizophreniform disorder, psychotic symptoms last &#8805;1 month and &lt;6 months.&nbsp; If this man&#39;s psychotic symptoms persisted beyond 1 month, a diagnosis of schizophreniform disorder could be considered.&nbsp; If symptoms persisted for &#8805;6 months, the accurate diagnosis would be schizophrenia.</p><p><strong>Educational objective:</strong><br>Brief psychotic disorder is characterized by the acute onset of psychotic symptoms (eg, disorganized speech and behavior, delusions, hallucinations) lasting between 1 day and 1 month.&nbsp; It can be triggered by a marked stressor such as the loss of a loved one.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17738,
            "topic": "Brief psychotic disorder",
            "titleId": 17738,
            "title": "Brief psychotic disorder",
            "topicAttributeId": 330661,
            "topicAttribute": "Psychotic disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Acute stress disorder",
                    "choiceNumber": 1,
                    "correctTaken": 3211,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Brief psychotic disorder",
                    "choiceNumber": 2,
                    "correctTaken": 11075,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Delusional disorder",
                    "choiceNumber": 3,
                    "correctTaken": 39,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Manic episode with psychotic features",
                    "choiceNumber": 4,
                    "correctTaken": 526,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal grief reaction",
                    "choiceNumber": 5,
                    "correctTaken": 1461,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Persistent complex bereavement disorder",
                    "choiceNumber": 6,
                    "correctTaken": 213,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Schizophreniform disorder",
                    "choiceNumber": 7,
                    "correctTaken": 485,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "661,1069,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23707641",
                    "mediaDataId": 0,
                    "title": "Structure of the&#160;psychotic disorders&#160;classification in DSM-5.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23707641",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 150,
            "othersAvgTimeSpent": 62,
            "notes": null,
            "peopleTaken": 17010,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 447,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 21,
            "questionId": 14637,
            "questionIndex": 16051,
            "questionText": "<p>A 68-year-old man comes to the office due to &#x22;strange visions.&#x22;&nbsp; He lives alone and has not seen a doctor in 30 years.&nbsp; The patient says, &#x22;I started seeing people passing through my peripheral vision in the evenings about 2 months ago.&nbsp; What&#39;s weird is that my closest neighbors are 2 miles away, and I rarely have visitors.&#x22;&nbsp; The patient is not forgetful and still drives, goes grocery shopping, prepares meals, and takes care of chores around the house.&nbsp; He says his energy is &#x22;not what it used to be,&#x22; and he has lost his balance a few times but has not fallen.&nbsp; The patient was told to see a doctor for his &#x22;shaky hands&#x22; several years ago but never sought an evaluation.&nbsp; Temperature is 37.1 C (98.8 F), blood pressure is 138/89 mm Hg, pulse is 78/min, and respirations are 14/min.&nbsp; There are decreased facial expression and reduced eye blinking.&nbsp; He has a tremor at rest that is most prominent in the right hand.&nbsp; There is resistance to passive movement in all limbs that is worse on the right.&nbsp; Gait is steady but slow.&nbsp; The patient has a score of 29/30 (normal: &#8805;26) on the Montreal Cognitive Assessment.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T97979\" style=\"overflow-x:auto;\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\"><p align=\"center\"><strong>Parkinson disease vs dementia with Lewy bodies</strong></p></td></tr><tr><td></td><td><p align=\"center\"><strong>Parkinson disease</strong></p></td><td><p align=\"center\"><strong>DLB</strong></p></td></tr><tr><td><p align=\"center\"><strong>Dementia</strong></p></td><td><ul><li>Late: &gt;1 year after parkinsonism onset</li><li>Eventually develops in most patients (&gt;10 years)</li></ul></td><td><ul><li>Early: &lt;1 year of parkinsonism onset</li><li>Essential to diagnosis</li></ul></td></tr><tr><td><p align=\"center\"><strong>Parkinsonism*</strong></p></td><td><ul><li>Prominent, typically asymmetric</li><li>100% at dementia diagnosis</li></ul></td><td><ul><li>Usually mild (&lt;50% at diagnosis), more symmetric</li></ul></td></tr><tr><td><p align=\"center\"><strong>Visual<br>hallucinations</strong></p></td><td><ul><li>Usually mild in untreated disease</li><li>Often late sign, worsen with dopaminergic drugs</li></ul></td><td><ul><li>Usually well-formed &amp; detailed</li><li>Prominent early sign</li></ul></td></tr><tr><td colspan=\"3\"><p>*Bradykinesia, rest tremor, rigidity &amp; postural instability.</p><p><strong>DLB</strong> = dementia with Lewy bodies.</p></td></tr></tbody></table></div><p><strong>Hallucinations</strong> in the setting of <strong>parkinsonism</strong> (ie, bradykinesia, tremor, rigidity, postural instability) can occur with both Parkinson disease (PD) and dementia with Lewy bodies (DLB), which share&nbsp;neuropathologic findings (ie, alpha-synuclein inclusions/Lewy bodies).</p><p>Some characteristics may help distinguish the 2 conditions:</p><ul><li><p>The major clinical distinction is the&nbsp;<a href=\"67876\">timing of dementia relative to parkinsonism</a>.&nbsp;<strong>Dementia</strong> occurring <strong>&gt;1 year</strong> after parkinsonism onset is classified as PD, whereas dementia preceding or starting &lt;1 year from parkinsonism onset denotes DLB.</p></li><li><p>Characteristics of <strong>hallucinations</strong>&nbsp;can also be helpful.&nbsp; DLB is characterized by well-formed visual hallucinations (eg, detailed images of people/small animals) that occur&nbsp;early in the disease;&nbsp;similar hallucinations are sometimes seen with PD,&nbsp;but they are classically related to drug (eg, dopaminergic) therapy and occur later in the disease.&nbsp; However, <strong>minor</strong> hallucinations (uncommon in DLB) occur in approximately 40% of patients with <strong>untreated PD</strong> and can be a premotor symptom; in contrast to well-formed visual hallucinations, minor hallucinations are characterized as <strong>sensations of presence</strong> (ie, someone nearby) and/<strong>or passage</strong> (ie, someone passing through peripheral vision), as seen in this patient.</p></li><li><p>Other features:&nbsp; Findings more characteristic of PD include asymmetric parkinsonism, more <strong>gradual progression</strong>, earlier onset, and increased levodopa responsiveness (vs DLB).</p></li></ul><p>This patient does not have dementia (eg, normal cognitive assessment, intact activities of daily living such as driving and shopping) despite longstanding parkinsonism (eg, tremor starting years ago); he also has minor hallucinations of passage.&nbsp; These features make PD more likely than DLB <strong>(Choice B)</strong>.</p><p><strong>(Choice A)</strong>&nbsp; Creutzfeldt-Jakob disease can cause extrapyramidal signs (eg, bradykinesia, rigidity) and visual hallucinations.&nbsp; However, neuromotor manifestations typically include myoclonus, cerebellar signs (eg, ataxia), and/or upper motor neuron findings.&nbsp; Moreover, patients have rapidly progressive dementia with decline to death usually occurring within one year of disease onset.</p><p><strong>(Choice C)</strong>&nbsp; Although major depressive disorder with psychotic features frequently involves hallucinations, the psychotic symptoms typically have depressive themes (eg, guilt, worthlessness), unlike the passage/presence hallucinations seen with untreated PD.&nbsp; In addition, this patient has only one clear symptom of depression (low energy), and depression would not explain parkinsonism.</p><p><strong>(Choice D)</strong>&nbsp; Normal pressure hydrocephalus is associated with urinary incontinence, gait disorder, and cognitive decline (&#x22;wet, wobbly, wacky&#x22;).&nbsp; Hallucinations and parkinsonism are not characteristic.</p><p><strong>Educational objective:</strong><br>Parkinson disease (PD) and dementia with Lewy bodies (DLB) both cause parkinsonism and dementia but can be distinguished by timing (PD: dementia &gt;1 year after parkinsonism; DLB: dementia prior to or &lt;1 year after parkinsonism).&nbsp; Well-formed hallucinations are more common in DLB (and can occur in PD patients receiving dopaminergic therapy), but minor hallucinations (presence/passage) can be seen even in untreated PD.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 9838,
            "topic": "Psychosis",
            "titleId": 9838,
            "title": "Psychosis",
            "topicAttributeId": 330661,
            "topicAttribute": "Psychotic disorders",
            "correctAnswer": "5",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Creutzfeldt-Jakob disease",
                    "choiceNumber": 1,
                    "correctTaken": 270,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dementia with Lewy bodies",
                    "choiceNumber": 2,
                    "correctTaken": 2059,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder with psychotic features",
                    "choiceNumber": 3,
                    "correctTaken": 5469,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal pressure hydrocephalus",
                    "choiceNumber": 4,
                    "correctTaken": 322,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Parkinson disease",
                    "choiceNumber": 5,
                    "correctTaken": 10151,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "271,302,true,-1,1*364,378,true,-1,1*855,894,true,-1,1*1391,1542,true,-1,1*1922,2078,true,-1,1*2395,2767,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28106066",
                    "mediaDataId": 0,
                    "title": "The psychosis spectrum in Parkinson disease.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28106066",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27042903",
                    "mediaDataId": 0,
                    "title": "Lewy body dementias: dementia with Lewy bodies and Parkinson disease dementia.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27042903",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26952120",
                    "mediaDataId": 0,
                    "title": "Minor hallucinations occur in drug-na&#239;ve Parkinson&#39;s disease patients, even from the premotor phase.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26952120",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "31289146",
                    "mediaDataId": 0,
                    "title": "Minor hallucinations in Parkinson disease: a subtle symptom with major clinical implications.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/31289146",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 100,
            "othersAvgTimeSpent": 52,
            "notes": null,
            "peopleTaken": 18271,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 56,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1471,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 22,
            "questionId": 14651,
            "questionIndex": 16066,
            "questionText": "<p>A 32-year-old woman with bipolar disorder comes to the office for follow-up.&nbsp; The patient was diagnosed and treated for a manic episode at age 29 and has been stable on a combination of lithium and risperidone.&nbsp; Her mood has been &#x22;fine&#x22; overall, but she has been stressed about work.&nbsp; After a staff meeting a few weeks ago, her supervisor said she appeared angry because she was repeatedly frowning while others were presenting.&nbsp; Since then, the patient has been increasingly self-conscious and has started eating lunch alone at her desk.&nbsp; Temperature is 37.0 C (98.6 F), blood pressure is 132/78 mm Hg, pulse is 72/min, and respirations are 14/min.&nbsp; Physical examination is unremarkable except for occasional grimacing and slow inversion and tapping movements of her right foot.&nbsp; Lithium level is 0.9 mEq/L (normal: 0.6-1.2).&nbsp; Which of the following is the most appropriate next step in pharmacological management?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T37658\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Tardive dyskinesia</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical features</strong></p></td><td><ul><li>Abnormal involuntary movements due to prolonged use of antipsychotics or metoclopramide</li><li>Orofacial dyskinesia (tongue protrusion, lip smacking, grimacing)</li><li>Limb dyskinesia (dystonic postures, foot tapping, chorea)</li><li>Trunk dyskinesia (rocking, thrusting, shoulder shrugging)</li><li>Greater risk with first-generation antipsychotics</li></ul></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><ul><li>Discontinue causative medication if feasible</li><li>Switch to second-generation antipsychotic (quetiapine, clozapine) if continued antipsychotic is required</li><li>Treat with valbenazine or deutetrabenazine</li></ul></td></tr></tbody></table></div><p>This patient&#39;s facial grimacing combined with foot tapping and inversion movements are most likely signs of <strong>tardive dyskinesia</strong> (TD) caused by exposure to <strong>risperidone</strong>, a second-generation <strong>antipsychotic</strong> (SGA) used in the treatment of bipolar and psychotic disorders.&nbsp; Although most commonly associated with first-generation antipsychotics and antiemetic metoclopramide, TD may also occur with some SGAs.&nbsp; The risk of TD varies significantly within the SGA class; risperidone is among the highest-risk SGAs whereas clozapine and quetiapine are among the lowest-risk SGAs.</p><p>Patients receiving maintenance antipsychotic medication should be assessed for TD at regular intervals and the <strong>causative medication</strong> tapered and <strong>discontinued if feasible</strong>.&nbsp; This patient has been stable (ie, no recurrent mood episodes for 3 years) and may not require maintenance risperidone because lithium may adequately control her symptoms.&nbsp; Therefore, a gradual taper and discontinuation of risperidone is the most appropriate initial management.&nbsp; When antipsychotic dose reduction or discontinuation is not feasible, treatment options include switching to a lower-risk agent (eg, clozapine) or treatment with a vesicular monoamine transporter 2 inhibitor (eg, valbenazine, deutetrabenazine).</p><p><strong>(Choice A)</strong>&nbsp; Anticholinergic drugs (eg, benztropine) are ineffective and may worsen TD.&nbsp; Benztropine is indicated in the treatment of acute dystonia.</p><p><strong>(Choice B)</strong>&nbsp; Propranolol has been used in the treatment of akathisia, a type of extrapyramidal symptom characterized by inner restlessness and inability to sit still.&nbsp; It is ineffective in treating TD.</p><p><strong>(Choice C)</strong>&nbsp; Lithium is not the causative agent of this patient&#39;s TD and should be maintained.&nbsp; Switching to valproic acid would risk destabilizing the patient.</p><p><strong>(Choice D)</strong>&nbsp; Continued exposure to risperidone would likely exacerbate the patient&#39;s TD.</p><p><strong>(Choice E)</strong>&nbsp; This patient is not in a major depressive episode.&nbsp; Adding an antidepressant (eg, fluoxetine) may have destabilizing effects in a bipolar patient and would not treat TD.</p><p><strong>Educational objective:</strong><br>Tardive dyskinesia is characterized by abnormal involuntary movements of the face, lips, tongue, trunk, or extremities that develop as a result of prolonged exposure to antipsychotic medication.&nbsp; If feasible, the causative medication should be tapered and discontinued.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 456,
            "topic": "Tardive dyskinesia",
            "titleId": 456,
            "title": "Tardive dyskinesia",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "6",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Add benztropine as needed",
                    "choiceNumber": 1,
                    "correctTaken": 5166,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Add daily propranolol",
                    "choiceNumber": 2,
                    "correctTaken": 964,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Discontinue lithium and start valproic acid",
                    "choiceNumber": 3,
                    "correctTaken": 287,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Maintain current regimen",
                    "choiceNumber": 4,
                    "correctTaken": 406,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe fluoxetine",
                    "choiceNumber": 5,
                    "correctTaken": 124,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Taper and discontinue risperidone",
                    "choiceNumber": 6,
                    "correctTaken": 9949,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "591,722,true,-1,1*993,1158,true,-1,1*1331,1854,true,-1,1*237,278,true,-1,1*297,335,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29022654",
                    "mediaDataId": 0,
                    "title": "Epidemiology, prevention, and assessment of tardive dyskinesia and advances in treatment.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29022654",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30192088",
                    "mediaDataId": 0,
                    "title": "Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30192088",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 95,
            "othersAvgTimeSpent": 59,
            "notes": null,
            "peopleTaken": 16896,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 59,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 486,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 23,
            "questionId": 14514,
            "questionIndex": 15924,
            "questionText": "<p>A 35-year-old man comes to the office due to persistent fatigue and insomnia for the past 3 weeks.&nbsp; The patient was fired from his job as an insurance salesman a month ago due to poor sales and has since felt increasingly tired.&nbsp; He has no difficulty falling asleep but, &#x22;for no reason,&#x22; awakens at 4 AM most nights.&nbsp; The patient&#39;s wife has told him he snores occasionally, although he has not awakened short of breath.&nbsp; He says, &#x22;I liked going to the gym with my friends, but now I just don&#39;t want to anymore.&nbsp; I&#39;m at home a lot now, but I don&#39;t have the energy to play with my kids.&#x22;&nbsp; The patient feels pressured to look for new job opportunities but is so unfocused that he has not been able to complete any applications.&nbsp; Medical history is significant for hypertension treated with enalapril.&nbsp; Weight is 81 kg (178.6 lb) and height is 180.3 cm (5 ft 11 in).&nbsp; Vital signs are within normal limits.&nbsp; Physical examination and laboratory studies show no abnormalities.&nbsp; The patient moves slowly and appears withdrawn.&nbsp; Polysomnography is recommended to assess for sleep abnormalities.&nbsp; This patient is most likely to have which of the following findings?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s 3-week history of low energy, sleep disturbance, decreased interest, and impaired concentration, as well as the finding of psychomotor slowing on mental status examination, is consistent with <a href=\"17482\">major depressive disorder</a> (MDD).&nbsp; <strong>Sleep abnormalities</strong> are a <strong>core symptom</strong> of depression and may include difficulty falling asleep, interrupted sleep, early morning awakening, and hypersomnia.</p><p>A characteristic polysomnographic finding in MDD is <strong>decreased REM sleep latency</strong> (the time from sleep onset until the start of the first REM sleep period), which is considered a biomarker for depression.&nbsp; Other sleep findings in depressed patients include <strong>decreased slow-wave sleep</strong> and increased REM sleep duration and density, as well as disruptions in sleep continuity.&nbsp; Sleep disturbances in MDD typically return to normal with antidepressant treatment.</p><p><strong>(Choice B)</strong>&nbsp; Increased periodic limb movements during sleep (ie, involuntary jerking movements of the legs) may cause nighttime arousals, which typically lead to excessive daytime somnolence.&nbsp; Periodic limb movement disorder would not explain this patient&#39;s marked depressive symptoms.</p><p><strong>(Choice C)</strong>&nbsp; Slow-wave sleep (also known as deep sleep) is decreased, not increased, in MDD.</p><p><strong>(Choice D)</strong>&nbsp; Loss of normal REM sleep atonia is a feature of REM sleep behavior disorder, a parasomnia characterized by dream-enactment behaviors.</p><p><strong>(Choice E)</strong>&nbsp; Sleep-related hypoventilation and apneas on polysomnography are characteristic of obstructive sleep apnea (OSA).&nbsp; These patients commonly have a history of observed breathing pauses, snoring, and gasping for air, as well as excessive daytime sleeping rather than early morning awakening.&nbsp; Although this patient has some risk factors for OSA (eg, male, hypertension, snoring), he has a normal BMI and no evidence of interrupted breathing.&nbsp; MDD is a better explanation for his 3-week history of symptoms.</p><p><strong>Educational objective:</strong><br>Sleep disturbance is a core symptom of depression.&nbsp; Polysomnographic findings in major depressive disorder include decreased REM latency and slow-wave sleep, as well as increased REM sleep duration and REM sleep density.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "1",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Decreased REM sleep latency",
                    "choiceNumber": 1,
                    "correctTaken": 3440,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased periodic limb movements during sleep",
                    "choiceNumber": 2,
                    "correctTaken": 118,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Increased slow-wave sleep",
                    "choiceNumber": 3,
                    "correctTaken": 432,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "REM sleep without atonia",
                    "choiceNumber": 4,
                    "correctTaken": 133,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sleep-related hypoventilation",
                    "choiceNumber": 5,
                    "correctTaken": 845,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1643,1706,true,-1,1*1707,1921,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26412074",
                    "mediaDataId": 0,
                    "title": "The neurobiological mechanisms and treatments of REM sleep disturbances in depression.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26412074",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23391633",
                    "mediaDataId": 0,
                    "title": "REM sleep dysregulation in depression: state of the art.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23391633",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 122,
            "othersAvgTimeSpent": 86,
            "notes": null,
            "peopleTaken": 5041,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 68,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 666,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 24,
            "questionId": 13629,
            "questionIndex": 15017,
            "questionText": "<p>A 23-year-old woman is brought to the emergency department by her roommate due to bizarre behavior.&nbsp; The roommate reports that, over the past few days, the patient has become increasingly paranoid.&nbsp; She stays up almost all night and believes the apartment is bugged.&nbsp; The roommate became alarmed when the patient did not go to work yesterday and started speaking in a whisper.&nbsp; When interviewed, the patient does not respond verbally to questions but calmly writes on a piece of paper, &#x22;I&#39;ve been warned not to say anything.&#x22;&nbsp; Her parents are contacted and report a history of depression treated with bupropion.&nbsp; They have never observed the behavior their daughter is exhibiting.&nbsp; The parents report that the patient drinks alcohol socially but do not believe she uses illicit drugs.&nbsp; Vital signs and physical examination are unremarkable.&nbsp; Family history is significant for bipolar disorder in a maternal uncle.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient demonstrates signs of <strong>new-onset acute psychosis</strong> (eg, delusions, possible hallucinations) of unclear etiology.&nbsp; Major depressive or manic episode with psychotic features should be considered given the patient&#39;s history of depression and family history of bipolar disorder.&nbsp; However, before making a primary psychiatric diagnosis, substance-induced and other medical causes should be ruled out.</p><p>The <strong>basic medical workup</strong> for new-onset psychosis commonly includes complete physical and mental status examinations, metabolic panel, complete blood cell count, and <strong>urine toxicology screen</strong>.&nbsp; It may also include tests for syphilis, HIV, vitamin B<font size=\"2\"><sub>12</sub></font> level, thyroid function, and antinuclear antibodies, as well as neuroimaging depending on specific findings and risk factors.&nbsp; In a young patient with no significant medical history and normal physical examination results, obtaining a urine toxicology screen is the most appropriate next step in evaluation (eg, a screen positive for cocaine or amphetamine suggests a stimulant-induced psychosis).&nbsp; The parents&#39; report cannot be relied on to rule out illicit or prescription drug use.</p><p><strong>(Choice A)</strong>&nbsp; Mood stabilizers (eg, lithium, valproate) are used in the treatment of bipolar disorder, which may present with psychotic features.&nbsp; However, the diagnosis of bipolar disorder requires evidence of at least 1 manic episode (eg, elevated or irritable mood, increased energy, flight of ideas, agitation, pressured speech), which is lacking in this patient.</p><p><strong>(Choice B)</strong>&nbsp; An antipsychotic medication would be appropriate for the treatment of primary mood disorder with psychotic features and/or to calm a severely agitated psychotic patient.&nbsp; However, the etiology of this patient&#39;s psychosis is unclear, and she is currently calm and cooperative.</p><p><strong>(Choice C)</strong>&nbsp; Like all antidepressants, bupropion may contribute to a manic presentation, but this is not known to correlate with bupropion levels.</p><p><strong>(Choice D)</strong>&nbsp; In the absence of focal neurologic findings, neuroimaging is not indicated.</p><p><strong>Educational objective:</strong><br>Substance-induced psychosis should be considered in the differential diagnosis of all patients who come to the emergency department with acute psychosis.&nbsp; Standard workup of new-onset psychosis includes obtaining a urine toxicology screen.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 9838,
            "topic": "Psychosis",
            "titleId": 9838,
            "title": "Psychosis",
            "topicAttributeId": 330661,
            "topicAttribute": "Psychotic disorders",
            "correctAnswer": "5",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Administer a mood stabilizer",
                    "choiceNumber": 1,
                    "correctTaken": 981,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Administer an antipsychotic medication",
                    "choiceNumber": 2,
                    "correctTaken": 5000,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain a bupropion blood level",
                    "choiceNumber": 3,
                    "correctTaken": 643,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain a CT scan of the head",
                    "choiceNumber": 4,
                    "correctTaken": 101,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain a urine toxicology screen",
                    "choiceNumber": 5,
                    "correctTaken": 11075,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1547,1822,true,-1,1*570,597,true,-1,1*628,737,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26131945",
                    "mediaDataId": 0,
                    "title": "Recognition and differential diagnosis of psychosis in primary care.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26131945",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "21999698",
                    "mediaDataId": 0,
                    "title": "Substance-induced psychoses: a critical review of the literature.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/21999698",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27538886",
                    "mediaDataId": 0,
                    "title": "Psychosis associated with acute recreational drug toxicity: a European case series.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27538886",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 217,
            "othersAvgTimeSpent": 57,
            "notes": null,
            "peopleTaken": 17800,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 560,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 25,
            "questionId": 3759,
            "questionIndex": 3759,
            "questionText": "<p>A 72-year-old man with a history of chronic pain and unknown psychiatric history comes for an initial visit due to diminished energy and anxiety for the past 3 months.&nbsp; He appears very sad and moves slowly.&nbsp; He has felt terrible since his wife died unexpectedly from a brain aneurysm 4 months ago and is filled with guilt because he did not get her to the hospital sooner.&nbsp; Since her death, the patient has suffered from disturbed sleep and is unable to focus on his favorite activities, including coin collecting and fishing.&nbsp; He drinks a bottle of wine nightly to fall asleep and isolates himself from others because he does not feel like socializing anymore.&nbsp; The patient feels hopeless and wants to end his life, saying, &#x22;I cannot carry on without her.&#x22;&nbsp; He has contemplated hanging himself and recently drove by a hardware store with thoughts of buying a rope, but ultimately did not.&nbsp; The patient is advised to enter a psychiatric hospital.&nbsp; However, he refuses and says, &#x22;I promise to try any help you could offer me as an outpatient.&#x22;&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t33523\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Management of suicidality</strong></p></td></tr><tr><td><p align=\"center\"><strong>Management</strong></p></td><td><p><strong>Imminent risk of suicide</strong> (voiced intent, high number of unmanaged risk factors, collateral concerns raised)</p><ul><li>Ensure safety: hospitalize immediately (involuntary if necessary) &amp; start 1:1 for constant observation</li><li>Remove personal belongings &amp; objects in room that may present self-harm risk</li><li>Security may be required to hold against will</li></ul>&nbsp;<p><strong>Nonimminent risk of suicide</strong> (no intent, strong social supports available, outpatient follow-up plan is reasonable)</p><ul><li>Create safety plan (eg, coping skills, social supports, crisis numbers)</li><li>Ensure close follow-up (eg, psychiatry, therapy, intensive outpatient program)</li><li>Plan to address modifiable risk factors (eg, depression, psychosis, substance use, pain)</li><li>Ensure family or friends available to support patient</li><li>Remove access to potential means (eg, secure firearms &amp; medications)</li></ul></td></tr></tbody></table></div><p>This patient has symptoms consistent with major depression and reports <strong>suicidal ideation</strong> with a specific method.&nbsp; His aborted trip to the hardware store to buy a rope indicates that the patient recently had some <strong>intent</strong> and an organized <strong>plan</strong> for self-harm (rehearsing a plan is not uncommon prior to suicide attempts).&nbsp; His depressive symptoms appear to be worsening, and he has several other major risk factors for suicide that can be remembered by using the mnemonic SAD PERSONS: <strong>old</strong> age, <strong>male</strong> gender, <strong>alcohol</strong> abuse, chronic <strong>pain</strong>, and <strong>lack of support</strong>/significant other.&nbsp; His anxiety, hopelessness, and disturbed sleep patterns are additional clinical risk factors.</p><p>Given this high level of suicide risk, it is necessary to admit the patient to a <strong>psychiatric unit (involuntarily if necessary)</strong> to ensure his safety as the first step in care.&nbsp; Significant concern about the patient&#39;s immediate safety overrides any &#x22;promises&#x22; that he may make about agreeing to outpatient treatment, especially when there is no established therapeutic alliance or relationship between patient and physician.</p><p><strong>(Choices B and G)</strong>&nbsp; Outpatient psychotherapy, with or without antidepressant treatment, would not adequately address the imminent safety concerns in this patient.&nbsp; His depressive symptoms (ie, suicidality and marked functional impairment) are more severe than those seen in normal bereavement.</p><p><strong>(Choice C)</strong>&nbsp; There is little evidence that a &#x22;no-harm&#x22; contract (a patient promise not to harm self when feeling suicidal) is effective in reducing suicide.</p><p><strong>(Choice D)</strong>&nbsp; Hypothyroidism, which can also present with sad mood, diminished energy, slow movement, and poor concentration, can be assessed with serum TSH testing.&nbsp; However, this patient&#39;s high suicide risk precludes outpatient management.</p><p><strong>(Choice E)</strong>&nbsp; Antidepressants can take weeks to become fully effective and alone would not adequately address the patient&#39;s suicide risk.&nbsp; It is also inappropriate to give family members responsibility for monitoring the patient&#39;s safety.</p><p><strong>(Choice F)</strong>&nbsp; Day programs are outpatient programs.&nbsp; This patient would remain at risk, particularly in the evenings when alcohol intoxication and loneliness could predispose him to a higher risk of suicide.&nbsp; His level of suicide risk requires treatment in an inpatient (ie, locked unit) setting.</p><p><strong>Educational objective:</strong><br>Active suicidality is associated with intent and plan for self-harm.&nbsp; The first step in the care of patients with active suicidality is to ensure their safety by admitting them to a psychiatric unit (involuntarily, if necessary).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 4449,
            "topic": "Suicide",
            "titleId": 4449,
            "title": "Suicide",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Admit the patient to a psychiatric unit involuntarily",
                    "choiceNumber": 1,
                    "correctTaken": 12373,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Arrange for bereavement-focused psychotherapy",
                    "choiceNumber": 2,
                    "correctTaken": 372,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Have the patient sign a &#x22;no-harm&#x22; contract",
                    "choiceNumber": 3,
                    "correctTaken": 905,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain serum TSH, start an antidepressant, and follow closely as an outpatient",
                    "choiceNumber": 4,
                    "correctTaken": 407,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe an antidepressant and advise family members to observe the patient closely at home",
                    "choiceNumber": 5,
                    "correctTaken": 394,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Refer the patient to a daily intensive outpatient program (day program)",
                    "choiceNumber": 6,
                    "correctTaken": 1770,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start an antidepressant and refer the patient for psychotherapy",
                    "choiceNumber": 7,
                    "correctTaken": 792,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1266,1450,true,-1,1*1721,1968,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "28639299",
                    "mediaDataId": 0,
                    "title": "Understanding suicide across the lifespan: a United States perspective of suicide risk factors, assessment &amp; management.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/28639299",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25226200",
                    "mediaDataId": 0,
                    "title": "Suicide risk assessment and suicide risk formulation: essential components of the therapeutic risk management model.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25226200",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 77,
            "othersAvgTimeSpent": 63,
            "notes": null,
            "peopleTaken": 17013,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 73,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 501,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 26,
            "questionId": 13684,
            "questionIndex": 15074,
            "questionText": "<p><u><strong>Patient Information</strong></u><br><strong>Age:</strong> 21 years<br><strong>Gender:</strong> F, self-identified<br><strong>Race/Ethnicity:</strong> unspecified<br><strong>Site of Care:</strong> office</p><p><u><strong>History</strong></u><br><strong>Reason for Visit/Chief Concern:</strong> follow-up of depression<br><strong>History of Present Illness:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>started taking fluoxetine 6 weeks ago for depression</li><li>feels partially better</li><li>continues to have low mood, fatigue, and cravings for sugary foods; weight gain of 2.7 kg (6 lb) over the past month</li><li>spends most evenings and weekends in her dorm room taking naps instead of going out with friends</li></ul><p><strong>Past Medical History:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>mood worsens at the end of every year, starting just before final exams and lasting through the holidays; symptoms resolve by spring break</li></ul><p><strong>Obstetric and Gynecologic History:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>menses at 28-day intervals preceded by several days of irritability, bloating, and swelling that resolve 2-3 days after the start of menstruation</li></ul><p><strong>Medications:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>fluoxetine</li></ul><p><strong>Allergies:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>no known drug allergies</li></ul><p><strong>Family History:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>mother has major depressive disorder and is currently taking venlafaxine with good response</li></ul><p><strong>Psychosocial History:</strong></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>college student</li><li>does not use alcohol or recreational substances</li></ul><p><u><strong>Physical Examination</strong></u></p><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"text-align:center;\"><tbody><tr><td><strong>Temp</strong></td><td><strong>Pulse</strong></td><td><strong>Resp</strong></td><td><strong>BP</strong></td><td><strong>O<font size=\"2\"><sub>2</sub></font> Sat</strong></td><td><strong>Ht</strong></td><td><strong>Wt</strong></td><td><strong>BMI</strong></td></tr><tr style=\"vertical-align:top;\"><td>37.2 C<br>(99 F)</td><td>74/min</td><td>14/min</td><td>128/80<br>mm Hg</td><td>&ndash;</td><td>&ndash;</td><td>&ndash;</td><td>21 kg/m<font size=\"2\"><sup>2</sup></font></td></tr></tbody></table><ul style=\"margin-left: -1.2em; \"><li>Appearance: dressed appropriately for the weather in jeans, sweater, and jacket; intermittently tearful</li><li>Mental status: cooperative and forthcoming; affect is appropriate and reactive; no suicidal ideation</li></ul><p><u><strong>Diagnostic Studies</strong></u></p><ul style=\"margin-left: -1.2em; margin-top:-15px;\"><li>none</li></ul><p><u><strong>Question:</strong></u> Which of the following is the best next step in management?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T89804\" style=\"overflow-x:auto;\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"3\" style=\"width:42.0%;:;vertical-align:top\"><p align=\"center\"><strong>Major depressive disorder vs seasonal affective disorder*</strong></p></td></tr><tr><td style=\"width:20.0%;:;vertical-align:top\"></td><td style=\"width:38.0%;:;vertical-align:top\"><p align=\"center\"><strong>MDD</strong></p></td><td style=\"width:42.0%;:;vertical-align:top\"><p align=\"center\"><strong>SAD</strong></p></td></tr><tr><td style=\"width:20.0%;vertical-align:top\"><p align=\"center\"><strong>Clinical features</strong></p></td><td style=\"width:38.0%;vertical-align:top\"><ul><li>Single or recurrent major depressive episodes (&#8805;2 weeks of &#8805;5 of depression + SIG&#8209;E&#8209;CAPS)</li><li>No seasonal pattern</li></ul></td><td style=\"width:42.0%;vertical-align:top\"><ul><li>Recurrent major depressive episodes</li><li>&#8805;2-year pattern of seasonal recurrence &amp; remission (eg, winter onset&ndash;spring remission)</li><li>No nonseasonal depressive episodes</li><li>Lifetime seasonal &gt;&gt;&gt; nonseasonal depressive episodes</li></ul></td></tr><tr><td style=\"width:20.0%;:;vertical-align:top\"><p align=\"center\"><strong>Management</strong></p></td><td style=\"width:38.0%;:;vertical-align:top\"><ul><li>Antidepressant (eg, SSRI)</li><li>Psychotherapy (CBT)</li><li>Combined therapy</li></ul></td><td style=\"width:42.0%;:;vertical-align:top\"><ul><li>Antidepressant (eg, SSRI) + light therapy</li><li>Psychotherapy (CBT)</li><li>Behavioral (eg, outdoor walks, aerobic exercise, sleep hygiene)</li></ul></td></tr><tr><td colspan=\"3\" style=\"width:42.0%;vertical-align:top\"><p>*Seasonal affective disorder = major depressive disorder with seasonal pattern.</p><p><strong>CBT</strong> = cognitive-behavioral therapy; <strong>MDD</strong> = major depressive disorder; <strong>SAD</strong> = seasonal affective disorder; <strong>SIG&#8209;E&#8209;CAPS</strong> = <strong>S</strong>leep, <strong>I</strong>nterest, <strong>G</strong>uilt, <strong>E</strong>nergy, <strong>C</strong>oncentration, <strong>A</strong>ppetite, <strong>P</strong>sychomotor changes, <strong>S</strong>uicidality; <strong>SSRI</strong> = selective serotonin reuptake inhibitor.</p></td></tr></tbody></table></div><p>This patient&#39;s history of recurrent major depressive episodes with onset in the fall and remission in the spring is characteristic of <strong>major depressive disorder with seasonal pattern</strong> (also known as <strong>seasonal affective disorder</strong> [SAD]).&nbsp; SAD with <strong>fall-winter onset</strong> and <strong>spring-summer remission</strong> is the most common type of seasonal depression.&nbsp; It is generally characterized by atypical features of depression such as increased sleep, increased appetite, carbohydrate craving, and weight gain.</p><p>First-line treatment consists of <strong>antidepressant</strong> and <strong>bright light therapy</strong>.&nbsp; This patient has had a partial response to antidepressant therapy and would benefit from the addition of light therapy.&nbsp; Bright light therapy is typically administered with a 10,000-lux light box shortly after the patient awakens.&nbsp; Most patients experience clinical improvement in 1-4 weeks and continue treatment through the fall or winter until spontaneous remission of symptoms in the spring or summer.&nbsp; Light therapy alone is also a reasonable first option for patients with mild to moderate SAD.</p><p><strong>(Choices A and F)</strong>&nbsp; Bupropion can be used to augment a partially effective antidepressant regimen or as monotherapy in the treatment of SAD.&nbsp; However, pharmacologic augmentation or changing to an alternate medication (eg, venlafaxine) should not be considered until the patient reaches an optimal dose of the current antidepressant to avoid polypharmacy and loss of therapeutic potential.</p><p><strong>(Choice B)</strong>&nbsp; Given the severity of this patient&#39;s symptoms, more regular follow-up intervals are needed.&nbsp; However, she has been taking the initial dose of fluoxetine long enough to determine its response; making no changes to her treatment at this time unnecessarily prolongs her symptoms.&nbsp; A suitable alternative would be to increase the fluoxetine dose.</p><p><strong>(Choices C and E)</strong>&nbsp; A symptom diary is helpful for timing a patient&#39;s mood symptoms when a diagnosis of premenstrual dysphoric disorder is being considered, and combined oral contraceptive pills can be used to manage premenstrual syndrome.&nbsp; However, this patient&#39;s depressed mood persists for months and is unrelated to menses, making a major depressive disorder more likely.</p><p><strong>Educational objective:</strong><br>Major depressive disorder with seasonal pattern (seasonal affective disorder) is characterized by seasonal onset and remission (most commonly fall-winter onset and spring-summer remission).&nbsp; Treatment consists of bright light therapy alone or with an antidepressant.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "6",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Add bupropion",
                    "choiceNumber": 1,
                    "correctTaken": 832,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Continue fluoxetine and follow up in 1 month",
                    "choiceNumber": 2,
                    "correctTaken": 497,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend daily symptom diary",
                    "choiceNumber": 3,
                    "correctTaken": 305,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start bright light therapy",
                    "choiceNumber": 4,
                    "correctTaken": 13883,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Start combined oral contraceptive pills",
                    "choiceNumber": 5,
                    "correctTaken": 474,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Switch to venlafaxine",
                    "choiceNumber": 6,
                    "correctTaken": 1034,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "2711,2777,true,-1,1*1309,1458,true,-1,1*1533,2034,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "27942239",
                    "mediaDataId": 0,
                    "title": "Seasonal affective disorder, winter type: current insights and treatment options.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/27942239",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 87,
            "othersAvgTimeSpent": 52,
            "notes": null,
            "peopleTaken": 17025,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 82,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 810,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 27,
            "questionId": 11064,
            "questionIndex": 12205,
            "questionText": "<p>A 27-year-old woman comes to the office due to headaches and neck and back pain.&nbsp; She has been coping with pain symptoms for several years but notes that they have increased since she was recently let go from her job as an administrative assistant.&nbsp; The patient worries about finding another job but says, &#x22;Most days I am just too tired to even look for work.&#x22;&nbsp; She is also concerned about gaining weight but has no motivation to go to the gym or leave the house.&nbsp; The patient has been to the office twice in the past year for similar symptoms and is worried that something is wrong.&nbsp; At her last visit 4 months ago, laboratory testing, including a basic chemistry panel, thyroid function tests, and complete blood count, were within normal range.&nbsp; The patient says, &#x22;I doubt that anything will ever improve for me.&#x22;&nbsp; Medications include ibuprofen for pain as needed.&nbsp; The patient drinks 1 or 2 glasses of wine 3 times a week.&nbsp; She has increased her use of marijuana to 3 or 4 times a week at bedtime to help her relax and fall asleep and has started smoking cigarettes after a 2-year abstinence.&nbsp; Family history includes hypertension and colon cancer in her father and hypothyroidism and anxiety in her mother.&nbsp; Vital signs and physical examination are normal except for a 2.27-kg (5-lb) weight gain since her last visit.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient has several findings concerning for <strong>depression</strong>, including hopelessness (doubts that anything will improve), amotivation, low energy, and weight gain.&nbsp; Patients with depression frequently have a <strong>somatic presentation</strong> (eg, headaches, neck and back pain) and may have difficulty describing their emotions.&nbsp; Further assessment of depression, including a careful <strong>screen for suicidal ideation</strong>, is the most appropriate next step in this patient&#39;s evaluation, particularly given her multiple risk factors for suicide (eg, chronic pain, recent job loss, self-medication with substances, isolation).</p><p>Inquiring about suicidality allows for the determination of an appropriate and safe treatment setting (eg, hospitalization if the patient is actively suicidal).&nbsp; This patient should be asked if she has wished for death or has thought of killing herself.&nbsp; If the answer is &#x22;yes,&#x22; additional questions should be asked regarding methods, plan, and intent to act on a plan.</p><p><strong>(Choices A, B, and C)</strong>&nbsp; Although exploring the relationship of substance use and stress to the patient&#39;s symptoms and performing a more detailed pain assessment are components of a comprehensive evaluation, inquiring about suicidal thoughts takes precedence.</p><p><strong>(Choice E)</strong>&nbsp; In light of this patient&#39;s recent laboratory results and the absence of new physical findings, repeat laboratory testing is unlikely to be helpful.&nbsp; Her weight gain is likely due to depression and lack of exercise rather than thyroid disease.</p><p><strong>(Choice F)</strong>&nbsp; Reassurance that serious illness has been ruled out with regular follow-up office visits is an appropriate intervention for somatic symptom disorder.&nbsp; However, this would not substitute for evaluation of suicidality in this patient with findings concerning for depression.</p><p><strong>Educational objective:</strong><br>In the primary care setting, patients with depression often have somatic symptoms.&nbsp; Any patient who reports feeling hopeless, even if the initial symptoms are somatic, should be screened for suicidal ideation.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 4449,
            "topic": "Suicide",
            "titleId": 4449,
            "title": "Suicide",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Address her substance use with motivational interviewing",
                    "choiceNumber": 1,
                    "correctTaken": 546,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Examine for point tenderness",
                    "choiceNumber": 2,
                    "correctTaken": 828,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Explore the relationship of her symptoms to stress",
                    "choiceNumber": 3,
                    "correctTaken": 3069,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Inquire about suicidal thoughts",
                    "choiceNumber": 4,
                    "correctTaken": 10633,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain a repeat TSH level",
                    "choiceNumber": 5,
                    "correctTaken": 456,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Offer reassurance and schedule regular follow-up",
                    "choiceNumber": 6,
                    "correctTaken": 722,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29809038",
                    "mediaDataId": 0,
                    "title": "Suicide interventions in primary care: a selective review of the evidence.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29809038",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26556217",
                    "mediaDataId": 0,
                    "title": "Primary care assessment of patients at risk for suicide.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26556217",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23413776",
                    "mediaDataId": 0,
                    "title": "Screening for suicidal ideation and attempts among emergency department medical patients: instrument and results from the Psychiatric Emergency Research Collaboration.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23413776",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 230,
            "othersAvgTimeSpent": 62,
            "notes": null,
            "peopleTaken": 16254,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 65,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 6,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 28,
            "questionId": 14515,
            "questionIndex": 15925,
            "questionText": "<p>A 31-year-old woman comes to the office due to fatigue and weight gain.&nbsp; She has felt tired over the past 2 months and is upset that she has been craving junk food and has gained 8 pounds.&nbsp; She says, &#x22;I have been under some stress at work lately, and I guess I&#39;ve been eating and sleeping more as a way to cope and escape.&nbsp; I know I&#39;ve gained weight but I feel slow&mdash;like my legs are in cement blocks.&#x22;&nbsp; The patient sleeps 10-12 hours a day but still feels tired throughout the day.&nbsp; She is feeling &#x22;down&#x22; and stopped socializing with friends &#x22;because I feel that I look awful and don&#39;t want to be around anybody.&#x22;&nbsp; However, she was able to enjoy a recent family reunion and was excited to meet her newborn nephew for the first time.&nbsp; The patient has no medical or psychiatric history.&nbsp; She has 1-2 glasses of wine 3 times a week and uses cannabis approximately once a month.&nbsp; Physical examination is normal.&nbsp; On mental status examination the patient appears sad and tired but is able to smile when appropriate.&nbsp; Laboratory evaluation, including complete blood count and thyroid function tests, is within normal range.&nbsp; Which of the following is the most likely diagnosis?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s 2-month history of depressed mood (eg, feeling &#x22;down&#x22;), social isolation (loss of interest), fatigue (loss of energy), hypersomnia,&nbsp;leaden paralysis (&#x22;my legs are in cement blocks&#x22;), and weight gain is most consistent with the atypical subtype of <strong>major depressive disorder (MDD)</strong>.</p><p>A core feature of <strong>atypical</strong> depression is&nbsp;<strong>mood reactivity</strong>&nbsp;(ie,&nbsp;positive&nbsp;responsiveness&nbsp;to pleasant events); other characteristic&nbsp;features include increased appetite or <strong>weight gain</strong>, <strong>hypersomnia</strong>, <strong>leaden paralysis</strong>&nbsp;(heavy feeling in limbs), and&nbsp;<strong>hypersensitivity</strong> to rejection.&nbsp; This patient&#39;s ability to enjoy the family reunion and smile during the interview are examples of the mood reactivity&nbsp;characteristic of the atypical subtype.</p><p>In contrast, the melancholic subtype of MDD is characterized by weight loss, insomnia, and pervasive anhedonia with an inability to respond to positive events.</p><p><strong>(Choices A and C)</strong>&nbsp; MDD can be differentiated from adjustment disorder and a normal stress response by the number and severity of symptoms and the degree of <a href=\"4588\">functional impairment</a>.&nbsp; Adjustment disorder involves depressive symptoms developing within 3 months of a stressor with resultant functional impairment but insufficient number and severity of symptoms to meet the criteria for MDD.&nbsp; A normal stress response is not excessive or out of proportion to the severity of the stressor and does not cause functional impairment.</p><p><strong>(Choice D)</strong>&nbsp; Persistent depressive disorder (dysthymia) requires a chronically depressed mood for &#8805;2 years.</p><p><strong>(Choice E)</strong>&nbsp; The extent of this patient&#39;s alcohol and cannabis use is unlikely to be causing her symptom severity and impairment.</p><p><strong>Educational objective:</strong><br>Atypical features of major depressive disorder include hypersomnia, hyperphagia, heavy feelings in limbs, hypersensitivity to rejection, and mood reactivity (ability to respond to positive events).</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Adjustment disorder",
                    "choiceNumber": 1,
                    "correctTaken": 3268,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder",
                    "choiceNumber": 2,
                    "correctTaken": 10042,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normal stress response",
                    "choiceNumber": 3,
                    "correctTaken": 2257,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Persistent depressive disorder (dysthymia)",
                    "choiceNumber": 4,
                    "correctTaken": 917,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Substance-induced depressive disorder",
                    "choiceNumber": 5,
                    "correctTaken": 427,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "100,136,true,-1,1*177,226,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29498147",
                    "mediaDataId": 0,
                    "title": "Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29498147",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23110213",
                    "mediaDataId": 0,
                    "title": "Clinical patterns and treatment outcome in patients with melancholic, atypical and non-melancholic depressions.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23110213",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 74,
            "othersAvgTimeSpent": 72,
            "notes": null,
            "peopleTaken": 16911,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 59,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 501,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 29,
            "questionId": 4055,
            "questionIndex": 4055,
            "questionText": "<p>A 28-year-old woman is brought to the hospital by her family due to depressed mood, disorganized behavior, and hearing voices.&nbsp; Over the past 2 months, the patient has developed worsening auditory hallucinations and now fears that her family has been replaced by imposters.&nbsp; She is afraid to leave the house, stays in bed most of the day, and is unable to care for herself.&nbsp; The patient&#39;s psychiatric history is significant for 4 previous hospitalizations for depressive and psychotic symptoms over the past 8 years.&nbsp; During the first hospitalization, she was suicidal and heard voices.&nbsp; During her most recent hospitalization a year ago, she was severely depressed and preoccupied with paranoid delusions and auditory hallucinations.&nbsp; Between hospitalizations, the patient has had rare month-long periods during which she is not depressed but continues to hear voices.&nbsp; On mental status examination, she makes poor eye contact.&nbsp; Her mood is depressed, but she has no suicidal ideation.&nbsp; She is convinced that her mother is an imposter trying to harm her.&nbsp; The patient does not use alcohol or illicit drugs.&nbsp; Physical examination is unremarkable.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t37651\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Schizoaffective disorder</strong></p></td></tr><tr><td><p align=\"center\"><strong>DSM-5 criteria</strong></p></td><td><ul><li>Major depressive or manic episode concurrent with symptoms of schizophrenia</li><li>Lifetime history of delusions or hallucinations for &ge;2 weeks in the absence of major depressive or manic episode</li><li>Mood episodes are prominent &amp; recur throughout illness</li><li>Not due to substances or another medical condition</li></ul></td></tr><tr><td><p align=\"center\"><strong>Differential diagnosis</strong></p></td><td><ul><li>Major depressive or bipolar disorder with psychotic features: &nbsp;Psychotic symptoms occur exclusively during mood episodes</li><li>Schizophrenia:<strong>&nbsp; </strong>Mood symptoms may be present for relatively brief periods</li></ul></td></tr></tbody></table></div><p>The course of this patient&#39;s illness is consistent with a diagnosis of <strong>schizoaffective disorder</strong>, which requires the following:</p><ul><li>Major <strong>mood</strong> (depressive or manic) episodes <strong>concurrent</strong> with symptoms of <strong>schizophrenia</strong> (&#8805;2 of the following for &#8805;6 months:&nbsp; delusions, hallucinations, disorganized speech, grossly disorganized behavior, negative symptoms)</li><li><strong>Delusions or hallucinations</strong> for &#8805;2 weeks in the <strong>absence</strong> of a major <strong>mood</strong> episode (depressive or manic)</li></ul><p>This patient has an 8-year history of psychotic symptoms with concurrent depressive symptoms but also has month-long periods during which psychosis persisted in the absence of mood symptoms (eg, hearing voices even when not depressed).&nbsp; This meets the criteria for schizoaffective disorder, depressive type.</p><p>Differentiating schizoaffective disorder from bipolar disorder, major depression with psychotic features, and schizophrenia requires determining the <strong>temporal relationship</strong> of psychotic symptoms to mood symptoms.&nbsp; In bipolar disorder and major depression with psychotic features, psychotic symptoms occur exclusively during manic or depressive episodes (ie, when the patient&#39;s mood is stable, there are no psychotic symptoms).&nbsp; In schizophrenia, if mood symptoms occur, they are present for a small portion of the illness.</p><p><strong>(Choice A)</strong>&nbsp; The diagnosis of bipolar I disorder requires &#8805;1 manic episodes, and psychotic symptoms, if present, occur exclusively during mood episodes.&nbsp; There is no evidence of manic symptoms in this patient.</p><p><strong>(Choice B)</strong>&nbsp; In delusional disorder, other symptoms of psychosis (eg, hallucinations, disorganized speech, disorganized behavior) are not present.&nbsp; In addition, delusional disorder would not explain this patient&#39;s current and previous history of depression.</p><p><strong>(Choice C)</strong>&nbsp; The persistence of hallucinations for &#8805;2 weeks in the absence of a major depressive episode rules out major depressive disorder with psychotic features.</p><p><strong>(Choices E and F)</strong>&nbsp; Schizophrenia and schizophreniform disorder are characterized by psychotic symptoms.&nbsp; If mood symptoms occur, they are present for only a small portion of the illness.&nbsp; Duration of psychotic illness differentiates schizophreniform disorder (&gt;1 month and &lt;6 months) from schizophrenia (&#8805;6 months).</p><p><strong>Educational objective:</strong><br>Schizoaffective disorder is diagnosed when major depressive or manic episodes co-occur with psychotic symptoms in a patient with a history of persistent psychosis for &#8805;2 weeks in the absence of mood symptoms.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 15461,
            "topic": "Schizoaffective disorder",
            "titleId": 15461,
            "title": "Schizoaffective disorder",
            "topicAttributeId": 330661,
            "topicAttribute": "Psychotic disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bipolar I disorder with psychotic features",
                    "choiceNumber": 1,
                    "correctTaken": 269,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Delusional disorder",
                    "choiceNumber": 2,
                    "correctTaken": 32,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder with psychotic features",
                    "choiceNumber": 3,
                    "correctTaken": 849,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Schizoaffective disorder",
                    "choiceNumber": 4,
                    "correctTaken": 13077,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Schizophrenia",
                    "choiceNumber": 5,
                    "correctTaken": 2290,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Schizophreniform disorder",
                    "choiceNumber": 6,
                    "correctTaken": 602,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26599364",
                    "mediaDataId": 0,
                    "title": "Characteristics and heterogeneity of schizoaffective disorder compared with unipolar depression and schizophrenia - a systematic literature review and meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26599364",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23707642",
                    "mediaDataId": 0,
                    "title": "Schizoaffective disorder in the DSM-5.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23707642",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 67,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 17120,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 786,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 30,
            "questionId": 11276,
            "questionIndex": 12431,
            "questionText": "<p>A 73-year-old man with bipolar disorder is brought to the emergency department by his daughter, who has been visiting him for several days.&nbsp; She reports that &#x22;he&#39;s not himself.&#x22;&nbsp; The patient has become increasingly confused, which is not typical for him.&nbsp; He has bilateral hand tremors, has difficulty walking straight, and has vomited over the past few days.&nbsp; Two weeks ago, he saw his new primary care physician, who added hydrochlorothiazide to the patient&#39;s medication regimen.&nbsp; The patient has been psychiatrically stable for many years and has been seeing a psychiatrist, who has prescribed mood stabilizers and antipsychotics.&nbsp; He has no history of alcohol or substance use disorders.&nbsp; His daughter does not know which psychiatric medications he takes.&nbsp; Temperature is 37.2 C (99 F), blood pressure is 130/80 mm Hg, pulse is 65/min, and respirations are 16/min.&nbsp; The patient&#39;s pulse oximetry shows 93% on room air.&nbsp; He is disoriented and ataxic.&nbsp; As he is being assessed, he has a generalized seizure that lasts 2-3 minutes.&nbsp; Which of the following medications is the most likely cause of this patient&#39;s symptoms?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_t42583\"><table class=\"table-default-style table-header-footer-style\"><tbody><tr><td colspan=\"2\" style=\"width: 100%;\"><p align=\"center\"><strong>Lithium toxicity</strong></p></td></tr><tr><td style=\"width: 25%;\"><p align=\"center\"><strong>Etiology</strong></p></td><td style=\"width: 75%;\"><p>Acute toxicity</p><ul><li>Intentional overdose</li></ul><p>Chronic toxicity</p><ul><li>Decreased renal perfusion (&darr; lithium clearance)<ul style=\"list-style-type:circle;\"><li>Dehydration</li><li>Thiazide diuretics, NSAIDs, ACE inhibitors</li></ul></li></ul></td></tr><tr><td style=\"width: 25%;\"><p align=\"center\"><strong>Clinical features</strong></p></td><td style=\"width: 75%;\"><p>Acute toxicity</p><ul><li>Gastrointestinal: nausea, vomiting, diarrhea</li><li>Late neurologic sequelae</li></ul><p>Chronic toxicity (neurologic)</p><ul><li>Lethargy, confusion, agitation</li><li>Ataxia, tremor/fasciculations, seizure</li></ul></td></tr><tr><td style=\"width: 25%;\"><p align=\"center\"><strong>Treatment</strong></p></td><td style=\"width: 75%;\"><ul><li>Intravenous hydration</li><li>Hemodialysis (severe cases)</li></ul></td></tr><tr><td colspan=\"2\" style=\"width: 100%;\"><p><strong>NSAID</strong> = nonsteroidal anti-inflammatory drug.</p></td></tr></tbody></table></div><p>This patient is exhibiting signs and symptoms of <strong>lithium toxicity</strong>.&nbsp; These may include new onset of severe <strong>gastrointestinal symptoms, confusion, ataxia, tremor</strong>, and other signs of neuromuscular irritability such as fasciculations and <strong>seizures</strong>.&nbsp; This patient was previously stable on his psychiatric medications; therefore, the recent addition of hydrochlorothiazide is likely responsible for increasing his lithium serum level.&nbsp; <strong>Thiazide diuretics</strong> can cause a decrease in the renal clearance of lithium and lead to lithium toxicity.&nbsp; The risk of lithium toxicity is higher in patients with dehydration from any cause (eg, vomiting, diarrhea, fever, diuresis) and in elderly patients due to a lower glomerular filtration rate and reduced volume of distribution.</p><p>Other medications that can increase lithium levels include <strong>ACE inhibitors</strong>, <strong>nonsteroidal anti-inflammatory drugs</strong>, <strong>tetracyclines</strong>, and <strong>metronidazole</strong>.</p><p><strong>(Choices A, B, and E)</strong>&nbsp; Bupropion is a dopamine and norepinephrine reuptake inhibitor used as an antidepressant and as an aid for smoking cessation.&nbsp; The antipsychotics haloperidol and risperidone are dopamine antagonists used to treat psychosis or as adjuncts to mood stabilizers in the treatment of bipolar disorder.&nbsp; Although bupropion, haloperidol, and risperidone can increase neuromuscular irritability and the risk of seizures, none are typically associated with this patient&#39;s other presenting symptoms.</p><p><strong>(Choices C and F)</strong>&nbsp; Lamotrigine and valproic acid are anticonvulsants that are also used in the treatment of bipolar disorder.&nbsp; Lamotrigine is associated with Stevens-Johnson syndrome.&nbsp; Valproic acid may cause gastrointestinal symptoms, hepatitis, pancreatitis, and hepatic encephalopathy.&nbsp; Both medications would decrease rather than increase the risk of seizures.</p><p><strong>Educational objective:</strong><br>Concurrent use of thiazide diuretics&mdash;as well as ACE inhibitors, tetracyclines, metronidazole, and nonsteroidal anti-inflammatory drugs&mdash;and lithium can increase serum lithium levels and lead to symptoms of lithium toxicity, including gastrointestinal symptoms, confusion, ataxia, tremor, and seizures.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 14210,
            "topic": "Lithium",
            "titleId": 14210,
            "title": "Lithium",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bupropion",
                    "choiceNumber": 1,
                    "correctTaken": 1529,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Haloperidol",
                    "choiceNumber": 2,
                    "correctTaken": 873,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lamotrigine",
                    "choiceNumber": 3,
                    "correctTaken": 316,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lithium",
                    "choiceNumber": 4,
                    "correctTaken": 13066,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Risperidone",
                    "choiceNumber": 5,
                    "correctTaken": 678,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Valproic acid",
                    "choiceNumber": 6,
                    "correctTaken": 543,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "947,1279,true,-1,1*1745,1937,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26936045",
                    "mediaDataId": 0,
                    "title": "Drug interactions with lithium:  an update.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26936045",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24579242",
                    "mediaDataId": 0,
                    "title": "Drug-related admissions due to interaction with an old drug, lithium.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24579242",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 81,
            "othersAvgTimeSpent": 56,
            "notes": null,
            "peopleTaken": 17005,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 77,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 251,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 31,
            "questionId": 18014,
            "questionIndex": 19477,
            "questionText": "<p>An 85-year-old man comes to the office for a routine health evaluation.&nbsp; The patient lives independently but is accompanied by his daughter who does his grocery shopping and visits him weekly.&nbsp; The daughter is concerned that her father seems increasingly withdrawn and forgetful over the past year.&nbsp; She reports that he does not socialize with his neighborhood friends as much as he used to and calls her less frequently.&nbsp; &#x22;When we do speak, he often seems to forget what I just told him and repeats the same question that I&#39;ve just answered.&#x22;&nbsp; The patient admits that he sometimes forgets names but attributes this to &#x22;old age.&#x22;&nbsp; He denies any changes in mood, sleep, or appetite.&nbsp; Medical history includes hypertension and osteoarthritis of the knees.&nbsp; Current medications include hydrochlorothiazide and ibuprofen.&nbsp; Vital signs are within normal limits, and physical examination is unremarkable.&nbsp; The patient is pleasant and cooperative and speaks loudly.&nbsp; Montreal Cognitive Assessment score is 26/30.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><strong>Age-related hearing loss</strong> (presbycusis) is extremely common, affecting more than half of all adults age &#8805;75.&nbsp; Some patients may be unaware of their deficits when hearing loss progresses slowly.&nbsp; Rather than seeking help for hearing loss, these patients may come in or be brought in with increasing <strong>social isolation</strong> and <strong>cognitive difficulties</strong> as they avoid engaging in conversations and misunderstand what is being said.</p><p>This patient&#39;s presentation includes several clues for hearing loss, including <strong>withdrawal</strong> from his neighborhood friends, fewer telephone calls to his daughter, <strong>repeated questions</strong>, and loud speaking; his daughter&#39;s impression that he forgets what she just told him (whereas he may have misheard or misunderstood what she had said) is likely a further reflection of presbycusis.&nbsp; Other clues for age-related hearing loss include turning the television or radio volume up and difficulty hearing in a crowd or when background noise is present.&nbsp; If not addressed, age-related hearing loss can lead to increasing loneliness, depression, cognitive impairment, and functional disability.</p><p>The most appropriate next step is to take a careful <strong>history of hearing changes</strong> and perform <strong>a whispered voice test</strong>.&nbsp; Audiometric testing can be used to confirm the diagnosis (if necessary) and direct management (eg, hearing aids, cochlear implants).</p><p><strong>(Choice A)</strong>&nbsp; Although depression can also cause social isolation and cognitive impairment, it is typically accompanied by other symptoms, such as changes in mood, sleep, and appetite, which are not present in this case.</p><p><strong>(Choice C)</strong>&nbsp; A home geriatric assessment identifies and coordinates planning for older adults with significant medical, psychosocial, and functional disabilities (eg, hip fracture, increased fall risk, depression, cognitive decline, those at risk for high use of health care services).&nbsp; A simple screen for hearing loss should precede an intensive evaluation in this patient.</p><p><strong>(Choices D and F)</strong>&nbsp; An MRI scan of the brain and thyroid function testing would be appropriate in the workup for suspected dementia.&nbsp; However, this patient&#39;s cognitive assessment score is within normal limits; a score &#8804;24/30 is generally used as a cutoff for significant cognitive impairment.&nbsp; Forgetting names occasionally is consistent with normal age-related changes.&nbsp; In addition, the patient has no additional signs or symptoms that suggest neurologic or thyroid dysfunction.</p><p><strong>(Choice E)</strong>&nbsp; It would be inappropriate to dismiss the daughter&#39;s concerns about her father&#39;s social withdrawal and cognitive difficulties without an evaluation for treatable conditions, such as hearing loss.</p><p><strong>Educational objective:</strong><br>Hearing loss in the elderly is common and may present with social isolation and cognitive decline.&nbsp; Careful history-taking and a whispered voice test should be conducted.&nbsp; Audiometric testing can help confirm the diagnosis and direct management.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 10015,
            "topic": "Mild cognitive impairment",
            "titleId": 10015,
            "title": "Mild cognitive impairment",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "2",
            "userAnswer": "2",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Antidepressant trial",
                    "choiceNumber": 1,
                    "correctTaken": 757,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Hearing evaluation",
                    "choiceNumber": 2,
                    "correctTaken": 10544,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Home geriatric assessment",
                    "choiceNumber": 3,
                    "correctTaken": 960,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "MRI scan of the brain",
                    "choiceNumber": 4,
                    "correctTaken": 414,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Reassurance that this is normal aging",
                    "choiceNumber": 5,
                    "correctTaken": 3496,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Thyroid function testing",
                    "choiceNumber": 6,
                    "correctTaken": 799,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1129,1377,true,-1,1*2113,2262,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30177417",
                    "mediaDataId": 0,
                    "title": "Age-related hearing loss and cognitive decline  the potential mechanisms linking the two.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30177417",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29661329",
                    "mediaDataId": 0,
                    "title": "Hearing loss in the elderly.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29661329",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29202654",
                    "mediaDataId": 0,
                    "title": "Sensation and psychiatry: linking age-related hearing loss to late-life depression and cognitive decline.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29202654",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 177,
            "othersAvgTimeSpent": 56,
            "notes": null,
            "peopleTaken": 16970,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 62,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 2414,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 32,
            "questionId": 7289,
            "questionIndex": 7289,
            "questionText": "<p>A 19-year-old man is brought to the office by his mother due to sad mood and declining grades at college.&nbsp; Previously a straight-A student, he is now getting Cs and Ds, and his mother worries he will not complete his freshman year.&nbsp; The patient says, &#x22;I feel depressed and hopeless about the future.&#x22;&nbsp; He has little interest in his classes, has difficulty concentrating on assignments, and abruptly decided to quit the soccer team.&nbsp; He refuses to answer any phone calls from his friends and keeps himself isolated at home.&nbsp; The patient feels that there is little point in living but has no suicidal intent or plan.&nbsp; He has tried alcohol at parties on 2 occasions but does not use illicit drugs.&nbsp; There is no history of mania.&nbsp; There is a family history of untreated depression in his mother and grandmother.&nbsp; Physical examination and laboratory values are normal.&nbsp; Major depressive disorder is diagnosed, and treatment is discussed.&nbsp; The patient is willing to take medication, but his mother is concerned that antidepressants can cause people to become suicidal.&nbsp; Which of the following is the most appropriate response to the mother?</p>",
            "questionHeader": "",
            "explanationText": "<p>In 2007 the US Food and Drug Administration extended its warning that all patients <strong>age &lt;25</strong> should be informed about the <strong>small risk</strong> of becoming suicidal during initial antidepressant treatment.&nbsp; The warning was based on studies showing a slightly increased risk of <strong>suicidal thoughts</strong> and behaviors (not completed suicide) among a small group of child and adolescent patients treated with antidepressants compared with placebo <strong>(Choice D)</strong>.</p><p>Decisions regarding prescribing antidepressants for adolescents must weigh the risk of antidepressant-related suicidal thoughts and behaviors against the established benefits of antidepressants and the long-term risk of completed suicide in untreated depression.</p><p>Although there is ongoing debate about the evidence for a link between antidepressants and suicidality, the consensus among experts and in practice guidelines is that the benefits of antidepressants for moderate to severe depression <strong>outweigh</strong> the risks.&nbsp; Antidepressant treatment should not be withheld due to this concern or limited to patients who have failed psychotherapy <strong>(Choice A)</strong>.</p><p>Physicians should closely monitor patients for increasing suicidal thoughts and behaviors, especially following initiation of antidepressant treatment.</p><p><strong>(Choice B)</strong>&nbsp; Although some antidepressants are avoided as first-line agents due to their adverse side-effect profile, there is no known or clear difference in the risk of suicidal thoughts or behaviors among different classes of antidepressants.&nbsp; All adolescents started on an antidepressant should be monitored closely.</p><p><strong>(Choice C)</strong>&nbsp; The warning is applicable to all patients under age 25 years, not just those under age 18.</p><p><strong>Educational objective:</strong><br>The slightly increased risk of antidepressant-related suicidal thoughts and behaviors in some children and adolescents must be weighed against the efficacy of antidepressants and the risk of completed suicide in depression.&nbsp; Patients should be carefully monitored for suicidality at the beginning of antidepressant therapy.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 11037,
            "topic": "Child and adolescent mental health",
            "titleId": 11037,
            "title": "Child and adolescent mental health",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Due to the slightly increased risk of suicidal thoughts in adolescents, antidepressants are prescribed only for patients who fail psychotherapy.",
                    "choiceNumber": 1,
                    "correctTaken": 121,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Some classes of antidepressants have a lower risk of increasing suicidal thoughts, and for adolescents we prescribe those first.",
                    "choiceNumber": 2,
                    "correctTaken": 2121,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "There is a slightly increased risk of suicidal thoughts in young people treated with antidepressants, but only in those under age 18.",
                    "choiceNumber": 3,
                    "correctTaken": 761,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "There is no association between antidepressants and an increased risk of suicidal thoughts in adolescents.",
                    "choiceNumber": 4,
                    "correctTaken": 1954,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "The slightly increased risk of suicidal thoughts with antidepressants in this age group needs to be weighed against the risk of completed suicide in untreated depression.",
                    "choiceNumber": 5,
                    "correctTaken": 15567,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1600,1690,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24452997",
                    "mediaDataId": 0,
                    "title": "Antidepressant drugs and the risk of suicide in children and adolescents.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24452997",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24942789",
                    "mediaDataId": 0,
                    "title": "Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24942789",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 162,
            "othersAvgTimeSpent": 53,
            "notes": null,
            "peopleTaken": 20526,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 491,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 33,
            "questionId": 10745,
            "questionIndex": 11884,
            "questionText": "<p>A 35-year-old woman comes to the office due to poor energy.&nbsp; She says, &#x22;Although I have no energy, I still can&#39;t sleep and am up most of the night.&nbsp; I drag myself to work but barely get anything done because I have no motivation and can hardly concentrate.&nbsp; I&#39;m a horrible wife and mother.&nbsp; I don&#39;t want to go out anymore or do anything.&nbsp; All I want to do is hide in my room and get into bed.&#x22;&nbsp; The patient has a history of 3 prior episodes of depression beginning at age 18.&nbsp; She was also hospitalized 3 years ago for aggressive behavior following an arrest for unauthorized use of her company&#39;s funds to finance a personal business venture.&nbsp; At that time, she had excessive energy, slept 2 hours a night, and believed that she had a brilliant idea that would revolutionize the computer industry.&nbsp; The patient has no history of recreational substance use.&nbsp; There is a family history of depression in her mother, whose condition responded well to tricyclic antidepressants.&nbsp; Mental status examination is remarkable for psychomotor retardation, frequent tearfulness, depressed mood, and suicidal ideation.&nbsp; Which of the following is the most appropriate pharmacotherapy?</p>",
            "questionHeader": "",
            "explanationText": "<p><img  draggable=\"false\" id=\"77605\" src=\"https://www.uworld.com/media/highresdefault/L106949.jpg\"  ></p><p>This patient is experiencing a major depressive episode.&nbsp; However, her history&mdash;a distinct period of aggressive mood with excessive energy; decreased need for sleep; increased goal-directed, risky behaviors (eg, personal business venture); and grandiosity severe enough to require hospitalization&mdash;is characteristic of a <a href=\"14074\">manic episode</a>.&nbsp; Therefore, she meets the criteria for <strong>bipolar I</strong> disorder.</p><p>Bipolar disorder has different phases (acute mania, acute bipolar depression, maintenance).&nbsp; Although a wide range of options for the management of bipolar disorder exists, in patients (such as this one) with <strong>acute bipolar depression</strong>, some&nbsp;<strong>second-generation antipsychotics</strong>&nbsp;(SGAs) and mood stabilizers are commonly used due to superiority.</p><ul><li><p>Select SGAs (eg, <strong>quetiapine</strong>, lurasidone) are often used because of simple dosing and comparative tolerability.</p></li><li><p><strong>Mood stabilizers</strong> (eg, lithium, lamotrigine) are also effective, although the slow, stepwise increases that are necessary with lamotrigine often require augmentation therapy with another mood stabilizer or antipsychotic.</p></li></ul><strong>Antidepressant monotherapy</strong> is <strong>avoided</strong> in patients with bipolar I disorder due to the <strong>risk</strong> for <strong>inducing mania</strong>.&nbsp; Antidepressants can sometimes be used with antipsychotics (eg, olanzapine plus fluoxetine) or mood stabilizers to decrease the risk for an antidepressant-induced switch from depression to mania.<p>Once the acute episode is controlled, the preferred strategy is to <strong>continue medication indefinitely</strong>&nbsp;(ideally at the lowest dose based on effectiveness and tolerability) to prevent harmful mood episodes from reemerging.&nbsp; Some SGAs and mood stabilizers can also be used for acute manic episodes, and different medications are more effective in different phases.&nbsp; All these characteristics help guide the regimen used in the maintenance phase.</p><p><strong>(Choices A, B, and F)</strong>&nbsp; Antidepressants can be used to augment the effects of first-line treatment options for bipolar depression.&nbsp; Compared to serotonin-norepinephrine reuptake inhibitors (eg, venlafaxine) and tricyclic antidepressants (eg, amitriptyline), the norepinephrine-dopamine reuptake inhibitor bupropion, followed by selective serotonin reuptake inhibitors (eg, citalopram), appears to carry less risk for inducing a switch to mania.&nbsp; However, the potential consequences of precipitating a switch to mania (eg, bankruptcy, divorce, incarceration) restrict unopposed antidepressant monotherapy in bipolar I disorder.</p><p><strong>(Choice C)</strong>&nbsp; Haloperidol is a first-generation antipsychotic that can be used in acute mania but not in acute bipolar depression.&nbsp; It is also associated with extrapyramidal adverse effects due to its potent dopamine receptor D<font size=\"2\"><sub>2</sub></font> antagonism.</p><p><strong>(Choice D)</strong>&nbsp; Although a family history of medication response can guide pharmacotherapy, unopposed tricyclic antidepressant use (eg, imipramine) is contraindicated in bipolar I depression, given the risk for a switch to mania.</p><p><strong>Educational objective:</strong><br>Some second-generation antipsychotics (eg, quetiapine, lurasidone) are effective in the depressed phase of bipolar illness.&nbsp; Antidepressant monotherapy should be avoided in patients with bipolar I disorder.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17629,
            "topic": "Bipolar disorder",
            "titleId": 17629,
            "title": "Bipolar disorder",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "5",
            "userAnswer": "5",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bupropion",
                    "choiceNumber": 1,
                    "correctTaken": 180,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Citalopram",
                    "choiceNumber": 2,
                    "correctTaken": 298,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Haloperidol",
                    "choiceNumber": 3,
                    "correctTaken": 178,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Imipramine",
                    "choiceNumber": 4,
                    "correctTaken": 256,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Quetiapine",
                    "choiceNumber": 5,
                    "correctTaken": 4072,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Venlafaxine",
                    "choiceNumber": 6,
                    "correctTaken": 170,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "940,1096,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "36595095",
                    "mediaDataId": 0,
                    "title": "A systematic review of interventions in the early course of bipolar disorder I or II: a report of the International Society for Bipolar Disorders taskforce on early intervention.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/36595095",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "29536616",
                    "mediaDataId": 0,
                    "title": "Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/29536616",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 72,
            "othersAvgTimeSpent": 80,
            "notes": null,
            "peopleTaken": 5154,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 79,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 962,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 34,
            "questionId": 13753,
            "questionIndex": 15145,
            "questionText": "<p>A 24-year-old woman comes to the emergency department due to sudden-onset blurry vision.&nbsp; She also describes intermittent numbness and tingling in the legs for the past several weeks.&nbsp; The patient has been under stress at school and is struggling to complete assignments on time.&nbsp; She is worried about her mother, who was recently diagnosed with breast cancer, and feels too distracted to concentrate.&nbsp; The patient&#39;s medical history is significant for 2 episodes of urinary incontinence that occurred 8 months apart and 1 episode of unilateral blindness that occurred after breaking up with her boyfriend last year.&nbsp; In each instance, her symptoms resolved spontaneously over several weeks without treatment.&nbsp; The patient has no other medical or psychiatric history.&nbsp; Brain MRI shows multifocal, white matter, hyperintense T2 lesions in the corpus callosum and periventricular area.&nbsp; This patient is most likely to develop which of the following conditions?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s history of &gt;2 clinically distinct episodes of CNS dysfunction with resolution and hyperintense lesions on MRI is consistent with <strong>multiple sclerosis</strong> <a href=\"4934\">(MS)</a>.&nbsp; MS typically occurs in women age 15-50, is the most common autoimmune inflammatory demyelinating disease, and is characterized by a relapsing-remitting course of CNS dysfunction (eg, monocular blindness due to optic neuritis, motor and sensory loss/paresthesia below the level of the lesion, incontinence).&nbsp; Relapses of MS may be more common after stressful life events.</p><p><strong>Depression</strong> has been found in up to two-thirds of patients with MS and is the <strong>most common psychiatric complication</strong>.&nbsp; Depression can occur at any time and is likely caused by a combination of factors, including inflammatory changes in the brain, immune system changes, and psychological reactions to neurological deficits and the challenges of living with MS.&nbsp; Depression in MS is commonly underdiagnosed and undertreated.&nbsp; Appropriate treatment, including psychotherapy and antidepressants, can alleviate suffering and improve quality of life.</p><p><strong>(Choices A and G)</strong>&nbsp; Conversion disorder, or functional neurological symptom disorder, is characterized by neurological symptoms (eg, weakness, abnormal movements, nonepileptic seizures) that are inconsistent with a neurological disease.&nbsp; Somatic symptom disorder is characterized by excessive preoccupation with one or more unexplained somatic symptoms.&nbsp; This patient&#39;s symptoms are due to a known neurological disease.&nbsp; Patients with MS are not at increased risk of developing these disorders.</p><p><strong>(Choice B)</strong>&nbsp; Although cognitive impairment (eg, impaired attention, short-term memory, speed of information processing, executive function) is common in MS, frank dementia is not.&nbsp; Cognitive impairment in MS is exacerbated by untreated depression.</p><p><strong>(Choices D and E)</strong>&nbsp; Although patients with MS commonly experience anxiety related to their illness, they are not at increased risk of developing generalized anxiety or panic attacks.</p><p><strong>(Choice F)</strong>&nbsp; Psychosis may be a complication of high-dose glucocorticoids used to treat MS but is not a common complication of the disease itself.</p><p><strong>Educational objective:</strong><br>Multiple sclerosis is frequently associated with depression.&nbsp; Treatment, which includes psychotherapy and antidepressants, can alleviate suffering and improve quality of life.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24163,
            "topic": "Depressive disorder due to another medical condition",
            "titleId": 24163,
            "title": "Depressive disorder due to another medical condition",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Conversion disorder",
                    "choiceNumber": 1,
                    "correctTaken": 3242,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Dementia",
                    "choiceNumber": 2,
                    "correctTaken": 2662,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Depression",
                    "choiceNumber": 3,
                    "correctTaken": 8848,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Generalized anxiety disorder",
                    "choiceNumber": 4,
                    "correctTaken": 548,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Panic attacks",
                    "choiceNumber": 5,
                    "correctTaken": 140,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Psychosis",
                    "choiceNumber": 6,
                    "correctTaken": 639,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Somatic symptom disorder",
                    "choiceNumber": 7,
                    "correctTaken": 886,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "425,506,true,-1,1*508,569,true,-1,1*687,927,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25112509",
                    "mediaDataId": 0,
                    "title": "The link between multiple sclerosis and depression.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25112509",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "24501169",
                    "mediaDataId": 0,
                    "title": "Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/24501169",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 130,
            "othersAvgTimeSpent": 56,
            "notes": null,
            "peopleTaken": 16965,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 52,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 551,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 35,
            "questionId": 7723,
            "questionIndex": 7723,
            "questionText": "<p>A 72-year-old woman with breast cancer comes to the office for follow-up accompanied by her daughter.&nbsp; The patient has undergone surgery and completed chemotherapy over the last 7 months; she was informed at her appointment last month that her cancer was in remission.&nbsp; The daughter says that &#x22;despite the news of remission, Mother isn&#39;t any happier.&nbsp; She eats very little, does not sleep more than 2 or 3 hours at a time, and cries frequently.&nbsp; She also doesn&#39;t seem to enjoy visits from the family, reading, or watching her favorite television programs.&#x22;&nbsp; The patient says, &#x22;Wouldn&#39;t anyone who has been through this be depressed?&#x22;&nbsp; She reports that her energy is still low following chemotherapy but that she is not in any pain.&nbsp; She has stopped reading as she has difficulty concentrating and remembering.&nbsp; The patient has lost 4.5 kg (10 lb) since her appointment a month ago.&nbsp; She has no suicidal thoughts.&nbsp; There are no changes on physical examination, and her laboratory results remain stable.&nbsp; In addition to providing support, which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>This patient&#39;s history of depressed mood, anhedonia (inability to enjoy normally pleasurable activities), sleep difficulty, appetite disturbance, low energy, and impaired concentration meet the criteria for <strong>major depressive disorder</strong> (MDD).&nbsp; The SIGECAPS mnemonic can assist in recall of the <a href=\"4647\">core signs and symptoms of MDD</a>.&nbsp; Diagnosis requires &#8805;5 of 9 symptoms for at least 2 weeks; one of these symptoms must be anhedonia or depressed mood.</p><p>Although some depressive symptoms in <strong>cancer patients</strong> are common, the development of major depressive disorder <strong>should not be normalized</strong> and considered an &#x22;expected&#x22; reaction <strong>(Choice C)</strong>.&nbsp; <strong>Untreated depression</strong>&nbsp;in medically ill patients causes <strong>reduced quality of life</strong> and additional anguish for families, and can negatively impact treatment adherence and medical management.&nbsp; Treatment options include pharmacotherapy and/or psychotherapy.&nbsp; Antidepressants are indicated for cancer patients with major depression and are safe and effective in this setting.</p><p><strong>(Choices A, B, and G)</strong>&nbsp; Encouraging the patient to express her feelings to her family, increase interaction with her family, and/or engage with a cancer support group may be beneficial adjunctive strategies to address her depression but alone are not adequate.&nbsp; Support groups can be particularly important for cancer patients and family members who are distressed but are not a substitute for treating major depression.</p><p><strong>(Choices E and F)</strong>&nbsp; It is inappropriate to monitor the patient without intervention or reassure her that the symptoms will gradually improve now that she has completed chemotherapy.&nbsp; Although chemotherapy side effects can overlap with neurovegetative features of depression (eg, fatigue, insomnia, weight loss), this patient&#39;s nonsomatic symptoms of depression (eg, pervasive and persistent sadness, anhedonia, tearfulness) are concerning for major depression.</p><p><strong>Educational objective:</strong><br>Medically ill patients who develop comorbid depression can benefit from treatment with antidepressant medications and psychotherapy to improve their quality of life.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "4",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Encourage the patient to express her feelings to her family",
                    "choiceNumber": 1,
                    "correctTaken": 119,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Encourage the family to spend more time with the patient",
                    "choiceNumber": 2,
                    "correctTaken": 61,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Normalize the patient&#39;s depression as an expected reaction to a cancer diagnosis",
                    "choiceNumber": 3,
                    "correctTaken": 1087,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend antidepressant therapy and psychotherapy",
                    "choiceNumber": 4,
                    "correctTaken": 13093,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Monitor the patient for worsening depression at monthly visits",
                    "choiceNumber": 5,
                    "correctTaken": 296,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Provide reassurance that symptoms should improve now that chemotherapy has been completed",
                    "choiceNumber": 6,
                    "correctTaken": 125,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Recommend support groups for cancer survivors",
                    "choiceNumber": 7,
                    "correctTaken": 2027,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1626,1903,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26118318",
                    "mediaDataId": 0,
                    "title": "Efficacy and acceptability of antidepressants on the continuum of depressive experiences in patients with cancer: systematic review and meta-analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26118318",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 59,
            "othersAvgTimeSpent": 59,
            "notes": null,
            "peopleTaken": 16808,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 78,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 258,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 36,
            "questionId": 14434,
            "questionIndex": 15843,
            "questionText": "<p>A 24-year-old woman is brought to the emergency department by her boyfriend due to her behavior for the past week.&nbsp; The boyfriend states that she has been unusually reactive to situations, frequently becoming angry or upset.&nbsp; The patient abruptly quit her job as a congressional aide a few days ago, saying, &#x22;My boss was trying to sabotage me because she&#39;s jealous of my intellect.&nbsp; The job was beneath me anyway.&nbsp; The time has come for me to run for public office myself.&#x22;&nbsp; She has been organizing her campaign since quitting and calling potential donors at all hours of the day.&nbsp; The patient yells at her boyfriend for bringing her to the hospital; a few minutes later, she hugs him and tearfully says, &#x22;I can&#39;t imagine my life without you.&#x22;&nbsp; She rarely drinks alcohol and does not use recreational substances.&nbsp; The patient has no history of psychiatric or medical illness.&nbsp; On mental status examination, she is easily agitated and cannot be redirected, jumping from one topic to another.&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<div id=\"div_T34762\" style=\"overflow-x:auto;\" tid=\"2957\"><table class=\"table-default-style\"><tbody><tr><td colspan=\"2\"><p align=\"center\"><strong>Manic episode</strong></p></td></tr><tr><td><p align=\"center\"><strong>Clinical<br>features</strong></p></td><td><ul><li>&#8805;1 week of elevated or irritable mood &amp; increased energy/activity</li><li>&#8805;3 of the following symptoms (4 if mood is irritable only) (<strong>DIGFAST</strong> mnemonic):<ul style=\"list-style-type:circle;\"><li><strong>Distractibility</strong></li><li><strong>Impulsivity</strong>/indiscretion, risky behavior</li><li><strong>Grandiosity</strong></li><li><strong>Flight of ideas</strong>/racing thoughts</li><li>Increased <strong>activity</strong>/psychomotor agitation</li><li>Decreased need for <strong>sleep</strong></li><li><strong>Talkativeness</strong>/pressured speech</li></ul></li></ul></td></tr><tr><td><p align=\"center\"><strong>Severity</strong></p></td><td><ul><li>Impaired psychosocial function</li><li>May have psychotic features (hallucinations, delusions)</li><li>May require hospitalization</li></ul></td></tr></tbody></table></div><p>This patient&#39;s weeklong history of abrupt behavior change is characterized by the following:</p><ul><li>Irritable mood</li><li>Increased activity (calling political donors at all hours)</li><li>Impulsivity (quitting job)</li><li>Pressured speech (inability to be redirected)</li><li>Flight of ideas (jumping from one topic to another)</li></ul><p>These changes are consistent with a <strong>manic episode of bipolar I disorder</strong>.</p><p>In addition to marked mood symptoms, during a manic episode, patients may exhibit <strong>psychotic features</strong>, which must be differentiated from primary psychotic disorders.&nbsp; <strong>Delusions in mania</strong> often involve <strong>grandiose themes</strong> in which patients believe that they have special abilities or powers or are extraordinarily talented (eg, running for public office) or that others are jealous of them.&nbsp; In contrast to primary psychotic disorders, delusions in bipolar disorder are present only during the <strong>active mood episode</strong>.</p><p>The mood episode at the onset of bipolar disorder may be manic (as in this patient), hypomanic, depressed, or mixed.&nbsp; At least one manic episode is required to diagnose bipolar I disorder.&nbsp; A history of depressive episodes is not required for the diagnosis, although most patients experience both manic and depressive episodes over the course of their lifetimes.</p><p><strong>(Choices B and E)</strong>&nbsp; Labile moods (eg, rapid shifts from anger to tears), impulsivity, unstable relationships, and chronic irritability are common in borderline personality disorder.&nbsp; Grandiosity, desire for powerful positions, belief in one&#39;s specialness, and claims of other&#39;s jealousy are consistent with narcissistic personality disorder.&nbsp; However, personality disorders involve patterns of long-standing behaviors.&nbsp; This patient&#39;s symptoms are related to an active period of acute illness and represent a distinct change from baseline, findings more consistent with bipolar disorder.</p><p><strong>(Choice C)</strong>&nbsp; Brief psychotic disorder is characterized by psychotic symptoms (eg, delusions, hallucinations) for &gt;1 day and &#8804;1 month.&nbsp; However, brief psychotic disorder does not explain this patient&#39;s irritability, increased activity, impulsivity, pressured speech, and flight of ideas that are more consistent with bipolar mania.</p><p><strong>(Choice D)</strong>&nbsp; Delusional disorder involves one or more delusions lasting &#8805;1 months.&nbsp; However, functioning and behavior generally remain intact at baseline.&nbsp; The presence of delusions with a significant mood change makes bipolar mania more likely.</p><p><strong>Educational objective:</strong><br>Patients with &#8805;1 manic episodes are diagnosed with bipolar I disorder.&nbsp; Depressive episodes are not required for the diagnosis but are common.&nbsp; Manic episodes may include psychotic symptoms, often with grandiose themes.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17629,
            "topic": "Bipolar disorder",
            "titleId": 17629,
            "title": "Bipolar disorder",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "1",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Bipolar disorder",
                    "choiceNumber": 1,
                    "correctTaken": 3163,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Borderline personality disorder",
                    "choiceNumber": 2,
                    "correctTaken": 1086,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Brief psychotic disorder",
                    "choiceNumber": 3,
                    "correctTaken": 666,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Delusional disorder",
                    "choiceNumber": 4,
                    "correctTaken": 47,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Narcissistic personality disorder",
                    "choiceNumber": 5,
                    "correctTaken": 62,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "723,768,true,-1,1",
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "36177878",
                    "mediaDataId": 0,
                    "title": "Understanding the development of bipolar disorder and borderline personality disorder in young people: a meta-review of systematic reviews.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/36177878",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 99,
            "othersAvgTimeSpent": 73,
            "notes": null,
            "peopleTaken": 5024,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 1100,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 37,
            "questionId": 13708,
            "questionIndex": 15098,
            "questionText": "<p>A 27-year-old man comes to the office for postdischarge follow-up of a recent psychiatric hospitalization for a depressive episode with suicidal ideation.&nbsp; The patient&#39;s depressive episode remitted with intensive inpatient psychotherapy and the initiation of a new medication regimen 1 month ago.&nbsp; The patient has been home for a week and is feeling well.&nbsp; He has a history of migraine headaches, bipolar disorder, and tobacco use disorder.&nbsp; Family history is significant for major depressive disorder in his father.&nbsp; Temperature is 37.5 C (99.5 F), blood pressure is 110/75 mm Hg, pulse is 72/min, and respirations are 14/min.&nbsp; Examination is significant for a maculopapular rash over the patient&#39;s left scapula.&nbsp; The patient is unaware of the rash, and discharge paperwork from the previous week does not document any rash.&nbsp; Which of the following medications is the most likely cause of this patient&#39;s condition?</p>",
            "questionHeader": "",
            "explanationText": "<p>The anticonvulsant <strong>lamotrigine</strong> is used as a <strong>mood stabilizer</strong> in <strong>bipolar disorder</strong> and is often used specifically to target <strong>bipolar depression</strong>.&nbsp; One of the most significant side effects of lamotrigine is a <strong>drug rash</strong>, a mild form of which occurs in up to 10% of those treated.&nbsp; The more severe mucocutaneous rashes of <strong>Stevens-Johnson syndrome</strong> (&lt;10% body surface area skin detachment) and toxic epidermal necrolysis (&gt;30% detachment) occur at a rate of 0.1% (10%-30% detachment is known as Stevens-Johnson syndrome/toxic epidermal necrolysis overlap).</p><p>Because of the challenge of predicting the eventual severity of lamotrigine-induced rash at the outset, lamotrigine should be <strong>discontinued</strong> at the <strong>first sign of rash</strong> and substituted with another agent.&nbsp; Most cases of lamotrigine-induced rash develop within the first 2 months of therapy.&nbsp; Risk of rash is greater in children and appears to be higher when coprescribed with valproate or when the dose is increased rapidly.</p><p><strong>(Choices A and G)</strong>&nbsp; Antidepressants such as the selective serotonin reuptake inhibitors escitalopram and sertraline should be used with caution in bipolar depression, given the limited evidence of benefit and the risk of mood-switching from depression to mania.&nbsp; Neither escitalopram nor sertraline is associated with a significant risk of rash.</p><p><strong>(Choices B, D, E, and F)</strong>&nbsp; Haloperidol, lurasidone, olanzapine, and quetiapine are all antipsychotic medications that may be used in the treatment of bipolar disorder; however, none are associated with a clinically significant risk of rash.</p><p><strong>Educational objective:</strong><br>A mild rash may develop in up to 10% of those treated with lamotrigine, whereas life-threatening Stevens-Johnson syndrome or toxic epidermal necrolysis may occur in 0.1%.&nbsp; Any occurrence of rash during the treatment of lamotrigine requires immediate discontinuation of the drug.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 17629,
            "topic": "Bipolar disorder",
            "titleId": 17629,
            "title": "Bipolar disorder",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Escitalopram",
                    "choiceNumber": 1,
                    "correctTaken": 866,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Haloperidol",
                    "choiceNumber": 2,
                    "correctTaken": 333,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lamotrigine",
                    "choiceNumber": 3,
                    "correctTaken": 14501,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Lurasidone",
                    "choiceNumber": 4,
                    "correctTaken": 659,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Olanzapine",
                    "choiceNumber": 5,
                    "correctTaken": 853,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Quetiapine",
                    "choiceNumber": 6,
                    "correctTaken": 851,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Sertraline",
                    "choiceNumber": 7,
                    "correctTaken": 970,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "25645637",
                    "mediaDataId": 0,
                    "title": "Risk of a lamotrigine-related skin rash:  current meta-analysis and postmarketing cohort analysis.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/25645637",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "26084665",
                    "mediaDataId": 0,
                    "title": "Management of adverse effects of mood stabilizers.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/26084665",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 101,
            "othersAvgTimeSpent": 61,
            "notes": null,
            "peopleTaken": 19033,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 76,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 38,
            "questionId": 11375,
            "questionIndex": 12530,
            "questionText": "<p>A 68-year-old man comes to the office due to headaches and unexplained weight loss.&nbsp; The patient says, &#x22;Something is definitely wrong with my brain.&#x22;&nbsp; Over the past month, he has become convinced that he has brain cancer despite reassurance by another physician that his laboratory and brain MRI results are normal.&nbsp; The patient reports low energy and little appetite for the last 3 months.&nbsp; He stopped cooking when his wife died 6 months ago and has lost 9 kg (19.8 lb).&nbsp; The patient also quit his volunteer job due to headaches and an inability to concentrate, explaining, &#x22;I no longer enjoy the work anyway.&#x22;&nbsp; Medical history includes hypertension and osteoarthritis.&nbsp; Physical and neurologic examinations are unremarkable.&nbsp; On mental status examination, the patient moves and speaks slowly with frequent pauses.&nbsp; He says, &#x22;Cancer is my punishment for sins I committed as a young child.&#x22;&nbsp; He denies suicidal ideation but says, &#x22;It doesn&#39;t matter because I am dying of cancer anyway.&#x22;&nbsp; Which of the following is the most likely diagnosis in this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p>In the absence of underlying medical illness, this patient&#39;s weight loss, low energy, impaired concentration, loss of interest, guilt, and psychomotor retardation are most likely due to major depression.&nbsp; His conviction that he has brain cancer despite normal test results and that cancer is punishment for sins he committed as a child represents a delusion that specifies the subtype as <strong>major depressive disorder with psychotic features</strong>.&nbsp; In this severe subtype of unipolar major depression, the depressive episode is accompanied by <strong>delusions and/or hallucinations</strong>, typically with <strong>depressive themes</strong> (eg, deserving punishment, worthlessness, nihilism).</p><p>Identification of psychotic features is important because treatment for psychotic depression is different than that for nonpsychotic depression.&nbsp; First-line treatment of major depressive disorder with psychotic features is combination pharmacotherapy with an <strong>antidepressant and antipsychotic</strong> or with <strong>electroconvulsive therapy</strong>.</p><p><strong>(Choice A)</strong>&nbsp; In delusional disorder, mood symptoms, if present, are brief and not a prominent part of the illness.&nbsp; They would not explain this patient&#39;s severe depressive symptoms.</p><p><strong>(Choices B and E)</strong>&nbsp; Patients with illness anxiety disorder are excessively concerned about having a serious, undiagnosed general medical condition.&nbsp; Somatic symptom disorder is characterized by excessive anxiety and thoughts about the seriousness of at least 1 somatic symptom.&nbsp; Neither diagnosis explains this patient&#39;s severe depression, associated somatic delusions, and delusions of guilt.</p><p><strong>(Choice D)</strong>&nbsp; Although this patient&#39;s depression may have been triggered by his wife&#39;s death, his symptoms are severe and meet the criteria for major depressive disorder.&nbsp; Patients with persistent complex bereavement disorder (also referred to as complicated grief) commonly have depressive symptoms, but their sadness centers on the loss of a loved one and is characterized by intense yearning for the deceased.&nbsp; It would not explain this patient&#39;s pervasive depression and delusions.</p><p><strong>Educational objective:</strong><br>Major depressive disorder with psychotic features is a severe subtype of unipolar major depression.&nbsp; It is characterized by an episode of major depression accompanied by delusions and/or hallucinations, typically with depressive themes.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "3",
            "userAnswer": "3",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Delusional disorder, somatic type",
                    "choiceNumber": 1,
                    "correctTaken": 2090,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Illness anxiety disorder",
                    "choiceNumber": 2,
                    "correctTaken": 1424,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Major depressive disorder with psychotic features",
                    "choiceNumber": 3,
                    "correctTaken": 10712,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Persistent complex bereavement disorder",
                    "choiceNumber": 4,
                    "correctTaken": 1575,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Somatic symptom disorder",
                    "choiceNumber": 5,
                    "correctTaken": 1123,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": null,
            "isCorrect": true,
            "isIncorrect": false,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "30677267",
                    "mediaDataId": 0,
                    "title": "Psychotic features in patients with major depressive disorder: a report from the European Group for the Study of Resistant Depression.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/30677267",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23599251",
                    "mediaDataId": 0,
                    "title": "Challenges in the treatment of major depressive disorder with psychotic features.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23599251",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 132,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 16927,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 63,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 0,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 0,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        },
        {
            "exhibits": null,
            "sequenceId": 39,
            "questionId": 2360,
            "questionIndex": 2360,
            "questionText": "<p>A 43-year-old woman presents to the emergency department complaining of feeling &#x22;horrible.&#x22;&nbsp; She has not been sleeping through the night, has been losing weight, and has crying fits throughout the day.&nbsp; These symptoms began about 3 months ago when she discovered that her husband was having an affair.&nbsp; She feels betrayed and foolish for having failed to recognize it sooner.&nbsp; She states that she has been doubting her abilities as a wife and mother.&nbsp; She has also stopped participating in her weekly book club and has not returned phone calls from friends and family recently, preferring to keep to herself instead.&nbsp; She says she &#x22;just can&#39;t take the embarrassment&#x22; and has been having frequent thoughts of suicide.&nbsp; The patient has been drinking 2-3 glasses of wine to help her fall asleep at night and using marijuana several times a month.&nbsp; She has no psychiatric history.&nbsp; Physical examination is unremarkable.&nbsp; Which of the following is the most appropriate next step in management of this patient?</p>",
            "questionHeader": "",
            "explanationText": "<p><div id=\"div_t32384\"><table class=\"table-default-style\"><tbody><tr><td><p align=\"center\"><strong>Suicide assessment: ideation, intent &amp; plan</strong></p></td></tr><tr><td><p>Evaluate <strong>ideation</strong></p><ul><li>Wish to die, not wake up (passive)</li><li>Thoughts of killing self (active)</li><li>Frequency, duration, intensity, controllability</li></ul><p>Evaluate <strong>intent</strong>&nbsp;</p><ul><li>Strength of intent to attempt suicide; ability to control impulsivity</li><li>Determine how close patient has come to acting on a plan (rehearsal, aborted attempts)</li></ul><p>Evaluate <strong>plan</strong></p><ul><li>Specific details: method, time, place, access to means (eg, weapons, pills), preparations<br />(eg,&nbsp;gathering pills, changing will)</li><li>Lethality of method</li><li>Likelihood of rescue</li></ul></td></tr></tbody></table></div></p><p><strong>All patients</strong> presenting with <strong>depression</strong> should be carefully <strong>screened for suicidal risk</strong>, as this screen is critical in determining the appropriate treatment setting and frequency of follow-up care (Table).&nbsp; This patient is having suicidal thoughts, but their content and intensity are unclear and there is no indication of whether she has a plan or <strong>intent</strong> to act on a <strong>plan</strong>.&nbsp; Before a treatment plan and setting is decided, it is essential to assess whether she is considering acting on a specific suicide plan.</p><p>Hospitalization to maintain safety is indicated for patients with active suicidal ideation that includes a plan and intent to act <strong>(Choice A)</strong>.&nbsp; Patients with suicidal ideation but no specific plan or intent need intensive outpatient treatment, but not necessarily hospitalization (eg, treat the underlying disorder with medication and/or psychotherapy, increase the frequency of clinical contact, mobilize supports).</p><p><strong>(Choice B)</strong>&nbsp; Ruling out medical conditions (eg, hypothyroidism, vitamin deficiencies) is common practice in patients with a new episode of depression.&nbsp; However, this patient&#39;s clear history of a stressor, lack of medical symptoms, and normal physical examination make a medical cause unlikely.&nbsp; Furthermore, suicidality is a psychiatric emergency, and a risk assessment is the most immediate concern at this point.&nbsp; Laboratory tests would not change immediate management.</p><p><strong>(Choice C)</strong>&nbsp; Assessing for drug use is important as many substances can cause or make depression worse.&nbsp; This woman is likely using alcohol and marijuana to manage her depressive symptoms and should be counseled against this.&nbsp; However, obtaining a urine drug screen would not affect immediate management.</p><p><strong>(Choices E, F, and G)</strong>&nbsp; These treatment recommendations may be appropriate, but suicide assessment and determination of the appropriate treatment setting take precedence.&nbsp; The selective serotonin reuptake inhibitor sertraline is a first-line antidepressant.&nbsp; Individual psychotherapy is useful in the treatment of mild to moderate depression with or without medications.&nbsp; Couples counseling may be considered after the patient is stabilized.</p><p><strong>Educational objective:</strong><br>All depressed patients should be screened for suicidal ideation, intent, and plan.&nbsp; Actively suicidal patients with intent and plan will often need to be hospitalized for stabilization and to maintain their safety.</p>",
            "abstractId": 0,
            "qbankId": 2,
            "sectionId": 1010,
            "section": "Step 2 Review",
            "subjectId": 105,
            "subject": "Psychiatry",
            "secondarySubjectId": 0,
            "secondarySubject": null,
            "systemId": 218,
            "system": "Psychiatric/Behavioral & Substance Use Disorder",
            "topicId": 24312,
            "topic": "Depression",
            "titleId": 24312,
            "title": "Depression",
            "topicAttributeId": 330626,
            "topicAttribute": "Mood disorders",
            "correctAnswer": "4",
            "userAnswer": "1",
            "parentQuestionId": 0,
            "subParentQuestionId": 0,
            "questionSetSequenceId": 0,
            "questionSetCount": 0,
            "questionToAnswerBeforeThis": 0,
            "answerChoiceList": [
                {
                    "questionId": 0,
                    "choice": "Arrange for psychiatric hospitalization",
                    "choiceNumber": 1,
                    "correctTaken": 5900,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain routine laboratory tests to rule out medical causes of depression",
                    "choiceNumber": 2,
                    "correctTaken": 381,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Obtain urine toxicology to rule out substance-induced depressive disorder",
                    "choiceNumber": 3,
                    "correctTaken": 336,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Perform a suicide risk assessment",
                    "choiceNumber": 4,
                    "correctTaken": 33252,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Prescribe sertraline and schedule follow-up in 2 weeks",
                    "choiceNumber": 5,
                    "correctTaken": 574,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Refer for couples counseling",
                    "choiceNumber": 6,
                    "correctTaken": 47,
                    "questionIndex": 0
                },
                {
                    "questionId": 0,
                    "choice": "Refer for individual psychotherapy",
                    "choiceNumber": 7,
                    "correctTaken": 344,
                    "questionIndex": 0
                }
            ],
            "formatTypeId": 1,
            "questionTypeId": 1,
            "highlights": "1077,1492,true,-1,1",
            "isCorrect": false,
            "isIncorrect": true,
            "isMarked": false,
            "isOmitted": false,
            "isQuestionDirty": false,
            "isAnswerChoiceDisabled": false,
            "isQuestionDisabled": false,
            "questionMappingReferencesList": [
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "23040403",
                    "mediaDataId": 0,
                    "title": "Literature-based recommendations for suicide assessment in the emergency department: a review.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/23040403",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                },
                {
                    "questionIndex": 0,
                    "contentId": 0,
                    "contentTypeId": 0,
                    "referenceId": "16816784",
                    "mediaDataId": 0,
                    "title": "Application of the APA practice guidelines on suicide to clinical practice.",
                    "referenceTypeId": 1,
                    "referenceLink": "http://www.ncbi.nlm.nih.gov/pubmed/16816784",
                    "superDivisionId": 0,
                    "subDivisionId": 0,
                    "level3DivisionId": 0,
                    "level4DivisionId": 0
                }
            ],
            "questionMedia": null,
            "timeSpent": 83,
            "othersAvgTimeSpent": 58,
            "notes": null,
            "peopleTaken": 40834,
            "hotspotImageUrl": null,
            "lastUpdatedDate": "01/01/2025",
            "correctPercentile": 81,
            "isSubmitted": false,
            "isActive": true,
            "activeStatusId": 1,
            "hint": null,
            "allowCalculator": false,
            "difficultyLevelId": null,
            "additionalText": null,
            "mobileExcerpt": null,
            "passageExcerpt": null,
            "confSurveyValue": 0,
            "timePerQuestionInMilliSec": 90000,
            "answerHeader": null,
            "standards": null,
            "totalTimeSpentReview": 680,
            "dailyTimeSpentReview": 0,
            "dailyTimeSpent": 0,
            "isHintUsed": null,
            "examYear": 2024,
            "newExamYearQuestionIndex": 0,
            "vocabularyList": null,
            "copyrightId": null,
            "copyrightText": null,
            "frequentHighlights": null,
            "totalWeight": 0,
            "weightScored": null,
            "maxAnswerSelection": 0,
            "scoreTypeId": null,
            "passingScore": 1,
            "questionSourceId": 1,
            "customSequenceId": null,
            "annotations": null,
            "competencyId": null,
            "scoringGuide": null,
            "skillId": null,
            "passageTypeId": null,
            "passageType": null,
            "skill": null,
            "gradeDetails": null
        }
    ],
    "abstractList": null,
    "deckList": [
        {
            "deckId": 9788456,
            "deckName": "Notes",
            "deckColor": "#36c8a3",
            "isDefault": true,
            "dateCreated": "01/01/0001 12:00:00 AM",
            "noOfFlashCards": 4,
            "groupId": null,
            "studySettingsId": null,
            "lastStudyDate": null,
            "isCustomStudyDeck": false,
            "parentDeckId": null,
            "customStudySettings": null,
            "subscriptionId": 0
        }
    ],
    "newExamYearQuestionList": null,
    "flashCardList": null,
    "questionModes": [
        {
            "id": 1,
            "name": "UNUSED"
        }
    ],
    "subscriptionElapsedTime": 0.0,
    "isFacultyControlled": null,
    "endCATTest": null,
    "questionSourceIds": null
}